The role ofthe transcription factor GATA-6 in mouse embryonic development by Koutsourakis, M. (Manousos)
The role ofthe transcription factor GATA-6 in mouse 
embryonic development 
(De rol van de transcriptie factor GATA-6 tijdens de embryonale 
ontwikkeling van de muis) 
Proefschrift 
ter verkrijging van de graad van doctor 
aan de Erasmus Universiteit Rotterdam 
op gezag van de 
Rector Magnificus 
Prof. Dr. Ir. J. van Bemmel 
en volgens besluit van het College voor Promoties 
De openbare verdediging zal plaatsvinden op 
woensdag 25 april 2001 om 09:45 uur 
door 
Manousos Koutsourakis 




Prof. dr. F. G. Grosveld 
Prof. dr. E. Dzierzak 
Dr. J. M. J. Philipsen 
Dr. Ir. D. N. Meijer 
Dit proefschrift kwam tot stand binnen de vakgroep Celbiologie en Genetica 
van de faculteit Geneeskunde en Gezondbeidswetenschappen van de Erasmus 
Universiteit Rotterdam. De vakgroep maakt deel uit van het Medisch Genetisch 
Centrum Zuid-WestNederland. 
Het onderzoek van dit proefschrift is finandiee1 ondersteunt door de 
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) en de 
European Community. 
Ia pyelr; UTOV 7C7Jya'l"j y,a VJv [MK1/, 
va e15)(G<JaI vaval paKpVr; 0 opopor;, 
yepU:ror; 1I:epl1l:rner;, yepaTor; yvWUelr;. 
Tovr; AalUTpvyovar; KaI TOVr; KVKAw1l:ar;, 
TOV Ovpmptvo IIOUelOwva P'l ffJOpaual, 
Thow UTOV opopo uov 1I:0n uov oev Oa ppelr;, 
av pev' 'l UK"'Jflr; uov VIfl1lAij, av eKJ.eKTij 
uvyKivqlJlr; TO 1/:Ve15pa KaI TO irwpa uov arril;eL 
Tovr; AalUTpvyovar; KaI TOVr; KVKAw1l:ar;, 
TOV ayplO IIOUelOwva oev Oa uvvavrijuezr;, 
av oev TOVr; Kovpaveir; per; UVJv IfIVXJi uov, 
av 'l IfIVXJi uov oev TOVr; lJ'CijVel ep1l:pOr; uov. 
Na e15XeUaI vavaI paKpVr; 0 opopor;. 
IIoV.a La KuJ..OKaIplVa 1!pwta va elval 
1I:0V pe n GVxapiUVJlJl, pe n xapa 
Oa p1l:aiVelr; Ue }.Jptvar; 1I:pmTOelomptvOVr; 
va (i'{ap.anjuezc; (1' ep,1Copeia tPOlvlKIKa, 
KaI Ter; KaJLr; 1I:paypaner; v' a7rOKTijUelr;, 
uevnffJw KaI Kop<iJJ.Ja, Kex/llp7rapW K' epevovr;, 
KaI 'l00VIKa pvpmolKa KaOe }.orijr;, 
ouo p1l:0peir; 11:10 affJOova 'l00vlKa pvpmolKa 
Ue 1I:O}.elr; AzrV1rTlaKer; va 1I:ar;, 
va paOelr; Kal va paOelr; a7r' TOVr; lJ1rovoauptvovr;. 
IIavra UTOV vov uov vaXelr; VJv [06.K1J. 
To ffJOalJlPOV eKei elV' 0 1I:POOp'UpOr; uov. 
AMa P'l plal;ezr; TO Ta~eiol OIOAOV. 
KaMfTepa xpOVW 1I:0V.a va OWpKeUel 
KaI yepor; ma v' apa~elr; UTO v'lui, 
1I:}.OVlJlOr; pe oua KepOIUer; UTOV opopo, 
P'l 1I:POUOOKwvrar; 7U.OVVJ va Ue OWUel'l [06.K1J. 
H [OaK1/ u' tomUe T' mpaio Ta~eiOI. 
Xmpir; avTijv oev OapyalVer; UTOV Opopo. 
]V..la oev exel va Ue OWUel ma. 
KI av 1I:TmM VJv PPelr;, 'l [06.K1J oev Ue yuaUe. 
'ETlJl UOffJOr; 1I:0V iyIVer;, pe TOU1f 1I:eipa, 
ijo'l Oa TO KaTw.aper; 01 [OaKer; n U1fpaivovv. 
«[€JAKH» 
KmvUTaVTivor; KapaffJ'lr; (1863-1933) 

As you set outfor Ithaka 
Hope U,e voyage is a long one, 
Full of adventure,full of discovery. 
Laistrygonians and Cyclops, 
Angry Poseidon-don't be afraid of them: 
you'll never fmd things like that on your way 
as long as you keep your thoughts raised high, 
as long as a rare excitement 
stirs your spirit and your body. 
Laistrygonians and Cyclops, 
wild Poseidon-you won't encounter them 
unless you bring them along inside your soul, 
unless your soul sets them up in front of you. 
Hope the voyage is a long one.. 
May there be many a summer morning when, 
wid, what pLeasure, what joy, 
you come into harbors seen for the first time; 
may you stop at Phoenician trading stations 
to buy fine things, 
mother of pearl and coral, amber and ebony, 
sensual petfume of every kind-
as many sensual perfumes as you can; 
and may you visit many Egyptian cities 
to gather stores of knowledge from their scholars. 
Keep IU.aka always in your mind. 
Arriving there is what you aTe destined/oT. 
But do not hurry the journey at alL 
Better if it lasts for years, 
So you are old by the time you reach the island, 
wealthy with all you have gained on the way, 
not expecting [thaka to make you rich. 
Ithaka gave you the marveLous journey. 
Without her you would not have set out 
She has nothing left to give you now. 
And ifyoufmd her poor, Ithaka won't havefooledyou. 
Wise as you will have become, so full of experience, 
you will have understood by then what these Ithakas mean. 
"ITHAKA" 
Constantinos Cavafy (1863-1933) 
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Aim and outline ofthis Thesis 
Different members of the GAT A family of transcription factors have 
been studied extensively in our lab. The role of GAT A-I in the differentiation 
of erythroid blood cells and ofGATA-3 during T-lymphocyte development are 
two typical examples. GATA-6 is the most recently characterized member of 
the family. Based on its expression pattern during mouse embryonic 
developmentfor a role for GATA-6 in cardiogenesis had been speculated. 
To investigate what role GATA-6 may play during embryogenesis we 
used targeted inactivation of the gene in Embryonic Stem (ES) cells (chapter 
2). Unexpectedly, homozygote mutant embryos die just after implantation at 
embryonic day 5.5. Generation of chimeric embryos in which the GATA-6 
mutant cell population was confmed in either the embryo or to the 
extraembryonic tissues revealed that the primary defect in GATA-6 null 
embryos lies in an extraembryonic cell lineage. Further in vivo and in vitro 
analysis of the mutant embryos suggested that the affected lineage is the 
visceral yolk sac endoderm, a derivative of the primitive endoderm. 
Cardiogenesis could not be directly studied since mutant embryos die 
well before heart development starts (embryonic day 8.5). However, in 
chimeric embryos, GATA-6 -/- ES cells give rise to cardiomyocytes in 
apparently normal hearts, possibly due to redundant functions with the co-
expressed GATA-4 and -5. In contrast, GATA-6 is the only member of the 
family that is expressed in the lung endoderm. Following on a published 
observation showing no contribution of GATA-6 null ES cells to the lung 
epithelium, we decided to generate more highly chimeric embryos to analyze 
the development of the lung, which is a derivative of another endoderm 
lineage, the definitive endoderm (chapter 3). Surprisingly, we found that lung 
endoderm can be formed from GATA-6 mutant cells. However, this mutant 
endoderm has subsequent morphogenetic and differentiation defects. 
The importance of GATA-6 protein levels during lung development 
was confirmed by a different approach. The gene was overexpressed in 
transgenic mice with a pulmonary epithelium specific promoter (chapter 4). 
High levels of the protein resulted in branching defects and more interestingly 
in a block oflung endoderm differentiation to distal alveolar epithelium. 
Chapter 1 is a general introduction. Since we have found that GATA-
6 has unique functions in both primitive and definitive endoderm, the 
endoderm lineages are introduced first. Their origin, development and current 
knowledge of their molecular control is presented. Then, the function of GATA 





THE ENDODERM IN THE MOUSE EMBRYO 
During development of the mouse embryo, endoderm characterizes two 
cell lineages with distinct origin and developmental fate. First, just before 
implantation, the primitive endoderm is formed. This is considered to be an 
extraembryonic lineage since it contributes to the membranes surrounding the 
developing embryo. Following gastrulation, the definitive endoderm is established 
as one of the three embryonic germ layers that give rise to all embryonic tissues. 
The endoderm layer forms the gut tube that further differentiates to generate a 
number of thoracic and abdominal organs. 
Primitive Endoderm 
Origin 
Primitive endoderm is first evident at embryonic day 4.5 (E4.5) when the 
hatched elongated blastocyst is about to implant. It is formed as an epithelial layer 
of cells on the free surface of the inner cell mass (ICM) facing the blastocoelic 
cavity and the distal mural trophectoderm (Figure IA) [I]. Subsequent to this 
differentiation event, the remaining population of cells in the ICM is referred to as 
the primitive ectoderm or epiblast. It is not quite clear how this endodermal cell 
layer arises, but transmission electron microscopy illustrated that cytological 
evidence for primitive endoderm differentiation is correlated with reorientation and 
loosening of the inner cell mass [2]. The differentiated character of primitive 
endoderm was demonstrated by cell lineage tracing studies in chimeric embryos, 
which showed that primitive endoderm cells do not colonize any other embryonic 
tissue except the primitive endoderm [3]. Likewise, primitive ectoderm cells 
colonize different parts of the embryo but not the primitive endoderm [4]. 
Following the demarcation of this lineage, further differentiation results in 
the formation of the two derivatives of the primitive endoderm, the parietal and the 
visceral endoderm. Originally, based on in vitro experiments, it was thought that 
there is a consecutive differentiation first to parietal and then to visceral endoderm 
[5]. However, cell tracing studies did not support this hypothesis and they actually 
revealed that primitive endoderm consists ofbipotential precursor cells [3, 6]. 
Parietal endoderm; Reichert's membrane 
From the primitive endoderm layer, a number of cells start to dissociate 
and migrate onto the inner surface of the trophectoderm (TE) (Figure lA). This 
detachment is thought to be the primary force for their further differentiation that 
will define them as the parietal endoderm (PE) lineage, a population of specialized 
cells synthesizing a thick basement membrane known as Reichert's membrane [2] 
(Figure 1 B). Initially, there is already a basement membrane secreted by the TE 
itself, which fosters adhesion and migration of the developing PE [7]. The 
Reichert's membrane acts as a filtrative layer between the conceptus and the 
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mother and during development there is a continuous recruitment of cells onto the 
membrane by migration of individual parietal endoderm cells from the margins of 
the epithelial layer bordering the visceral endoderm [8]. 
The process of PE differentiation can be mimicked in vitro by using F9 
embryonal carcinome cells (EC) and from such experiments it was revealed that 
trophectoderm can actually induce PE [9] and that both extracellular matrix and 
molecules like parathyroid hormone-related peptide and TGF-j3 regulate this 
differentiation [1 0-12].In vivo, differentiation ofPE is defined by the expression of 
a set of molecular markers, including the extracellular matrix component laminin 
(LN) [13], the secreted protein acidic and rich in cysteine (SPARC) [14] and the 
intermediate filament vimentin [8]. These markers distinguish PE cells from other 
primitive or visceral endoderm cells. 
Visceral endoderm 
The primitive endoderm cells that remain in contact with the epiblast 
form a continuous, simple epithelium specialized for secretion and absorption, 
known as the visceral endoderm (VE) or visceral yolk sac endoderm [2] (Figure 
lB). The constant contact of the primitive endoderm cells with the epiblast is 
believed to be necessary for the further differentiation of the VE lineage [15]. This 
view is supported by emerging molecular data from in vitro studies implicating 
BMP and Hedgehog signaling. BMP-4 is expressed in the core of the epiblast (or 
embryoid body in in vitro experiments) and the newly differentiated primitive 
endoderm surrounding the epiblast expresses BMP-2 and Indian Hedgehog. The 
latter two signals are transduced to the core of the epiblast and newly induced, as 
yet unknown molecules, together with BMP-4 act on the primitive endoderm to 
promote VE differentiation. In the absence of these signals, PE is formed instead 
[16, 17]. The exact molecular cascade in this interaction is far from clear but the 
important role of members of the TGF-j3 family, such as BMPs, is further 
supported by the mutant phenotype of downstream transducers of this pathway. 
ActRIA, a Type I receptor of TGF-j3 ligands, and the downstream transducer 
Smad4 are both required for differentiation and further function of the VE [18, 19]. 
In addition, other molecules, like GATA-4 [20-22], GATA-6 (chapter 2) [23], 
hepatocyte nuclear factor-4 (HNF-4) [24] and variant hepatocyte nuclear factor-l 
(vHNF-I) [25,26] were shown to be important regulators ofVE differentiation by 
loss of function studies in the mouse. 
Once the VE is formed, it has an influence on the further development of 
the underlying epiblast. Such effect is first evident in the formation of the 
proamniotic cavity just after implantation (Figure I C). The process involved is 
known as cavitation and results in the organization of the compact epithelial mass 
of the epiblast into a pseudostratified columnar epithelium that by day 6.0 lines a 
cavity formed in the core of the epiblast. Cavitation starts near the periphery of the 
epiblast (embryoid body) and proceeds inward. In vitro studies suggest that it is the 
result of the interaction of two signals. One signal depends on the presence of the 
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Figure 1. Schematic representation of mouse development from implantation (E4.5) up to gastrulation (E6.5). (A) At the time of implantation, 
the embryo is composed of three distinct tissue lineages: trophectoderm (TE), primitive endodenn and epiblast (or inner cell mass, ICM). (B) 
The primitive endoderm subsequently differentiates into parietal (PE) and visceral endodenn (VE). Visceral endoderm surrounds the epiblast 
and it subsequently fonns the yolk sac, while parietal endodenn forms the Reichert's membrane that is the outer most membrane surrounding 
the embryo. (C) Before gastmlation, anterior visceral endodenn (AVE) is a molecularly distinct patt of the visceral endoderm that marks the 
anterior site of the embryo. (D) At gastrulation, the primitive streak (PS) is formed at the posterior site of the embryo, through which epiblast 
cells migrate and form either the mesoderm or the defmitive endodenn. The latter emerges from the anterior-most primitive streak. In C and D 
the parietal endodenn of the Reichert's membrane is not shown. The figure is adapted from Hogan e/ 01. [I]. 
outer endodermal layer and causes the death of the inner ectodermal cells, and 
another promotes survival of the single layer of columnar epithelial cells lining the 
cavity [27]. In a more recent study it was shown that BMP signaling is involved in 
this process and specifically, BMP-2 from the VE, alone or with BMP-4 from the 
epiblast, promotes apoptosis of the inner cells and differentiation of the outer layer 
of columnar cells [16]. Since inactivation of individual BMPs has not resulted in a 
cavitation-specific defect, BMP-2 and -4 are considered as functionally redundant 
in this model [28, 29]. 
Studies of different targeted mutations in the mouse have shown that the 
function of a number of genes that are expressed in the visceral endoderm is crucial 
for the further survival and development of the underlining epiblast. Two members 
of the hepatocyte nuclear factor (HNF) family of transcription factors represent a 
well-studied example. HNF-4 is expressed exclusively in the VE before 
gastrulation and when inactivated, the maturation of VE as a tissue is affected and 
the epiblast undergoes apoptosis. Although primitive streak and mesoderm are 
initially formed, embryonic structures are severely affected and the embryo dies 
[24, 30]. Targeted mutation of HNF-3, also expressed in VE, results in 
abnormally formed derivatives of the primitive streak, like the node and the 
notochord [31]. A chimeric study, confining the HNF-3 mutation exclusively to 
the VE or to the epiblast, demonstrated that the gene function is required in the VE 
for the proper morphogenesis of the primitive streak [32]. Similar effects have been 
described for other genes, like the homeobox even-skipped evxl [33] and msd [34] 
genes, establishing a crucial role of the VE in the normal progression of 
gastrulation. 
The influence of the VE on derivatives of the epiblast, has also been well 
documented. The first example came from the in vitro study of erythropoiesis and 
vasculogenesis in GATA-4 mutant embryoid bodies, which lack visceral yolk sac 
endoderm [22]. Although, primitive erythrocytes and endothelial cells were 
differentiated, the absence of VE resulted in the lack of organized yolk sac blood 
islands and vascular channels [35]. A subsequent study using an explant culture 
system demonstrated that VE is necessary for specifying posterior fate in the 
mesoderm, such as the formation of haemotopoietic and endothelial cell 
progenitors. During normal development, the extraembryonic mesoderm that 
migrates beneath the VE in the exocoelomic cavity differentiates and forms blood 
islands and a mesothelial layer. In the absence ofVE this differentiation is blocked. 
Furthermore, when epiblast cells that are destined to form anterior structures are 
exposed to the same part of the VE, they are respecified to form blood and 
endothelial cells [36]. Such an instructive role of the VE in a specific derivative of 
the epiblast is not a sole case. Anterior neural patterning has been attributed to gene 
function in the VE and nodal, a member of the TGF-/3 family, is an example ofVE 
influence on the development of rostral neural structures [37]. HNF-3 mutants 
also have impaired anterior patterning [31]. Additionally, and more interestingly, a 
part of the VE which is called anterior visceral endoderm (AVE) marks the anterior 
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site of the embryo before gastrulation begins and it has been shown to be crucial 
for anterior neural patterning [38]. 
AVE (anterior visceral endoderm) 
A VB is a medial strip of visceral endoderm that underlies approximately 
the anterior third of the embryo at a stage when no primitive streak has formed 
(E6.0, Figure lC). The identification of this anterior center came as a contradiction 
to the widely accepted idea that the formation of the primitive streak at the 
beginning of gastrulation (E6.5) marks the posterior side of the embryo and 
therefore establishes the anterior-posterior (A-P) axis of the conceptus [39]. In the 
mouse, AVE is not morphologically different from the rest of the VB. However, it 
is distinct in the rabbit embryo A VB where it is more columnar in character than 
the rest of the VE [40]. Cell lineage studies showed that the origin of the A VB is a 
handful of endoderm cells situated at the distal tip of the E5.5 embryo [41]. These 
cells then migrate to one side, opposite to where the primitive streak will be 
formed, and they give rise to the stripe of the VB that marks the anterior side of the 
embryo. Although this anisotropic cell movement has not been explained so far, it 
is well-documented from the expression pattern of a number of genes that mark 
this tissue, like the homeobox gene Hex [41]. Furthermore, in embryos mutant for 
Otx-2, which is also expressed in AVE, there is a failure of such migration and 
Otx-2 mutant endodermal cells accumulate at the tip of the embryo. As a result 
A VB is not formed [42, 43]. TGF-~ signaling seems to be important for the 
formation of the A VB since the downsream transducer Smad-2 is required in VB 
for its A-P polarity. In the absence of the gene product A VB is not formed and the 
epiblast gives rise to posterior derivatives only [44]. 
There are more genes that molecularly identifY the A VB in the mouse. VE-
l antigen [45], Lim-I, goosecoid and cerberus-related I [46, 47] specific 
expression in the VE precedes the onset of gastrulation. At the time of primitive 
streak formation, the A VB is further patterned and it is subdivided at least in two 
distinct domains. The most anterior domain, which corresponds to the site of future 
heart development, is marked by the onset of Mrg-I expression [48]. Immediately 
posteriorly, Hesx-I is expressed in a population of A VB, which overlies epiblast 
destined to form anterior CNS [49, 50]. Most of these genes that are expressed in 
the early A VB are also expressed in the node (anterior most end of the streak), 
which is necessary for expression of CNS markers in the anterior ectoderm. 
Removal of the A VB during early stages of gastrulation results in the compromise 
of subsequent expression of anterior CNS markers [49]. Additionally, in the Cripto 
mouse mutant there is no primitive streak or node formed, yet the distally localized 
AVE in these embryos is sufficient for the adjacent epiblast to assume an anterior 
character [51]. These observations were suggestive ofa potential role of the AVE 
in anterior patterning. Further functional proofs came from the studies of targeted 
inactivation of genes that are expressed in the AVE. 
17 
One of the important questions was whether gene expression in the AVE 
itself is critical for anterior patterning or the subsequent gene expression in the 
node. The most valuable experiment to address this question has been the 
generation of chimeric embryos with different combinations of genotypes between 
the host blastocyst and the injected ES cells. This experiment enables the specific 
loss of function of a gene either in the extraembryonic endoderm (blastocyst 
derivative) or in the epiblast (ES cells derivative). In that way any defect present in 
the embryo could be attributed to the function of the gene in a particular tissue, 
either extraembryonic VE or embryonic node. Inactivation of Otx-2 and Lim-l 
resulted in embryos that had a compromised anterior development exhibiting 
varying degrees ofholoprosencephaly or more extensive foreshortening of the eNS 
[52, 53]. When mutant ES cells were used to generate chimeric embryos in which 
the VE was derived from the wild type host blastocysts the anterior ectoderm 
defects where rescued [43, 54]. In the converse experiment, when Otx-2 or Lim-l 
mutant blastocysts were injected with wild type ES cells, chimeric embryos had the 
same anterior defect as seen in the null embryos. Thus, regardless of the presence 
of wild type embryonic tissues, including the node, the mutant VE provided by the 
injected blastocyst was causing the same malformations [43, 54, 55]. These 
experiments establish that in the null embryos the primary defect for anterior neural 
patterning lies in the VE and more specifically in the AVE where Otx-2 and Lim-l 
are expressed. 
Although the chimeric studies prove that the defect is in the AVE, they do 
not actually explain how this induction is achieved. It seems that one of the action 
of the AVE onto the underlying epiblast is to induce expression of the same 
molecules that pattern the AVE itself and thereby transferring this pattern across to 
the epiblast. This is evident for Otx-2 and Hesx-l in the prospective neurectoderm 
[49,50,56] and for Mrg-l in the cardiac mesoderm [48]. Therefore it is thought 
that AVE is initially responsible for establishing anterior-most identity and that 
other signals including the ones from the node and its derivatives serve to maintain 
and further establish this pattern [38, 39]. This combinatorial interaction among the 
embryonic layers has been demonstrated in transplantation studies of axis induction 
in the mouse embryo. AVE alone was not able to induce ectopic neural tissue and 
only when combined with both anterior epiblast and node tissue the ectopic axis 
exhibited full induction of anterior neural genes [57]. Additionally, germ-layer 
explant assays suggested that AVE may actually suppress the induction of posterior 
character, indirectly allowing generation of anterior identity. In Otx-2 mutant 
embryos AVE is not able to prevent posteriorizing signals and as a result there is 
no anterior induction [42]. Furthermore, the BMP antagonists Chordin and Noggin, 
which are produced by the node, are required for forebrain development [58], 
suggesting that in the presence of a normal AVE there are other molecules in the 
epiblast required for subsequent elaboration of anterior patterning. This is also 
supported by the phenotype of Wnt-3 mutant embryos. Although AVE is formed 
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and patterned properly, there is no anterior-posterior neural patterning as a result of 
the absence of the primitive streak and its derivatives [59]. 
Definitive Endoderm 
Origin 
The definitive endoderm derives from the epiblast or primitive ectoderm as 
one of the three germ layers that are formed during gastrulation (E6.5). 
Gastrulation follows the formation of the primitive streak (PS) at the posterior site 
of the egg cylinder (Figure lD) and is the process by which the totipotent epiblast 
cells are partitioned into three germ layers [60]. The ectoderm forms skin and eNS; 
the mesoderm forms blood, bone and muscles; and the endoderm contributes 
mainly to respiratory and digestive tracts. This elaborate cell differentiation and 
rearrangement is achieved by the migration of epiblast cells through the streak with 
both mesoderm and endoderm emerging out of the PS. This process of 
specification is not yet clear and may happen before the cells enter the streak or as 
they are passing through it. There is even the possibility that as the cells exit they 
remain multipotent and by entering the right environment their fate is specified. 
From cell lineage tracing studies it has been shown that the first endoderm 
originates from the most anterior site of the streak [61]. However, a well-defined 
progenitor pool that gives rise to this cell lineage has not been identified and 
single-cell labeling experiments suggest that sharp boundaries in cell fate do not 
exist in the early streak stage embryos [62]. In fact 75% of cells labeled in the 
region of the anterior streak contribute to multiple germ layers. 
Endoderm has not been studied as extensively as the other two germ 
layers, largely because of a lack of specific molecular markers. However, a better 
understanding of the molecular control of its formation has been obtained in lower 
vertebrates [63]. In Xenopus, although specification is mediated by maternally 
provided molecules (vegT), the subsequent maintenance relies on cell-cell 
interaction and the importance of signaling pathways, like TGF-j3, and WNT, is 
well documented. Recently, GATA-5 has been implicated in Xenopus endoderm 
specification by its early endoderm specific expression and mainly by its ability to 
respecify mesoderm towards an endodermal fate [64]. In the mouse embryo there is 
little knowledge of the molecular control of endoderm formation and only loss of 
function studies have implicated some genes in this process. 
As mentioned earlier, embryos mutant for Smad-2, one of the downstream 
transducers of TGF-j3 signaling, have a primary defect in the visceral endoderm 
resulting in the lack of proper anterior patterning [44]. When this primary defect 
was rescued in chimeric embryos by wild type extraembryonic tissues, a 
requirement of Smad-2 function was revealed for the formation of definitive 
endoderm [65]. Mutant cells never became endoderm and they could only be 
detected as mesoderm or ectoderm. Furthermore, in highly chimeric embryos the 
identification of a wild type endoderm sheet next to almost exclusively Smad-2 
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mutant ectodenn and mesodenn implies that only a small number of precursor cells 
give rise to the definitive endodenn. Another TGF-~ related activity, nodal, is a 
possible candidate for endodenn induction. In addition to its function in the VB to 
induce anterior identity [37], the gene is expressed in the posterior epiblast at the 
onset of gastrulation and it is essential for proper PS fonnation [66]. Specific 
defects in the fonnation and migration of endodenn cells have been demonstrated 
in embryos lacking FurinlSPCl, a protease controlling proteolytic maturation of 
TGF-~ and related molecules including Nodal and BMP-4 [67]. This is consistent 
with the idea that a balance of TGF-~/activin and BMP signals regulate definitive 
endodenn fonnation. However, specific mutations of BMPs do not directly prove 
this since BMPs, like BMP-4, have a more general function during gastrulation 
[28]. A more indirect support is the phenotype of embryos mutant for the BMP 
antagonists Noggin and Chordin, which are expressed in the node and its 
derivatives. Their function is crucial for anterior patterning but in their absence 
there is a marked reduction of definitive endodenn leading to a later reduction in 
pharyngeal endodenn [58]. 
Early endoderm patterning 
Anterior-posterior identity of the endodenn seems to be coupled with its 
initial generation since the first endodenn to emerge out of the streak becomes 
anterior endodenn. However, a molecular A-P patterning along the endodenn sheet 
has not been established yet and there is only a handful of molecules that are 
known to be differentially expressed along the A-P axis. The initial induction of 
their expression is not fully understood but the involvement of adjacent tissue 
layers has been suggested by the nature of the molecules themselves and by explant 
recombination assays. 
Most of the molecules expressed in the anterior endodenn are the same as 
can be found earlier in the anterior ectodenn and even earlier in the AVE. 
Therefore, it is likely that the pattern in the anterior ectodenn is relayed back to the 
gut endodenn. A typical example is the expression of Hesx-l that is first detected 
in the A VB and then in the underlying ectodenn. At the end of gastrulation, Hesx-l 
expression is maintained in anterior head ectodenn and is induced in the adjacent 
gut endodenn as it displaces visceral endodenn [49]. Expression of HNF-3, 
goosecoid, cerberus-like, Hex, and Otx-2 [43, 49] has also been reported in the 
anterior endodenn, while intestinal fatty acid binding protein (IFABP) [68] and 
Cdx-2 [69] are expressed in the posterior endodenn. The significance of this 
pattern has not been elucidated but gene targeting studies have revealed that some 
of these genes function in subsequent differentiation of gut tube and in 
organogenesis. Anterior endodenn gives rise to foregut and in mice lacking the 
transcription factor HNF-3 ~ in the embryonic lineages, both foregut and midgut 
were absent [32]. The function of Hex in anterior endodenn is required for proper 
liver fonnation while in the thyroid it is necessary for specification [70]. Otx-2 null 
embryos die early during gastrulation [53]. However, in embryos highly chimeric 
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with Otx-2 mutant cells, the rostral foregut fails to form (Ang, S-L unpublished 
observation). 
An in vitro germ layer explant study with mouse embryos has recently 
suggested that during gastrulation both mesoderm and ectoderm direct the 
differentiation of the adjacent endoderm [71, 72]. Furthermore, it has been 
demonstrated that soluble factors are potential mediators of this interaction and that 
they act in a concentration dependent manner. Specifically, FGF-4 was implicated 
as one of the inductive signals of the mesoderm, which was able to induce specific 
gene expression in the endoderm. Higher levels of the factor could induce 
somatostatin (SS) expression, a later marker of posterior gut endoderm that give 
rise to the pancreas and small intestines. NeuroD is expressed more anterior in the 
gut tube, marking the domain of stomach and pancreas and is induced by lower 
levels of FGF-4. These two observations support a role of FGF-4 as a posterior 
morphogen since the in vivo source of the protein is the PS [73], which is more 
proximal to the posterior SS expressing endoderm than to the endoderm expressing 
NeuroD. In support of a role of FGF signaling in endoderm patterning is the study 
ofES cells mutant for the receptor FGFR-l. These cells accumulate in the PS and 
although they can form neural structures, they were never detected in endoderm 
derivatives [74]. 
These data suggest that, although initial endoderm formation could be cell 
autonomous or maternally controlled like in Xenopus, the subsequent specification 
and possible early A-P patterning of the endodermal sheet depends on signals from 
adjacent embryonic layers. The major issue that is not fully clarified yet is whether 
these signals are permissive or instructive. In other words, is the mesectoderm only 
reinforcing a pre-pattern within the endoderm or is it actively specifYing the 
endoderm? In agreement to previous studies in chick embryos, the explant 
recombination study in mouse [72] suggests that the signals from the other layers 
are instructive since they are able to induce gene expression patterns in a na'ive 
endoderm and to some extent to respecifY fate in the endoderm. However, some 
anterior markers were already present in the endoderm at the time of its isolation 
before culturing. Additionally, the respecification activity of the mesenchyme was 
not equally affecting all endoderm markers. Therefore, the possibility of a pre-
existing pattern still remains. It rather seems that there is a combination of both 
instructive and permissive signals from the mesectoderm, which supports the 
further differentiation and specification of distinct domains within the endoderm. 
Gut tube morphogenesis 
Subsequent to its formation, endoderm undergoes a complex and well-co-
ordinated morphogenesis that results in the formation of the gut tube. According to 
cell lineage-tracing studies [61, 75], the first endoderm originates from the most 
anterior site of the streak and intercalates into the overlying visceral endoderm 
(E6.5). The newly formed endoderm eventually displaces the primitive visceral 
endoderm as it migrates in an anterior direction to form the anterior endoderm. 
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Cells that emerge later from the streak form more posterior endoderm together 
resulting in a sheet of endoderm cells that extends from the anterior head folds to 
the posterior primitive streak (E7.5) (Figure 2). The anterior- and posterior-most 
endoderm invaginates into the embryo, forming the foregut and hindgut pockets 
respectively (E8.5). These pockets, known also as anterior and caudal intestinal 
portal (AlP and CIP, respectively), extend towards the midgut and eventually fuse 
to form the gut tube (E9). The ends of this tube are initially closed but they open by 
the fusion of the ectoderm and endoderm at the level of the oral and urogenital/anal 
plates. Most of the mouth as well as the rectum derive from the ectoderm. From the 
three different parts of the gut tube a number of organs originate: the foregut is the 
progenitor of thyroid, lung, liver, pancreas and stomach; the midgut of the small 
intestines and the hindgut of the large intestines. 
The whole process of gut tube formation is not understood either at a cell-
cell interaction or at a molecular level. Targeted mutations in the mouse have 
implicated, thus far, very few molecules in gut folding. As explained earlier, 
GATA-4 mutation results in abnormal ventral closure of the gut tube and chimeric 
studies have shown this to be an effect of the overlying visceral endoderm [76]. 
Members of the BMP (-2, -4, -5 and -7) signaling family can be added to this list 
since in their absence similar folding defects were observed [28, 77, 78]. 
Patterning of the gut tube 
With the formation of the gut tube and the aforementioned A-P patterning 
in the early endoderm a question emerges. Do specific regions of the endodermal 
sheet or the early gut tube correlate with organ formation? And furthermore, is 
there a pattern in the gut tube that directly links gene expression domains and 
specific organ territories? 
The first question has been addressed in different vertebrates by fate 
mapping experiments that trace the fate of endoderm cells in definitive digestive 
organs. Although organisms like the chick have been predominantly used due to 
accessibility and ease of embryo culturing [79], similar conclusions were drawn by 
Lawson et al. [61] in a study of mouse endoderm cell fate. The labeling of single 
mouse endoderm cells after gastrulation and their tracing later, following foregut 
and hindgut formation, resulted in the definition of four regions (I-IV) along the 
gut endoderm that are fated to generate specific organs, as illustrated in Figure 2. 
However, in agreement with the chick studies, there are no sharp boundaries of 
domains of contribution and the organs have rather overlapping presumptive 
territories. The data from the explant studies is consistent with these observations 
and taken together, they strengthen the notion that the A-P nature of gastrulation 
stage endoderm is quite plastic. In fact, it is the interaction with the mesoderm at 
this stage that renders the endoderm in a more determined state, resulting gradually 
in a gut tube endoderm that is irreversibly specified. The significance of this initial 
specification is more apparent later, during organ formation, when new inductive 
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Figure 2. Development of the definitive endodcnn and formation of the gut tube. On the upper panel, embryonic development is shown subsequent to 
gastrulation up to the initiation of organogenesis. The gut tube is outlined by white dotted line. Below each embryonic stage, a schematic representation of the 
endodermal sheet or the developing gut tube is depicted. At the end of gastrulation the endodenn is a sheet of cells surrounding the embryo proper. At ES.O, 
gut tube formation begins at the anterior foregut by the folding of region lover region II, which results in the formation of the anterior intestinal portal (AlP) 
that then migrates in a posterior direction. The same time, region IV in the hindgut folds over to form the caudal intestinal portal (CIP) that migrates in an 
anterior direction. These migrations, in combination with embryonic tuming, close the midgut and form the primitive gut tube by E9.0. The roman numerals 1-
IV represent regions ofE7.5 endoderm that fate map to regions I-IV ofE8.5 gut, as it was demonstrated by Lawson and Pedersen using single endoderm cell-
tracing experiments [75]. Region I contributes to the ventral foregut and derivative organs such as thyroids, lungs, liver and ventral pancreas. Region II and 
III give rise to dorsal foregut and midgut, which contribute to dorsal pancreas, stomach, duodenum and part of the intestines. Region IV forms the hindgut, 
which contributes to the large intestine and colon. The lower right schematic representation depicts the initiation of organogenesis, which does not necessarily 
correspond to its above embryonic stage ofE9.5. The figure is adapted from Wells & Meltoll [72, 86]. 
process of sequential induction allows for broad regions of endodenn to become 
progressively detennined towards the establishment of organ domains. 
An interesting mechanism of gut endodenn detennination has been put 
forward recently from studies on presumptive liver endodenn. Specification of 
hepatocytes is associated with the expression of liver specific genes like serum 
albumin. The investigation of the liver-specific enhancer of this gene revealed that 
prior to gene expression, binding sites for both GATA and hepatocyte nuclear 
factor (HNF-313) proteins are occupied [80]. This occupancy was suggested as a 
mechanism of rendering the endodenn competent for further specification into liver 
primordia. The necessary subsequent signals would provide the additional factors 
that are needed for the actual transcriptional activation of the liver specific genes. 
Such a way of enabling competence of a gene to be activated during development 
is described as genetic potentiation [81]. The involvement of both of these families 
of transcription factors in differentiation of endodennal lineages [20,21,32,82] 
and their characterized interactions with other cofactors [83, 84] make this 
mechanism a plausible way of specification at a molecular level. In addition, this 
mechanism was subsequently coupled to the mesodennal role on gut endodenn 
detennination. Initially, the occupancy of binding sites is not restricted to the 
prospective liver endodenn and it is the posterior mesodenn that actually prevents 
albumin expression and allows furtber specification in the prospective intestinal 
endodenn. This correlates with the pluripotency of the gut endodenn at that early 
stage. However, two days later the posterior mesodenn mediates the loss of binding 
site occupancy and the posterior endodenn is then irreversibly specified as 
intestinal [85]. 
A better understanding of genetic potentiation would require the 
identification of more of the molecules involved and their regulated expression 
along the different territories of the gut tube. Although a variety of gene expression 
patterns have been described along the gut tube, they do not necessarily imply a 
well-defined A-P pattern [86, 87]. Logical candidates would be the Hox genes 
since they provide positional infonnation along the A-P axis in other genn layers. 
However, it is unlikely that they do so in the endodenn. Only a few Hox genes are 
expressed in the endodenn and their expression limits do not always correlate with 
boundaries between the organs. Furtbennore, mutations in these genes do not cause 
A-P transfonnations of the organs in the gut but only some tissue malfonnations 
[87]. In fact, gut mesodenn has a more defined Hox expression pattern [88], which 
could have an indirect influence on the patterning of the gut tube. Studies in the 
chick gut suggest that the endodenn itself might dictate mesodennal Hox 
expression and that signaling molecules like those of the Hedgehog family could be 
involved in this induction [89]. Additionally, Sonic hedgehog from the endodenn 
seems to influence the differentiation of the mesodenn and induction of BMPs 
could be one of the mechanisms [90,91]. The importance of Hedgehog and TGF-13 
signaling in the development of the gut has been confinned in mice mutant for 
Sonic and Indian hedgehog [92] and for the Type II receptors of the TGF-13 related 
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ligand, activin [93]. Overall it seems that boundaries of gene expression do not 
strictly correlate with domains of specific organs. Even in the case of the ParaHox 
gene pancreatic-duodenum-homeobox 1 (Pdx-l) that is necessary for pancreatic 
outgrowth and development [94], its expression pattern is wider than the pancreatic 
bud. In figure 3, a schematic representation is depicted with the expression of a 
number of transcription factors in different domains of the gut tube, according to 
Wells and Melton [86]. Some organ-specific gene functions that were revealed by 
targeted inactivation in the mouse are also indicated. 
Organogenesis 
Morphogenesis of the gut tube is coupled to the initiation of organ 
formation so that by the time the tube is fully folded (E9.5) differentiation of organ 
specific tissue is evident (Figure3). Apart from the digestive tract, the rest of the 
organs are branching out from the main tube by the formation of an initial bud. 
Although it is not known how overlapping gene expression patterns may dictate 
where organ buds will arise, it is established that organ budding and subsequent 
morphogenesis involve reciprocal interactions between gut epithelium and the 
adjacent condensed mesoderm, referred to as mesenchyme. So, at this stage gut 
endoderm that is already specified by combination of possible intrinsic signals and 
early mesodermal induction (discussed earlier) is receiving new signals for further 
organ specific differentiation. There is no longer plasticity and the signals from the 
neighborhood can only be permissive now. Thus, mesenchymal signals cannot 
instruct endoderm fate anymore, they can only be effective on endoderm pre-
determined for the formation of a specific organ. Such interactions have been 
described in both chick and mouse during the formation of liver, pancreas and 
lung. 
The liver primordium is first evident as a thickening of the ventral 
endodermal epithelium and then as a bud of cells that proliferate and migrate into 
the surrounding septum transversum mesenchyme. Classical transplantation 
experiments in the chick by LeDouarin [95] showed that it is actually the cardiac 
mesoderm that induces liver formation in its adjacent ventral endoderm. Further 
studies in the mouse confirmed this interaction and showed that cardiac mesoderm 
induces both hepatic gene expression and outgrowth of endodermal epithelium 
[96]. At the molecular level members of the fibroblast growth factors family 
(FGFs) were implicated by their dynamic expression pattern in the cardiac 
mesoderm and their ability to substitute for cardiac mesoderm in in vitro endoderm 
differentiation into liver [97]. While this substitution was complete for the 
induction of liver specific gene expression, the morphogenetic action of the cardiac 
mesoderm seemed to require additional, yet unknown signals. Subsequent to the 
formation of the liver bud there are more signals required, as revealed by loss of 
function studies of different mouse genes. The homeobox protein Hex was recently 
characterized as providing a critical function for early migration of hepatic 
endoderm into the septum transversum [70]. Earlier studies have highlighted the 
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Figure 3. The upper part is a schematic representation of the E9.5 gut tube showing expression of 
several transcription factors along the tube, and regions of the gut that contribute to specific organs. 
Transcription factors have been grouped according to their relative A-P expression at this time of 
development, but any D-V expression differences that some of them have are not shown. The 
transcription factors that have been genetically disrupted in mice show a corresponding phenotype, 
indicated by the arrows. In the lower part a scheme of mouse-chicken embryo shows the position of 
the glands that bud out from the gut tube. Genes that are participating in the initiation of these organs 
are indicated, while question marks imply that there is no knowledge of budding genes. The figure is 
adapted from Wells & Melton [86] and from Grapin-Botton & Melton [87]. 
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orchestrating role at that stage of the septum transversum mesenchyme and have 
identified a number of different signaling molecules [98, 99]. For example, 
hepatocyte growth factor (HGF) initiates a well-defmed molecular pathway crutial 
for hepatic growth that involves comet and c-jun. Another molecule from the 
mesenchyme, the homeobox gene Hlx, seems to control a distinct signaling 
cascade. Although the phenotype of mutant embryos is related to defective 
haematopoiesis, the mutant cells are able to support haemotopoiesis in a different 
environment [100]. This would suggest that proliferation and integrity of 
hepatocytes as maintained by mesenchymal signals are required not only for the 
proper formation of the organ but also for the development of some of its 
functions. 
Tissue interaction is critical for pancreas development as well. The 
formation of this organ begins with a dorsal and a ventral protrusion of the gut 
tube. The ventral component derives from the ventral foregut that is immediately 
adjacent to the hepatic endoderm and its initiation and further differentiation is less 
well defined. For the dorsal component, the notochord is initially in immediate 
contact during pancreatic differentiation. When notochord was deleted in chick 
embryos, expression of dorsal pancreatic genes was lost [101] and instead, shh was 
induced. As it was known that only the presumptive pancreatic endoderm does not 
express shh in the gut tube, this observation implied that notochord promotes 
pancreatic differentiation by inhibiting shh expression. In accordance with this, 
cyc10pamine mediated inhibition of shh in the gut tube induced ectopic pancreatic 
gene expression [102]. Molecular analysis identified FGF-2 and activin-betaB as 
the notochordal signaling molecules responsible for endodermal shh repression 
[103]. For further differentiation of the organ, a number of different gene functions 
are required (Figure 3) and the Notch signaling pathway has been implicated in the 
decision between the endocrine and exocrine fate [104]. 
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Lung Development 
Lung endoderm specification 
Lungs derive from the anterior ventral foregut, just anterior to the stomach 
and liver, as illustrated in Figure 2. The onset of lung development coincides with 
the appearance of the dorsal pancreatic bud, but occurs later than thyroid and liver 
bud outgrowth. A number of transcription factors, as shown in Figure 3, and 
signaling molecules, like shh, are expressed along the anterior endoderm that give 
rise to the lung primordium. However, to date there is no correlation between a 
specific gene expression domain and a presumptive lung territory on the primitive 
gut tube. Additionally, the absence of a defined structure that is in close contact 
with this territory, like notochord in the pancreatic endoderm, has made the study 
of pulmonary endoderm specification more elusive. 
One of the molecules that is considered important for such specification is 
HNF-3j3. Inactivation of the gene does not affect definitive endoderm formation 
but only subsequent invagination and gut tube formation [31]. Chimeric rescue of 
the primary defects revealed that the HNF-3j3 function is essential in the definitive 
endoderm for the formation of both foregut and midgut [32]. This implies that the 
role of HNF-3 13 in lung endoderm specification is not direct since in its absence the 
foregut itse1fis not formed. Another molecule that has been implicated is GATA-6. 
Its function is considered essential for pulmonary endoderm specification on the 
basis of the observation that GATA-6 -/- ES cells do not contribute to the lung 
epithelium in chimeric embryos [23]. However, highly chimeric embryos with 
GATA-6 -/- ES cells have lung epithelium consisting of GATA-6 mutant cells in 
extensive areas (chapter 3). Although the mutant epithelium has subsequent 
morphogenetic and differentiation defects, this study implies that GATA-6 is not 
essential for pulmonary endoderm specification, at least in a chimeric context. 
Initial morphogenetic events 
At E9.5, the first step in the development of the lungs is the protrusion of 
the two primary lung buds on the ventrolateral wall of the foregut (Figure 2). 
Concomitantly, the foregut is divided by a longitudinal septum into two tubes. The 
dorsal one will become the esophagus and the ventral one with the two buds forms 
the trachea (Figure 4A). In this way the alimentary and the respiratory systems are 
permanently separated. Further morphogenesis is distinct for the trachea and the 
lung buds. While the trachea remains as an endodermal tube surrounded by 
mesenchyme, the two endodermal buds undergo extensive branching 
morphogenesis to generate the two main bronchi and the respiratory tree. Each bud 
has a left-right (L-R) identity that is retained even if the organ develops isolated in 
culture and it follows a distinct branching pattern. The left primary bud grows out 
as the future left bronchus and sprouts several secondary buds along its lateral side 
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Figure 4. Schematic representation of mouse lung development and molecular pathways involved in 
epithelial-mesenchymal interactions. (A) Around E9.5, the trachea and primary buds develop from 
the ventral foregut The tracheal-oesophageal groove eventually closes and separates the alimentary 
and pulmonary systems. By EI2.5, the precursors of the five primary lobes have been established and 
the regular branching pattern of the epithelial endoderm can he clearly followed. L-R asymmetry is 
well established. At EI4.5, the five lobes (right cranial, medial, caudal and accessory lobes and left 
lobe) are well developed. (B) Two different branching processes seen in early lung development. 
lateral and dichotomous branching. The mesenchyme surrounding the epithelial layer is distinctly 
marked by a stippled pattern. (C) A representation of key inductive and suppressive signalling 
mechanisms that mediate epithelial-mesenchymal interactions during branching morphogenesis and 
epithelial differentiation. For more details see Branching Morphogenesis in text. The figure is adapted 
from Hogan el al. [105] and from Warburlon el al. [165]. 
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generates an asymmetric series of secondary buds, but the pattern is quite different. 
The first bud to arise projects dorsally, followed closely in time and space by a 
lateral and a ventral bud, and then by several lateral buds. This highly organized 
branching pattern is of great significance. The first three secondary buds on the 
right eventually give rise to separate lung lobes, resulting in a right lung that is 
composed of four distinct lobes, compared with only one on the left (Figure 4A) 
[105, 106]. In humans there are three lobes on the right and two on the left lung. 
Molecular control of early morphogenesis 
Although the mechanisms controlling the site of lung bud initiation are not 
yet known, epithelial-mesenchymal interactions seem to be critical for primary bud 
outgrowth. The importance of the mesenchyme has been demonstrated long ago by 
transplantation experiments. The inability of the trachea endoderm to bud was 
reversed when trachea mesenchyme was exchanged for distal mesenchyme. The 
result was the formation of ectopic buds that grow, branch and differentiate like 
normal pulmonary epithelium. In the converse experiment, proximal mesenchyme 
from around the trachea was able to inhibit outgrowth and branching in the distal 
endoderm [107, 108]. The nature of the molecules involved in such an interaction 
had already been suggested by these experiments since the mesenchymal influence 
could be exerted even in the absence of direct contact. Further genetic studies have 
now directly implicated FGF and Shh signaling in early pulmonary morphogenesis. 
Retinoids and the homeobox transcription factor TTF-I are also involved in these 
early morphogenetic events. 
FGF signaling during lung bud initiation and outgrowth is mediated by the 
local expression of FGF-IO (the homologue of the Drosophila branchless) in the 
immediate mesoderm [109] and its receptor FGFR2-111b in the foregut endoderm 
[110]. In mice with a targeted inactivation of FGF-IO, the trachea is normally 
formed, but there is no initiation of lung bud formation [III, 112]. The same 
phenotype was observed in mice with different mutations in the FGFR-2 gene 
[113]. Further use of in vitro explant systems gave a better insight into the function 
ofFGF signaling in lung bud outgrowth. FGF-IO in the mesenchyme seems to act 
as chemoattractant for the adjacent endoderm and induces and promotes its 
budding [114]. Additionally, FGF-IO alone is able to induce budding from trachea 
endoderm denuded from proximal mesenchyme [115]. The FGF signaling is 
critical throughout branching morphogenesis and the mechanism of its action will 
be discussed in more detail later. However, the initial induction and localization of 
FGF-IO in the mesenchyme remains elusive. 
The secreted molecule Shh binds to its receptor patched (Ptc) resulting in 
the activation of the segment polarity gene smoothened (Smo) and the Gli zinc 
finger proteins that start to function as transcription factors. Shh is expressed in the 
foregut endoderm and persists during the formation of the lung endoderm [116]. 
The receptor Ftc and the three identified Glis (Glil-3) are all expressed in the lung 
splanchnic mesoderm [II7, 118]. Failure to initiate signaling in shh-/- embryos 
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results in a respiratory system that has no separation between trachea and 
esophagus (tracheoesophageal fistula) and primary buds that give rise to sac-like 
lungs without any lobes or endoderm branches [119]. Inactivation of both Gli2 and 
Gli3 genes results in a number of overlapping respiratory defects. Gli3 mutant 
embryos have lungs that are smaller and show localized shape changes [117], while 
lack of Gli2 results in stenosis of the esophagus and trachea and hypoplastic, 
abnormally lobulated lungs. When Gli3 was reduced by heterozygous deletion in a 
complete Gli2 deficient background the lung phenotype is more severe and the 
embryos show tracheoesophageal fistula. Remarkably, compound null mutant 
embryos, deficient for both Gli2 and Gli3, do not form oesophagus, trachea or 
lungs [120]. Thus, Glis have specific and overlapping functions in transducing shh 
signaling during the early morphogenetic stages. Furthermore, the differences in 
shh and Gli mutant phenotypes suggest that Gli may be a common mediator of 
different signaling pathways or that Shh can also act independent of Gli. Currently, 
this is not clear and downstream targets of the Gli transcription factors are not 
known. 
Malformations similar to shh null lungs are observed in embryonic lungs 
mutant for the homeobox transcription factor TTF-l. The gene is expressed in the 
ventral foregut and subsequently in the respiratory endoderm. When TTF-l is 
deleted the abnormal sac-like lungs originate directly from an unseparated tracheo-
esophageal tube [121]. Tracheoesophageal fistula with a variety of lung defects, 
including lung agenesis, is observed in embryos deprived for vitamin A [\22]. 
Accordingly, similar phenotypes are observed in the lungs of embryos double 
mutant for the RAR and RAR receptors [\23]. The importsnt role of retinoids 
(RA) in early pulmonary development is further demonstrated by the expression of 
the RA-synthesizing enzyme (RALDH-2) in the ventral foregut [124], including the 
area where the lung buds form. The use of a mouse with a RA responsive element 
in a reporter gene also showed that by E9.5, RA and its receptors are activated in 
the foregut [124]. These findings suggest that there are several signaling pathways 
involved in early morphogenesis of the respiratory system and that initial trachea 
and lung morphogenesis share most of them. However, the argument that trachea 
and lung morphogenesis are coordinated by independent events is supported by the 
normal development of the trachea in the absence of FGF signaling. Both FGF-IO 
and FGFR-2 mutant embryos have lung agenesis but formation of the trachea 
proceeds normally [111-113]. 
The left-right (L-R) identity of the two initial lung buds is determined by 
the L-R asymmetry in the gut tube [39]. Expression of the bicoid class of 
homeobox gene Pitx2 marks the left side of the gut and subsequently the left bud 
[125]. Pitx2 expression starts in the lateral plate mesoderm (LPM) where it is 
induced by lefty-I, lefty-2 and nodal, all members of the TGFI3 family that are 
expressed in the left side of the embryo [126]. Inactivation of Pitx2 affects 
asymmetry in the lungs and results in right isomerism [127, 128]. In accordance 
with this, bilateral expression of the gene, as a result of bilaterallefty-2 and nodal 
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expression in lefty-l mutant embryos, leads to left isomerism [129]. Random L-R 
laterality in the lungs is observed in embryos mutant for HNF-4 (also known as 
HFH-4). This laterality defect is caused by the absence of cilia due to 
downregulation of the left-right dynein (lrd) gene, coding for a microtubule-based 
motor protein [130]. 
Branching morphogenesis 
In each one of the five lobes the branching pattern can be traced up to 
about E12.5 and it is highly reproducible from embryo to embryo. This highly 
ordered sequence of patterning events referred to as branching morphogenesis and 
results in the establishment of the bronchial tree by the end of the pseudoglandural 
stage of lung development (EI6.5). There are mainly two branching processes, the 
lateral and the dichotomous branching (Figure 4). The former is particularly 
important in establishing the length and overall shape of the lobes. It involves a 
single bud growing out for an extended distance accompanied by the sprouting of 
secondary lateral buds at specific distances from the leading tip. In the latter, a 
terminal bud splits into two branches, each of which continues to grow along a 
different axis, but not necessarily to the same extent [lOS]. 
As for the primary bud outgrowth, epithelial-mesenchymal interactions are 
also crucial for branching morphogenesis. Initially, it was thought that this 
interaction is mediated exclusively by the interaction of the extracellular matrix of 
both tissues. Components of the basement membrane regulate cell proliferation and 
absence or inhibition of the interaction of epithelial cells with basement membrane 
has a direct effect in lung development [131, 132]. Branching morphogenesis was 
considered to be the result of continued assembly and degradation of extracellular 
matrix [133]. According to this hypothesis the proximal epithelium is constrained 
by a well-organized, sheath-like extracellular matrix. In contrast, the rapid growth 
and expansion of the distal epithelium is associated with the matrix degrading 
activity of the adjacent distal mesenchyme. This activity and the growth of the 
epithelium leads to disruption of the basal lamina, which cannot be assembled fast 
enough to keep pace with epithelial proliferation. This results in the local collapse 
of the epithelial sheet and the formation of a cleft in which assembly of an intact 
basal lamina can be restored and the growth is restrained. Bilateral to this cleft, 
proliferating epithelial cells can expand resulting in dichotomous branching. 
Lateral sprouting is less well served by this model. However, it can be seen as the 
result of a localized degradation of basal lamina by the mesenchyme that allows the 
bud to grow out through the site of disruption (Figure 4B, page 17). The molecular 
study of different components of the extracellular matrix confirms its important 
role during branching morphogenesis. Gene inactivation of the laminin 5 chain 
isoform leads to abnormal lobe septation and bronchiolar branching [134]. In lung 
explant cultures blocking expression of fibrillin-2 and SPARe (secreted protein 
acidic and rich in cystein) result in mesenchymal expansion and branching defects, 
respectively [135, 136]. Nevertheless, extracellular matrix cannot be the sole 
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regulator of branching morphogenesis. Recent molecular studies have implicated 
different secreted signaling molecules as regulators of the epithelial-mesenchymal 
interactions that underlie the branching process (Figure 4C, page 17) [105, 137]. 
FGF signaling, mentioned already in primary bud outgrowth, is an 
important player during branching morphogenesis. In fact the branching pattern 
seems to be controlled by FGF signaling. For the very first branching event, the 
outgrowth of the primary bud, expression of FGF-IO in the splanchnic lung 
mesenchyme is essential. In the absence of the ligand lung buds are not formed 
[Ill, 112]. The expression pattern of the gene subsequent to this initial event 
(EI0.S-EI2.S) correlates with positions in the mesenchyme towards which 
endoderm will bud and grow. That includes the mesenchyme surrounding the distal 
tips as well as mesenchymal domains adjacent to the lateral buds. FGF-IO 
expression in these domains precedes the formation of lateral buds and it actually 
marks the endodermal sites from which lateral buds will initiate [109]. This 
mechanism is evolutionary conserved since the Drosophila homologue of FGF-IO, 
branchless, is expressed in an analogous manner during trachea budding [138]. 
-The significance of this dynamic expression pattern and the mechanism 
with which FGF-I0 induces budding have been studied in mouse lung explant 
cultures. Implantation of an FGF-I0 bead in whole lung cultures results in 
deviation of epithelial growth towards the bead, distorting the architecture of the 
branching tubules [114]. This effect is evident only in the distal epithelium. The 
proximal mesenchyme seems to inhibit the action of FGF-I0 and proximal 
epithelium is not responsive. However, both proximal and distal epithelium 
denuded from mesenchyme respond to the FGF-I0 source. When isolated 
endoderm is placed on a Matrigel (a mixture of basal lamina components) opposite 
to a source of FGF-IO (bead), the result is expansion and migration of the 
endoderm towards the bead [114, 115]. Thus, FGF-I0 exerts a proliferative and 
chemoattractant effect on the endoderm and it induces local budding. The absence 
of mesenchyme in these experiments indicates that FGF-I0 alone is able to induce 
budding and that its action is in the endoderm rather in the mesenchyme where it is 
expressed. This is mediated by the FGFR-2 receptor, which is expressed in the 
epithelium throughout early lung development [110]. However, the precise 
mechanism of how the epithelial cells sense the FGF-I0 gradient and move in the 
Matrigel is not yet known. 
A member of the TGF-J3 family, BMP-4 is expressed in the growing tips of 
the distal epithelium [139]. The in vitro bud induction system with the FGF-I0 
source revealed that local expression of BMP-4 in the growing tip is the result of 
the response to the FGF-I0 gradient. During bud initiation there is no BMP-4 
expression and the response to FGF-I0 results in the induction of BMP-4 during 
the bud extension [115, 140]. But what is the function ofBMP-4 in the epithelium? 
Exogenous BMP-4 in the culture system and transgenic overexpression in the distal 
lung epithelium affects cell proliferation. Blocking endogenous BMP-4 with its 
antagonist Noggin promotes budding and outgrowth [115, 139]. Thus, the 
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induction of BMP-4 expression in the growing tips might serve to control epithelial 
proliferation and restrain the further growth of the bud. This would imply that 
BMP-4 counteracts the action of its inducer FGF-IO. In transgenic lungs 
overexpressing BMP-4 branching is severely affected suggesting that absence of 
BMP-4 expression is needed for bud induction and that epithelium with constant 
high levels of the protein cannot respond to FGF-IO from the mesenchyme [139]. 
Expression of FGF-10 in these lungs has not been studied and therefore any 
conclusion about the involvement of BMP-4 in the dowregulation of FGF-10 that 
occurs subsequent to bud outgrowth cannot be drawn. 
Downregulation of FGF-10 expression in the mesenchyme seems to be 
influenced by endoderm since lung mesenchymal cells grown alone in culture 
show a marked increase in the levels of FGF-10 mRNA [141]. It therefore seems 
likely that soluble factors produced by the epithelium have an inhibitory effect on 
FGF-10 expression. A potential mediator for such interaction is shh, which is 
expressed in the epithelium. Its downstream effectors Ptc, smo and Gli are all 
expressed in the lung mesenchyme. Although shh can be detected throughout the 
lung epithelium, the branching distal tips express higher levels of the protein [139]. 
In the lungs of shh-/- embryos, FGF-10 expression is no longer focal as in wild 
type, but it is rather diffuse and branching morphogenesis is impaired [142]. 
Addition of shh recombinant protein in lung cultures results in inhibition of FGF-
10 expression in the mesenchyme [141]. In vivo transgenic overexpressing of shh 
leads to increased proliferation in the mesenchyme and FGF-10 downregulation 
[143]. 
The above mentioned molecular observations led to a model for branching 
morphogenesis that is based on the localized expression of FGF-10 in the lung 
mesenchyme. The ligand acts on the endoderm via its receptor FGFR-2. The result 
of this signaling is an increase in epithelial cell proliferation and a chemotactic 
movement of the epithelial sheet towards the high levels of FGF-I0. Following 
initiation, during the expansion of the bud, FGF signaling induces BMP-4 
expression in the growing epithelium. At certain BMP-4 levels growth of the tip is 
arrested, probably due to decrease in cell proliferation. The endoderm is no longer 
responsive to FGF-IO and initiation of additional buds from the same point is 
prevented. At the same time shh activity at the distal tip extinguishes expression of 
FGF-10 in the adjacent mesenchyme. As the FGF-10 expression domains have 
now become lateral and symmetrical, initiation of two buds is induced on either 
sides of the grown tip where BMP-4 expression is lower. This is dichotomous 
branching. In a similar fashion, if subsequent to tip arrest the FGF-I0 domain 
moves to one lateral site it can induce a bud in the endoderm that expresses lower 
level of BMP-4. The result is lateral branching [106, 115]. 
This model explains branching morphogenesis as continues cycles of 
dichotomous and lateral branching, which are directed by the dynamic expression 
pattern of FGF-1 0 in the mesenchyme. Considering the reproducibility of the early 
branching, FGF-10 expression has to be highly patterned. At present, there is no 
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knowledge of the molecular control of this patterning. It has been speculated that 
hox genes, which are expressed in the splanchnic mesenchyme may provide the 
patterning for FGF-10 expression, at least in the very early stages [144, 145]. 
However, there is no direct evidences for that. It is also not known whether the 
FGF signaling in this process is mediated exclusively by FGF-IO. FGF-I is also 
chemotactic for lung endoderm in vitro, although weaker than FGF-IO [114]. It can 
bind with high affinity to FGFR-2, like FGF-IO, but it is expressed later during 
lung development in a pattern distinct to FGF-10 and its role in lung 
morphogenesis is still elusive [109]. FGF-7 expression is also detected in lung 
mesenchyme although at a lower level and at stages when branching is well under 
way [146, 147]. FGF-7 promotes proliferation of the endoderm in the in vitro 
system, but it does not significantly induce bud outgrowth [144]. The targeted 
inactivation of FGF-7 does not affect normal lung development in vivo [148] but 
overexpression of the ligand results in some pulmonary malformations (dilation of 
epithelial tubules) [149]. 
It is also not known how FGF-IO induces BMP-4 expression in the 
endoderm and whether it is the only inducer. The in vitro bud outgrowth 
experiments clearly indicate that BMP-4 induction is not direct since a 
considerable time interval is required [liS]. The transcription factor 1TF-1 is also 
expressed at the bud tip epithelium [ISO] and in the abnormally branched 1TF-1-1-
lungs BMP-4 expression is dramatically reduced [121]. Although expression of 
FGF-IO has not been studied in these lungs, an independent regulation of BMP-4 
by TTF-I cannot be excluded. A good example of FGF independent regulation of 
BMP-4 is seen in the lungs that lack the basic helix-loop-helix factor Podl that is 
normally expressed in the mesenchyme. In these lungs expression of FGF-10 
remains normal but epithelial BMP-4 is markedly reduced [lSI]. Thus, BMP-4 
induction requires at least one more distinct regulatory pathway initiated in the 
mesenchyme. 
It is also not clear whether shh is the only signal from the endoderm that in 
turn downregulates FGF-10 expression in the mesenchyme. TGFf3-1 negatively 
regulates branching in cultured lungs in vitro. It downregulates FGF-10 expression 
and presumably interferes with FGF-IO mediated chemoattraction [141]. It also 
affects epithelial cell proliferation [152]. Inhibition of its type II receptor or the 
intracellular effectors Smad2, 3 and 4 block the influence of TGFJ3 and results in 
enhanced branching [153, 154]. TGF -1 is expressed in the subepithelial 
mesenchyme in areas where FGF-10 is not expressed [141]. It was shown that it 
stimulates synthesis of matrix components that are deposited in the epithelial-
mesenchymal interface and are crucial in stabilizing clefts and preventing local 
budding [ISS]. Such action would counteract the influence of FGF-IO from the 
mesenchyme. However, in vivo gene targeting of TGF -1 does not affect lung 
development [156, 157] while targeting of TGF -2 and -3 does [158, 159]. 
Recently a more defined negative feed back loop has been identified based on 
Drosophila branching where the sprouty gene is induced by FGFs and the encoded 
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cysteine-rich protein antagonizes the action ofFGFs [160]. In mice, there are three 
sprouty-re1ated genes and two of them are expressed in the lung, Spry2 in the 
epithelium and Spry4 in the mesenchyme [161]. In vitro antisense oligonucleotide 
inactivation of Spry2 expression leads to significant enhancement in branching 
morphogenesis [162]. Conversely, in transgenic lungs overexpressing Spry2 the 
epithelium is hypoblastic (D. Warburton, unpublished). 
A number of other transcription factors and signaling molecules are 
expressed during branching morphogenesis, either in the epithelium or in the 
mesenchyme of the lung [163-165]. Some, like GATA-6, are required for normal 
branching (chapter 3), although it is not clear how they interact with other factors. 
The current model of branching morphogenesis is probably incomplete as it is 
based on a very few signaling pathways. Moreover, the upstream signals that 
control these pathways and the downstream effector molecules are not yet known. 
Clarification of more gene functions and molecular interactions during lung 
development will result in a more comprehensive model for branching and 
ultimately, in the integration of the molecular and the extracellular matrix models. 
Lung epithelium 
The initial branching of the two primary lung buds (E9.5) results in the 
formation of a tubular system, which is called the primordial system. This tubular 
structure is lined by columnar epithelium that is considered as primordial 
epithelium up to around EI4.5. Then, differentiation results in two sharply 
demarcated parts, a proximal part with columnar epithelium and a distal part with 
more cuboidal epithelium. The former constitutes the bronchial, air conducting part 
of the lung while the latter is restricted to the acinar tubules in the respiratory 
portion of the lung. The similarity in the shape of primordial and proximal 
epithelium led initially to the conclusion that the bronchial system is established 
first and that subsequent branching at its distal tips generates the distal respiratory 
epithelium. However, a more extensive histological analysis does not support this 
hypothesis [166] and it is also contradicted by recent molecular data [165]. 
Epithelial differentiation begins in an extensively branched epithelium. 
The sharp demarcation of the two different epithelia simply suggests that the 
bronchial and respiratory systems each originate from a separate part of the 
primordial system. Branching morphogenesis is however, not completed by EI4.5. 
Even in the bronchial system the number of generations of bronchial branches may 
not be the final. New branches can only arise by lateral branching of primordial 
epithelium that is still present in the bronchial part of the lung. In the distal part, the 
acinar tubules undergo a more extensive morphogenesis, which occurs during the 
developmental stages that follow the pseudograndular stage, after E16.5 until 
puberty (P30). It involves transitional structures with a duct-, sac-, or pouch-like 
shape that all constitute the prospective pulmonary acinus, which is the distal 
respiratory unit of the developing lung [166]. The definitive pulmonary acinus is 
established when growth has stopped, after puberty. Scanning electron microscopy 
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revealed that it consists of one or two generations of rather short respiratory 
bronchioles and about three generations of alveolar ducts opening into alveolar 
sacs [167]. The abrupt transition of the epithelium can be seen in the respiratory 
bronchioles where the distal part consists of cuboidal/squamous epithelium while 
the more proximal part contains columnar epithelium [168]. 
In the developing lung the columnar epithelium consists of tall cells 
studded with microvilli. Around E17 there is an increasing number of ciliated 
columnar cells, which are interspersed with protruding nonciliated cells. The latter 
are known as Clara cells and can be recognized after EI8 by their apical 
cytoplasmic protrusion, their tall shape, oblong nuclei, and the fact that they rise 
higher than the adjacent ciliated columnar cells. Molecularly they are marked by 
the expression of the Clara Cell marker-fO (CCfO) protein [169]. The ciliated cells 
of the lung, like other ciliated cells, are molecularly identified by expression of the 
winged-helix protein HFH-4 (hepatocyte nuclear jactor-3ljorkhead homologue-4) 
[170]. 
The cuboidal epithelium in the prospective pulmonary acinus is 
exclusively of the alveolar type. By E15 the embryonic Type II alveolar cells can 
be identified. They have large, fairly round nuclei and distinct ultrastructural 
features with the most typical being large apical and basal glycogen fields [171]. In 
general, glycogen may constitute a source of energy and in these particular cells it 
may serve as a substrate for surfactant phospholipid biosynthesis, which is their 
main subsequent function. Before birth the glycogen fields disintegrate and 
normally their presence is considered as a distinct sign of cell differentiation in 
prenatal Type II cells. Ultrastructural studies revealed that endoplasmic reticulum 
is regularly found in the glycogen fields and it constitutes the envelope of glycogen 
containing cytoplasmic inclusions. These inclusion bodies show a widespread 
distribution and they are extremely variable in appearance. In fact, five main types 
of inclusion bodies have been identified during the course of Type II cell 
maturation and they occur with intermediate and composite forms [172]. 
Morphological similarities and differences in electron density suggest that these 
inclusion bodies are primary stages in the formation of multilamellar bodies, which 
are structures typical for the mature Type II alveolar cells [168, 172]. 
The embryonic Type II cells have a primary morphogenetic function in 
pulmonary acinus formation since they are the only dividing cells. Furthermore, 
they are the stem cells of the complete alveolar epithelium. In addition to the 
mature Type II alveolar cells, which are mainly involved in surfactant production, 
they also give rise to the more flat Type I alveolar cells that appear before birth in 
the derivative structures of the acinar tubules (ducts, sacs and pouches). The 
function of Type I cells is to mediate gas exchange and they are always in close 
proximity with the capillaries. This proximity is thought to be the main driving 
force of their differentiation [172]. However, the transformation process of the 
embryonic Type II cells into Type I cells is not understood. It has been even 
suggested that Type I cells are the result of further differentiation of mature Type II 
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cells. Support for this hypothesis comes from in vitro transdifferentiation 
experiments [173, 174]. From the moment of epithelial differentiation (EI4.5), the 
precursor-Type II cells can be molecularly identified by the expression of different 
surfactant proteins, like Surfactant Protein-C (SP-C) [175]. The mature Type II 
cells sustain surfactant protein expression, while the differentiation to Type I cells 
is associated with diminishing surfactant expression. 
The aforementioned cell types are only a few, out of the many, present in 
the lung epithelium. Some of their functions, like mucus secretion, production of 
surfactant and gas exchange are among the essentials for normal respiration. 
However, the other cell types may influence their development and differentiation. 
The puhnonary endocrine cells (PNE) could be such an example. These clusters of 
cells (or individual cells) are among the first to differentiate from the primitive 
lung epithelium and it is thought that they may regulate further epithelial 
differentiation by expressing a number of cytokines [165, 176, 177]. 
The current knowledge of the molecular control of pulmonary epithelial 
differentiation is very limited. Gene targeting studies have implicated some gene 
functions as essentials for this process. In most of the cases the differentiation 
defect is coupled to an earlier branching morphogenesis defect, making evaluation 
more difficult. However, for others, the clear involvement in branching only 
implicates that the gene function is dispensable for normal differentiation. The shh 
pathway appears to be a typical example. Mutant lungs fail to branch and they form 
two bilateral sacs subsequent to the formation of the primary buds. Nonetheless, 
proximo-distal (P-D) differentiation appears to take place and both proximal and 
distal epithelial markers were detected in the mutant lungs [142]. The function of 
TTF-l, GATA-6, HNF3-j3 and TGFj3-1 seem to be important for both branching 
and epithelial differentiation. Gene inactivation of TTF-J results in a phenotype 
similar to shh mutant lungs with the difference that distal epithelial differentiation 
is also impaired [142]. The generation of highly chimeric lungs with GATA-6-1- ES 
cells resulted in abnormally branched lungs that lack any P-D differentiation 
(chapter 3). Furthermore, transgenic embryos overexpressing the protein under the 
control of the human surfactant protein-C promoter [178], have an epithelium that 
is less extensively branched but more interestingly its differentiation to distal 
alveolar epithelium is blocked. None of the mature forms of the alveolar epithelium 
(Type I and II) are detected, while proximal epithelium is fully differentiated 
(chapter 4). The same promoter was used to generate transgenic lungs 
overexpressing HNF3-j3 or TGFj3-L In addition to morphogenetic arrest, epithelial 
differentiation in these transgenic lungs was blocked at the pseudoglandunal stage 
oflung development [179, 180]. 
Proximal cell fate has been associated with HFH-4, which is specifically 
expressed in ciliated proximal epithelium [170]. Mutant mice lack cilia and they 
have random left-right laterality of the lung [130]. Interestingly, transgenic lungs 
with ectopic expression of the gene in the distal epithelium have an altered 
epithelial differentiation in addition to branching defects. Instead of alveolar 
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epithelium, the pulmonary acinus is lined with ciliated cells, which are typical for 
proximal epithelium [170]. Thus, HFH-4 seems to be required for developing the 
proximal phenotype and the protein is able to induce this phenotype in epithelium 
that is destined to be distal [181,182]. 
BMP-4 is considered as an important determinant for distal epithelial fate. 
Transgenic overexpression of BA1P-4 resulted in markedly decreased distal 
differentiation, monitored as SP-C expression. However, ultrastructural analysis 
suggested that Type I cell fate was promoted instead, although molecular 
confirmation could not be obtained due to a lack in Type I specific markers [139]. 
A subsequent transgenic study in which BMP-4 was blocked, either by a dominant 
negative BMP-4 receptor (BA1P RIB) or by the secreted BMP-4 antagonist Noggin, 
introduced the idea of signaling centers regulating P-D cell fates in the lung [140]. 
Inhibition of BMP-4 activity resulted in a severe reduction in distal epithelial cell 
types and in a concurrent increase in proximal cell types. Both morphology 
(presence of cilia) and expression of markers, like HFH-4 and CClO, confirm the 
latter. According to the proposed model, BMP-4 is part of an apical signaling 
center that influences epithelial cell fate in its close proximity. Cells exposed to 
high levels of BMP-4 would maintain or adopt a distal character, while cells 
receiving little or no BMP-4 signal would initiate a proximal differentiation 
program. FGF-I0 is anticipated to be part of such a signaling center since it is one 
of the inducers of BA1P-4 expression in the epithelial tip of the growing bud [115]. 
However, endoderm that buds towards an FGF-l 0 bead does not show a particular 
distal character, at least with regard to surfactant protein expression [114]. In the 
trachea transdifferentiation experiments, FGF-7 in combination with other factors 
was able to induce distal fate, but FGF-IO was unable to do so [183]. Nevertheless, 
the proposed role of BMP-4 concentration in pulmonary cell fate acquisition is 
analogous to the mechanism of cell fate determination in the limb. The progressive 
zone that is induced in the mesenchyme by FGF signaling from the apical 
ectodermal ridge (AER) shows high levels of BA1P-4 expression. Cells leaving this 
zone differentiate as proximal cell types, while cells remaining in the zone continue 
to proliferate and acquire a more distal cell character [184, 185]. It therefore seems 
likely that combinatorial FGF-I0 and BMP-4 signaling may generate an apical 
signaling center in lung endoderm, which coordinates both branching 
morphogenesis and P-D epithelial differentiation. 
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GATA FAMILY OF TRANSCRIPTION FACTORS 
The GAT A family of transcription factors consists of proteins that are able 
to regulate transcription by binding to DNA elements in cis containing the 
consensus sequence AlTGATAAIG. This activity is mediated by a higbly 
conserved Cys-X2-Cys-Xl7-Cys-X2-Cys zinc fmger motif which is present in the 
carboxy-terminus of each of the members of the family. A second zinc fmger 
motif, more proximal to the amino-terminus of the protein, modulates DNA 
binding and interacts with other proteins-cofactors. GATA factors have been 
characterised in a number of different species ranging from yeasts to humans. In 
fungi they regulate nitrogen metabolism, ligbt induction, siderophore biosynthesis 
and mating-type switching [186]. The Caenorhabditis elegans ENDI GATA factor 
controls gut endoderm specification [187] and in Drosophila, the serpent gene is 
involved in haematopoiesis and endodermal midgut specification [188, 189] while 
pannier functions during specification of cardiac cell fate [190]. In higber 
vertebrates there are six members identified to date and they are subdivided into 
two subfamilies. The first three members consist the haematopoietic subfamily 
since they all have unique functions during the development of different 
haematopoietic lineages although they are also expressed in other tissues [191, 
192]. GATA-4, -5, --6 are the heart and gut related members [84, 193]. 
GATA-l 
Expression and mutant phenotype 
GATA-I is the founder and the best studied member of the GATA family 
of transcription factors. In the haematopoietic system, it is expressed 
predominantly in the erythrocyte lineage but also in megakaryocytes and mast cells 
[194-196]. It is also expressed in the Sertoli cells of the testis [197]. Loss of 
function studies in mice revealed that GATA-I protein is required for survival and 
maturation of both primitive and definitive erythroid precursors [198-202]. GATA-
I promotes erythropoiesis not only by the induction of lineage specific gene 
expression but also by controling cell proliferation [203] and apoptosis [192]. 
When GATA-l expression is elevated the precursor cells proliferate at the expense 
of differentiation, resulting in the block of erythropoiesis [205, 206]. In the 
megakaryocyte lineage, GATA-I controls proliferation and growth of precursor 
cells affecting platelet development [207, 208]. In Sertoli cells there is no in vivo 
data demonstrating a unique function of GAT A-I and only expression and in vitro 
studies have implicated the protein in the repression of anti-Mullerian hormone 
expression after birth [209]. 
Regulations and interactions 
Within the haematopoietic system, GATA-I exerts its function by binding 
to the consensus sites in the DNA of target genes and by interacting with other 
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proteins. This dual function is important not only for developing a lineage-specific 
phenotype but also in determining cell fates for lineage specification. Of the two 
zinc fingers, the carboxy-terminal one is both necessary and sufficient for binding 
to the DNA, while the amino terminal one shows no independent DNA binding 
activity [210]. However, the amino terminal zinc finger was shown to bind to a 
more diverse site, with potential implication in transcriptional repression [211]. 
Furthermore, the amino finger influences the specificity of the binding of the 
carboxy terminal finger to the DNA. Depending on the binding site(s), it can 
stabilize, disrupt or modify binding to the DNA resulting in diverse transactivation 
properties of the GATA-l protein [212]. By this mechanism GATA-l (and 
probably other GAT As ) can discriminate between genes and elicit distinct 
responses from them. 
The amino terminal zinc finger mediates interaction with other proteins. 
The best example is the Friend of GAT A-I (FOG-I) zinc finger protein, which can 
enhance or repress GATA-l-mediated activation [213, 214]. The significance of 
this interaction is demonstrated by the phenotype of mice mutant for FOG-I, which 
is similar to that of GAT A-I mutants but with a more enhanced defect in the 
megakaryocyte lineage [215]. Furthermore, humans carrying a mutation in the 
amino terminal finger of GATA-I, which is shown to affect interaction with FOG-
1, have dyserythropoietic anemia and thrombocytopenia [216]. GATA-l 
interaction with the widely expressed molecules CBP and p300 could extend the 
function of the protein beyond the erythroid lineage. These transcription cofactors 
were shown to promote GATA-l activity and although acetylation could be one of 
the mechanisms, the nature and significance of the interaction is not yet clear [217-
219]. There are better-understood interactions that demonstrate the role of GAT A-I 
outside the erythroid and megakaryocyte lineages. Generally, GATA-l together 
with FOG-l is thought to maintain the multipotency of the haematopoietic 
precursors. Modulating GATA-l activity by removing FOG (CIEBP mediated 
downregulation) leads to the differentiation of eosinophils [220]. Inhibition of 
GATA-l binding to the DNA by the myeloid specific transcription factor PD.l 
allows the differentiation of the myeloid lineage [221, 222]. 
Thus, the crucial role of GATA-l during haematopoiesis is mediated by 
the DNA binding ability of the carboxy-terminal finger and by the crucial function 
of the amino-terminal finger in modulating this binding and furthermore in 
interacting with other tissue specific or general transcription cofactors. However, 
the two zinc fingers of GATA-l alone are not sufficient to recapitulate the full 
function of the protein. The recombination of a GATA-3 cDNA into the GATA-I 
locus resulted in a partial rescue of the survival of the erythroid precursors due to 
the insufficient accumulation of GATA-3 protein [223]. When different GATAs 
were expressed under a GAT A-I locus control construct, which is able to dictate 
proper protein accumulation, embryonic haematopoiesis was rescued but adult 
erythropoiesis was impaired [224]. This suggests that the almost identical zing 
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fingers possessed by the haematopoietic GAT As do not make them functionally 
equivalent and that GATA-I has a unique function during haematopoiesis. 
GATA-2 
Expression and mutant phenotype 
GATA-2 is highly expressed in haematopoietic precursors and at a lower 
level in early erythroid cells, mast cells and megakaryocytes [225]. Outside the 
hematopoietic system, GATA-2 expression overlaps with that of GATA-3 in many 
sites of the developing central nervous system [226] and in the placenta [227]. 
Lack of GATA-2 in mice results in early embryonic lethality due to defective 
haematopoiesis, and virtually all lineages are affected [228]. This phenotype 
pointed to a crucial role of GATA-2 in the survival and expansion of early 
haematopoietic precursors or stem cells [229]. During differentiation of pluripotent 
haematopoietic cells, GATA-2 expression declines and in the erythroid lineage this 
is necessary for the further development of the erythroid phenotype [230-232]. The 
erythroid specific GATA-l protein mediates this GATA-2 downregulation, which 
does not occur in embryos lacking GATA-l [200]. When GATA-2 expression is 
sustained in the haematopoietic progenitors, there is a block in their amplification 
and differentiation, implying that GATA-2 protein is a crucial determinant in 
influencing self-renewal versus differentiation [232]. In the placenta, GATA-2 
together with GATA-3 regulates the synthesis of placental hormones. Placentas 
lacking GATA-2 secrete less angiogenic activity and the decidual tissue adjacent to 
these placentas displays markedly reduced neovascularization [233]. 
GATA-2 and Central Nervous System 
During development of the central nervous system, GATA-2 is expressed 
as early as embryonic day 9 in the developing hindbrain. More specifically, the 
protein is detected in ventral rhombomere 4 and transiently in rhombomere 2 [226]. 
In rhombomere 4, expression of GATA-2 is induced by Hoxbl and it is necessary 
for further induction of GATA-3 expression. Studying null mutant embryos proved 
this hierarchy and furthermore, it was shown to be critical for the correct projection 
and migration of neuron originating from rhombomere 4 (vestibuloacoustic 
efferent, facial branchiomotor) [234]. After embryonic day 9, GATA-2 is expressed 
in many different sites of neuronal differentiation and it has been suggested that, 
like in haematopoiesis, GATA-2 is involved in the maintenance of the pool of 
ventral neuronal progenitors [226]. This was clearly demonstrated for the V2 
intemeurons, which were drastically diminished in GATA-2 null mutant embryos 
[235]. When all three critical functions of GATA-2 mentioned above were rescued 
by a YAC transgene, another unexpected role of the protein was revealed. Rescued 
pups died of hydrouretemephrosis caused by severely deformed kidneys and 




Expression and mutant phenotype 
Although GATA-3 is considered the third haematopoietic GATA factor, its 
only site of expression in the haematopoietic system is in T-lymphocytes of the 
thymus. Outside the haematopoietic system, it is expressed in a number of different 
tissues and organs like ectoplacental cone, central and peripheral nervous system, 
otic and optic vesicles, kidneys, liver, adrenal glad, endothelial cells [237, 238]. 
Loss of function of GATA-3 in mice results in an early lethality around embryonic 
day 12 due to extensive internal bleeding and severe deformities of the brain and 
the spinal cord [239]. In vitro culturing of GATA-3 mutant fetal liver cells 
suggested that the protein is required for definitive fetal liver haematopoiesis 
although no lineage specificity was demonstrated. Only recently, expression of 
GATA-3 was described in intraembryonic hemogenic sites, like the floor of the 
dorsal aorta and some mesodermal aggregates beneath the aorta, suggesting a 
potential role in intraembryonic stem cell generation [240]. 
GATA-3 and T-cell development 
GATA-3 mutant ES cells are able to contribute in vivo to all different 
haematopoietic lineages except thymocytes and mature peripheral T-cells [241, 
242]. In this lineage GATA-3 is required for the development of the early T-cell 
progenitors and protein expression is associated with distinct differentiation stages 
[241]. It is involved in the induction of all the Th2 cells specific cytokines, thereby 
playing a key regulatory role as mediator of the humoral immune response [243-
245]. Increased levels of the protein have been associated with allergic response 
[246] and a dominant negative form of GATA-3 inhibits allergic inflammation in a 
murine model of asthma [247]. This dominant negative form revealed that 
acetylation is an important modification of the protein and that this alone affects T-
cells survival and homing to secondary lymphoid organs [248]. Interaction with 
other proteins (RaG-repressor of GATA) is emerging as one of the mechanism 
through which GATA-3 regulates expression of cytokine genes and thereby 
differentiation to Th2 versus Thllineage [249]. The crucial function ofGATA-3 in 
the T-cell lineage and more specifically in the Th2 cells, renders the protein as a 
key regulator in this haematopoietic lineage and further as a potential therapeutic 
target of asthma and allergic diseases [250]. 
GATA-3 and Nervous System 
The expression of the gene in the central nervous system and the study of 
the genomic sequences conferring this expression pattern [251, 252] led to a 
pharmacological rescue of the embryonic lethality in the GATA-3 mutant mice. 
Early embryonic development was rescued by providing the embryos in vivo with 
catechol intermediates to stabilize noradrenaline production [253]. This rescue 
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established an important role of the protein in the sympathetic nervous system and 
furthermore implies that absence of GATA-3 in this system is actually the primary 
cause of the previously described embryonic lethality [239]. In the rescued 
embryos, subsequent necessary functions of the protein were revealed in a number 
of other tissues and organs. Derivatives of the cephalic neural crests, like lower jaw 
and part of the ear were affected and organs like thymus and kidneys were 
hypoplastic [253]. As explained above, thymus development was not surprisingly 
affected and GATA-3 was already implicated in human kidney development [254] 
as well as in the differentiation of the hair cells in the cochlea of the mouse ear 
[255]. More interestingly, GATA-3 haplo-insufficiency has been recently associated 
with the hypoparathyroidism, sensorineural deafness, renal anomaly (HDR) 
syndrome in humans [256]. This also holds true in mice, at least with regard to 
deafuess (van der Wees, unpublished). 
Since the gene is expressed in multiple sites in the central and peripheral 
nervous system [226], a more detailed analysis of the pharmacologically rescued 
mutants may reveal more distinct functions of GATA-3 protein within these 
systems. However, there are some sites in the nervous system in which GATA-3 
function has already been explored. As mentioned earlier, induction of GATA-3 
expression by the Hoxbl induced GATA-2 in rhombomere 4 is critical for the 
correct projection and migration of neurons originating from this rhombomere 
[234]. Furthermore, the study of chimeric embryos generated with GATA-3 mutant 
ES cells implicated the protein in the development of serotonergic neurons in the 
caudal raphe nuclei and in their function in locomotion [257]. 
GATA-4 
Expression and mutant phenotype 
GATA-4 is the best studied member of the heart and endoderm related 
subfamily of GATAs. During embryogenesis, it is expressed in the visceral yolk 
sac endoderm, in the cardiogenic mesoderm and subsequently in the developing 
heart, in proximal and distal gut, testis, ovary and liver [258, 259]. Expression 
persists in the adult heart, ovary, testis, liver and small intestines [259]. GATA-4 
inactivation in the mouse results in embryonic lethality around day 8.5 due to 
defects in heart morphogenesis and ventral closure of the foregut [20, 21]. The 
cardia bifida displayed by the mutant embryos is the result of a failure in ventral 
fusion of the lateral aspects of the embryo and the cardiac tissue that is present 
bilaterally is fully differentiated. Although in vitro studies in P19 cells suggested 
that GATA-4 is required for terminal cardiac differentiation [260], GATA-4 -/- ES 
cells are able to contribute to all three heart layers in chimeric embryos and the 
mutant cardiomyocytes in such embryos have a fully differentiated phenotype 
[261]. Furthermore, in embryos mutant for the cardiac basic helix-loop-helix 
protein dHAND, there is no GATA-4 expression in the cardiac mesoderm and yet 
cardiac differentiation and morphogenesis proceed to latter stages when embryos 
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die due to underdeveloped right ventricle and abnonnal outflow tract [262]. These 
data imply that the GATA-4 protein is not essential for tenninal differentiation of 
cardiomyocytes and suggests that other GATAs, such as GATA-5 or GATA-6, 
may compensate for the lack of GATA-4. 
Primary defect in mutants embryos 
The phenotype of the GATA-4 null embryos points to a more general defect 
in the proper ventral closure of the embryo resulting from an abnonnal 
morphogenesis of the definitive endodenn. However, this is not due to an intrinsic 
defect in the definitive endodenn lineage but rather due to a defective signaling 
from the primitive yolk sac endodenn. When GATA-4 -1- ES cells were 
differentiated in vitro, the mutant embryoid bodies were deprived from fully 
differentiated visceral yolk sac endodenn [22]. In vivo, chimeric embryos 
exclusively derived from GATA-4 mutant ES cell were nonnal due to the wild type 
primitive yolk sac endodenn that is provided by the wild type host blastocyst [76]. 
In the quail system, transplantation of nonnal anterior primitive endodenn is able 
to rescue defects in heart tube morphogenesis caused by absence of GATA-4 
expression due to vitamin A deficiency [263]. These observations are in support for 
a role of GATA-4 in the extraembryonic primitive endodenn and although in the 
GATA-4 mutant embryos the yolk sac was fonned, its function and signaling ability 
has not been assessed. Additionally and more interestingly, it was observed that 
one third of the GATA-4 null embryos were arrested before gastrulation when the 
gene is nonnally expressed in the visceral yolk sac endodenn [20]. The null 
embryos that were characterized at embryonic day 8.5 are likely to represent the 
ones that survived due to a compensatory effect of the GATA-6 protein, which has 
been shown to also be expressed in the primitive endodenn and it is upregulated in 
the GATA-4 mutant embryos [20,21,264]. 
Role in cardiogenesis 
Although the in vivo data from the GATA-4 null embryos and ES cells 
suggest redundancy among the GATA factors during heart development there are 
numerous in vitro studies demonstrating the transcriptional regulation of cardiac 
specific genes by GATA-4. Very few of these transcriptional regulations are 
specific for GATA-4 but there are some protein interactions appearing to be 
specific for GATA-4 protein. Furtbennore clinically associated conditions have 
been specifically connected to GATA-4 function. The protein was shown to 
regulate a number of structural cardiac genes such as - and -myosin heavy chain 
(-, -MHC) [265], cardiac troponin-C (cINC) [266], atrial natriuretic factor 
(ANF) [267], brain natriuretic peptide (BNP) [268], cardiac troponin-I [269, 270], 
sodium/calcium exchanger (NCXl) [271], cardiac-restricted ankyrin repeat protein 
(CARP) [272], Al adenosine receptor [273], m2 muscarinic receptor [274] and the 
myosin light chain 113 [275]. Among all these cardiac genes only - and - myosin 
heavy chain gene are preferentially regulated by GA TA-4 due to higher affinity of 
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the protein for their promoters [276]. For most of the other genes there is 
cooperative interactions among the GATAs, and especially GATA-6, which is 
coexpressed with GATA-4 in both myocardium and endocardium [258, 259, 277]. 
The two proteins are able to form an heterotypic complex that binds a single 
GATA site and synergistically activates transcription [276]. The complexity of the 
heart with the dynamic, but non fully overlapping, expression pattern of all three 
GAT As during heart morphogenesis suggests that only heart specific gene 
depletion of each one of the members will reveal a possible unique function during 
cardiogenesis. In humans, a chomosomal deletion resulting in GATA-4 
haploinsufficiency has been associated with congenital heart diseases [278] and 
although other genes may also be involved, they are certainly not GATA-5 or -6. 
Protein interaction with Nkx 2.5 
An interesting regulation and interaction is with the homeobox gene Nkx 
2.5 (the homologue of the Drosophila tinman), which is required for proper looping 
of the heart [279]. In promoter studies of Nkx 2.5, GATA sites were identified 
which are functional at different stages during cardiogenesis [280, 281]. From 
GATA-4 dominant negative experiments in Xenopus it has even been suggested 
that GATA factors may normally antagonize transcription of Nkx2.5 thereby 
limiting the boundaries of its expression domain during specification of the 
cardiogenic field [282]. The two proteins are co-expressed very early during the 
specification of the cardiac mesoderm and in the chick embryo they were shown to 
be direct mediators of the cardiac inductive signal of the bone morphogenetic 
proteins (BMP) [283-285]. However, neither of them alone is able to induce the 
full cardiogenic program, both proteins need to be present [286,287]. 
This observation led to the hypothesis that the two genes may function in 
concert to induce cardiac development. Indeed, the study of the ANF and cardiac 
-actin promoter proved that there is a synergistic transcriptional activation of both 
genes by Nkx 2.5 and GATA-4 proteins. Additionally, a direct physical interaction 
of the two proteins was demonstrated, which involves the carboxy-terminus part of 
GATA-4 (including the zinc finger) and the carboxy-terminus part (with the 
homeodomain) ofNkx2.5 [288,289]. The result of such an interaction depends on 
the promoter and the binding sites present. If Nkx2.5 binds to the DNA its 
autorepressive domain is blocked by interacting with GATA-4 allowing Nkx2.5 
mediated transcriptional activation [290]. When only a GATA site is present, 
interaction with Nkx2.5 reduces the ability of GATA-4 to activate transcription 
[291]. Interestingly, this interaction with Nkx2.5 appears to be the only specific 
one for GATA-4, for example GATA-6 cannot substitute for GATA-4 [290]. 
Other important interactions 
Other proteins such as the MADS box proteins, serum response factor 
(SRF) and myocyte enhancer factor-2 (MEF-2), also interact with the carboxy-
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terminus of GATA-4 to activate cardiac specific gene expression [292, 293]. 
Similar to GATA-l, interaction with the general factor CBP was shown to 
stimulate transcription dependent on GATA-4 [217]. The amino-terminal zinc 
finger of GATA-4 mediates an interaction with the transcriptional modifying 
protein friend of GATA-2 (FOG-2) [294-296]. It is uncertain if FOG-2 acts as a 
transcriptional activator or repressor of GATA-4, but its interaction with the 
repressor protein CtBP2, implies that FOG-2 may be a transcriptional repressor of 
GATA-4, -5 and -6 [297]. This interaction is likely to play an important role in 
regulating GATA factor-dependent gene expression in the heart since FOG-2 null 
mice die during embryogenesis with significant cardiac abnormalities [298,299]. 
Last but not least, a very interesting interaction with significance for heart 
failure is that with the Nuclear Factor of Activated T-cells 3 (NF-AT3). GATA-4 
was implicated in hypertrophic heart development that results in heart failure by 
the upregulation of its expression, necessary for the induction of genes required for 
the growth of the cardiac tissue [300-302]. The interaction of GATA-4 with NF-
AT3 (GATA-5 and -6 can also interact) upon translocation of the latter to the 
nucleus is one of the ways that this induction is mediated. Since NF-AT3 
translocates to the nucleus subsequent to calcium dependent phosporylation, it 
suggests a link between the increased calcium levels detected in heart failure and 
the resulting cardiac gene transcription [303, 304]. 
Gonadal differentiation 
Among all the other tissues expressing GATA-4, the dynamic expression 
pattern of the gene in the gonads implicated GATA-4 in early gonadal 
differentiation and sexual dimorphism. By embryonic day 11.5, when there is no 
sex-specific differentiation, GATA-4 is expressed in the primitive gonads of both 
male and female embryos. Shortly after the histological differentiation of the 
ovaries, expression is markedly reduced while in the testis expression persists 
throughout development and adulthood [305]. Specifically, GATA-4 expression is 
associated with the somatic cell lineages, the Sertoli and Leydig cells in the testis 
and the granulosa cells in the ovary, rather than the primordial germ cells [306, 
307]. However, in humans expression of GATA-4 has been reported in fetal germ 
cells and prepubertal spermatogonia and it is downregulated after puberty [308]. 
Consistent with the role of GATA-4 in sexual dimorphism of the gonads, 
the protein was shown to regulate expression of the Mullerian inhibiting substance, 
which is necessary for male sex differentiation [305]. This regulation is mediated 
by protein interaction with another sex determination protein, the steroidogenic 
factor-I (SF-I) [309,310]. Furthermore, GATA-4 and the co-expressed GAT A-I 
were shown to transactivate inhibinlactivin beta-B-subunit gene transcrption in 
testicular cells [311]. 
Although the gene is downregulated in the embryonic ovaries, there is 
strong expression after birth in the granulosa cells of the follicles. This expression 
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declines as the cells differentiate or undergo apoptosis, suggesting a function of 
GATA-4 as a cell survival factor in granulosa cells, analogous to GATA-I in 
erythroid cells [312]. Another role in reproduction has been speculated for GATA-
4, though not directly relevant to gonadal development. Gene expression was 
shown in migrating gonadotropin-releasing neurons and the protein was shown to 
regulate the promoter of the gonadotropin-releasing hormone (GnRH) gene [313, 
314]. 
GATA-4 and definitive endoderm 
Within the definitive endoderm lineage, not much is know about specific 
functions of GATA-4. GATA-factor-binding activity has been described in gnt 
endodermal cells at their pluripotent stage. Such activity, at least half contributed to 
GATA-4, potentiates gene expression and endoderm specification to organs such 
as the liver, as it will be discussed later [80, 81]. This was studied iil the liver 
specific albumin gene and gave insight not only in a liver specific GATA-
regnlation but in a general mechanism of gnt endoderm specification [80]. Another 
gene that is expressed in the liver and is activated by GATA-4 is the homeobox 
gene Hex. GATA-4 together with Hepatocyte Nuclear Factor-3b (HNF-3b) 
transactivate the gene specifically in this organ [3 IS]. In the small intestines, 
expression of all three GATAs has been described in different vertebrates. GATA-4 
and -5 seem to have overlapping expression pattern and they have been both 
associated with terminal differentiation of epithelial cell at the tips of the villi. 
GATA-6 has a distinct, complementary expression pattern [316]. 
GATA-5 
Expression and mutant phenotype 
During embryogenesis, GATA-5 is expressed in the allantois, heart, 
outflow tract, lung mesenchyme, urogenital ridge, bladder and gut epithelium. 
Expression persists in the small intestine, stomach, bladder and lungs in adult life 
[317]. Surprisingly, for a GATA protein, targeted disruption of GATA-5 in the 
mouse did not result in embryonic lethality. Male mutant mice are 
indistinguishable from wild type mice and only in the mutant females there are 
some abnormalities in their genitourinary tract [318]. Specifically, these females 
show malpositioning of the urogenital sinus, vagina and urethra, a phenotype 
mimicking a condition of proximal hypospadias in human females. This result 
clearly demonstrates that GATA-5 has a unique function during female 
genitourinary tract development and that in other organs expressing the protein 
other GAT As may compensate for its lack. 
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Role in cardiogenesis 
During cardiogenesis, GATA-5 has a more restricted expression pattern that 
overlaps with both GATA-4 and -6. At the early primitive steak stage it is 
expressed in the precardiac mesoderm and later, during and after heart looping, 
GATA-5 transcripts are detected in both atrial and ventricular chambers [317]. 
Expression markedly declines at midgestion and becomes restricted to the 
endocardium and finally it ceases during late fetal and postnatal development. 
Given this restricted expression pattern and the already mentioned fact that most 
cardiac genes can be equally efficient regulated by all GATA proteins, the 
normally formed hearts in the GATA-5 null embryos did not come as a surprise. 
However, GATA-5 specific cardiac regulation has been suggested in rat 
cardiomyocytes due to higher affinity of the protein for some promoters [319]. 
Furthermore, specific protein interaction with the ubiquitously expressed 
transcriptional activator p300 was shown to regulate transcription of the cardiac 
restricted atrial natriuretic factor gene (ANF) [320]. Also transcription of the -
myosin heavy chain gene in myocardial cells undergoing leukemia inhibitory 
factor-induced hypertrophy was attributed specifically to GATA-5 [321]. 
Interestingly, in zebrafish, mutation of the GATA-5 affects the production of 
normal numbers of myocardial procursors, the expression of cardiac specific genes 
and the migration of the cardiac primordia to the embryonic midline [322]. In fact 
the phenotype is quite reminiscent of the mouse embryos mutant for GATA-4, 
suggesting a potential reversal in the roles of these two GATA proteins between 
mammals and fish. 
GATA-5 and definitive endoderm 
As can be predicted from the mouse GATA-4 null phenotype, endoderm 
morphogenesis is also affected in the zebrafish GATA-5 mutants [322]. However, 
Xenopus is an organism in which GATA-5 plays a key role in the endodermal 
lineage. As in other vertebrates, during gastrulation endoderm is one of the three 
germ layers that subsequently gives rise to most of the thoracic and abdominal 
organs. During Xenopus development, GATA-5 is specifically expressed in the cell 
population that will become the endoderm. But more importantly, when it is 
ectopically expressed in another germ layer, like mesoderm, it is able to respecifY 
the cells towards an endodermal fate [64]. In higher vertebrates GATA-5 was 
shown to regulate expression of the pepsinogen gene in the developing chicken 
stomach and its own expression is affected by epithelial-mesenchymal interaction 
[323]. Additionally, there is the study of intestine epithelial cell differentiation, 
which is already mentioned in the function of GATA-4. The two genes are 
coexpressed at the villus tip where there is extensive cell differentiation and they 
have been both implicated in activation of terminal differentiation genes like 




GATA-6 is presently the last member of the GATA family of transcription 
factors and it is expressed in a number of different tissues. When the expression 
domains of all the other members are also considered, there is hardly any tissue of 
mesodermal or endodermal origin that does not express one of the GATAs at some 
stage during development. GATA-6 is first expressed at the blastocyst stage in part 
of the inner cell mass and in the trophectoderm (chapter2). During and after 
gastrulation, expression can be seen clearly in the derivatives of the primitive 
endoderm, visceral yolk sac and parietal endoderm. Subsequent to mesoderm 
formation, the gene is expressed in the lateral plate mesoderm and it marks the 
cardiogenic plate [23, 258] (chapter2). Throughout heart tube development 
transcripts are present in both myocardium and endocardium. However, subsequent 
to the formation of the four chambered heart, high expression levels are found in 
the left ventricle and atrium as well as in the endocardial cushions of the outflow 
tract, the atrioventricular canal and the interventricular septum [258, 324]. Parallel 
to the dynamic expression during heart tube formation and morphogenesis, strong 
expression is detected in the developing primitive gut and throughout foregut, 
midgut and hindgut development. Later during embryonic and fetal development, 
GATA-6 transcripts are detected in the bronchial epithelium of the developing 
lungs, in the liver, dorsal aorta, urogenital ridge, granulosa cells of the ovary, 
Sertoli cells of the testis, arterial smooth muscle cells and in the epithelial layer of 
the stomach, small and large intestines [258, 307, 312, 325]. Postnatally, GATA-6 
expression persists in the heart, aorta, lung, stomach, small intestines, gonads, 
adrenal cortex and bladder [258, 326]. 
Mutant phenotype 
Although GATA-6 is the last member of the family it is actually the one 
that is required frrst during development since mice depleted of its function die 
around embryonic day 6 [23] (chapter2). The lethality is caused by a defect in the 
primitive endoderm lineage, most likely in the visceral yolk sac endoderm. 
Evidence in support of this is the expression pattern of the gene in this tissue and 
the dowregulation of visceral endoderm specific genes, like Hepatocyte Nuclear 
Factor- 4 (HNF-4) and GATA-4, in the null embryos. AdditionalIy, the mutant 
embryoid bodies developed in vitro show a defective visceral endoderm with a 
similar effect on gene expression [23]. 
Consistent with this explanation is the study using chimeric embryos 
(chapter2). The analysis is based on a previous observation that in chimeric 
embryos the visceral endoderm as a derivative of the extraembryonic primitive 
endoderm, receives very low, if any at all, contribution from the injected ES celIs 
[327]. Therefore, the generation of chimeric embryos by using different 
combinations between wild type or GATA-6 mutant blastocysts and ES cells can 
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attribute tbe defect to tbe embryo or to an extraembryonic tissue. When GATA-6-/-
ES cells were used to generate higbly chimeric embryos, which were almost 
exclusively GATA-6 -/-, tbe early letbality was overcome. This was due to tbe 
presence of wild type extraembryonic tissues tbat were provided by tbe host 
blastocyst. In tbe complementary experiment, GATA-6 -/- blastocysts tbat were 
injected with wild type ES cells did not survive later tban embryonic day 5.5. This 
implies tbat the lack of GATA -6 in tbe extraembryonic tissues provided by tbe 
mutant blastocyst is sufficient to cause tbe letbality. 
Morphology of botb in vitro' and in vivo developed mutant embryos 
suggests tbat visceral endoderm is tbe extraembryonic tissue tbat is defective in tbe 
absence of GATA-6 and indirectly influences tbe growtb and survival of tbe 
underling embryo (chapter 2). Furtber study and comparison of wild type and 
mutant embryoid bodies revealed tbat GATA-6 directly regulates tbe expression of 
the mitogen-responsive phoshoprotein Dab2 in tbe visceral endoderm. This 
regulation is specific to GATA-6 since Dab2 is not detected in tbe visceral 
endoderm of GATA-6 null embryos and GATA-4 not only is unable to confer any 
regulation in vitro but also its absence in vivo does not affect expression of tbe 
Dab2 protein [328]. 
Role in cardiogenesis 
The early letbality of GATA-6 null embryos does not allow direct 
assessment of its potential role during cardiogenesis. As mentioned earlier, 
regulation of different cardiac specific genes has been attributed to botb GATA-4 
and GATA-6 proteins [84, 193] and in tbe case of ANF and BNF tbe two proteins 
form an heterotypic complex to cooperatively activate tbeir transcription [276]. 
Furtbermore, Nkx2.5 regulates an element in both mouse and chicken GATA-6 
genes, which is required for gene expression in the cardiogenic mesoderm [329, 
330]. Considering tbe fact tbat enhancers controlling Nkx2.5 expression in tbe heart 
contain essential GATA binding sites [281, 331], it seems tbattbe two factors cross 
regulate one anotber's expression in tbe cardiac crescent and early heart tube. 
However, it is not known which factor starts tbe feedback loop of tbis cross 
regulation but it is likely tbat tbis loop serves to reinforce an expression induced by 
otber molecules and/or endodermal inductive signals [330]. 
When GATA-6 -/- ES cells were differentiated in vitro, beating 
cardiomyocytes were formed indicating tbat tbe cardiogenic program was 
completed altbough expression of individual genes including Nkx2.5 has not been 
assessed (chapter2). Additionally, in chimeric embryos generated witb GATA-6 
mutant ES cells, contribution is evident in tbe early heart tube suggesting that tbere 
is no cell autonomous defect in cardiomyocytes depleted for GATA-6 [23] 
(chapter2). These data point to a redundant function of tbe protein during 
cardiogenesis and only tbe generation of heart specific mutants will reveal any 
possible unique functions of protein. Interestingly, in Xenopus cardiomyocyte 
GATA-6 expression has been associated witb maintenance of the precursor stage of 
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the cells and differentiation is the result of GATA-6 downregulation. When 
expression of the gene was kept constant normal differentiation was blocked [332]. 
GATA-6 and differentiation 
Association between GATA-6 expresssion and differentiation has been 
studied in human and rat vascular smooth muscle cells (VSMCs). The VSMCs of 
the normal adult vessels are quiescent cells and display characteristics of a 
differentiated phenotype [325]. Upon stimulation to proliferate by mitogens or 
following an arterial injury GATA-6 expression normally declines. When GATA-6 
levels are sustained, sebsequent stimulation with mitogens has no effect since 
GATA-6 induces cell cycle arrest by activating the general cyclin-dependent kinase 
inhibitor p21 [333]. In agreement, in balloon injured rat carotid arteries, GATA-6 
expression normally declines but when it is artificially sustained, the intimal 
hyperplasia associated with the injury is inhibited [334]. At the molecular level, 
GATA-6 was shown to physically interact with the general transcriptional activator 
p300 in order to induce expression of the smooth muscle-myosin heavy chain gene 
(Sm-MHC), a specific marker for the differentiated phenotype of VSMCs [335]. 
This specific function ofGATA-6 in the control of the VSMCs phenotype suggests 
a potential role of the protein in the pathogenesis of atherosclerotic and restenotic 
lesions in humans. Recently, a similar function has been described in the 
glomerular mesangial cells (GMCs) of the kidneys. In these cells GATA-6 
expression is also associated with quiescent phenotype and in a similar fashion 
when the gene was overexpressed, proliferation arrest was induced by upregulation 
ofp2l [336,337]. 
GATA-6 and definitive endoderm; function in the lungs 
In derivatives of the definitive endoderm GATA-6 expression has been 
described in the gastric endocrine cells of the rat [338] and in the stomach 
epithelium the protein activates expression of the Trefoil Factor Family 1 and 2 
genes (TFFI and 2) [339]. In the intestinal epithelium the gene is expressed in a 
pattern complementary to that of GATA-4 and -5. While the two other GATAs are 
expressed in the differentiating epithelium of the villus tip, GATA-6 is expressed in 
the region of the proliferating progenitor cells at the proximal sites of the villus tip 
[316]. During embryonic development, GATA-factor binding activity has been 
associated with endoderm specification to liver promordia, as mentioned already 
for GATA-4 [80, 81]. Additionally, the GATA-6 protein was shown to regulate in 
vitro lung endoderm specific genes like Thyroid Transcription Factor-l (TTF-I) 
and surfactant protein-A [340, 341]. 
The only in vivo data implying an important role of the protein in a 
definitive endodermal lineage was the observation that GATA-6 -1- ES cells do not 
contribute to the broncial epithelium of the developing lungs in chimeric embryos 
[23]. This observation led to a widely accepted conclusion that GATA-6 protein is 
required for early pulmonary endoderm specification [165]. When a more 
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extensive study of the contribution of the GATA-6 mutant ES cells into the lung 
endoderm was carried out, a different and more specific role of the protein was 
revealed (chapter3). The generation of chimeric embryos by using genetically 
marked blastocysts (ROSA26), the progeny of which could be traced in the 
developing embryos, and higher number of injected mutant ES cells demonstrated 
that GATA-6 -/- cells are able to form pulmonary endoderm. Nevertheless, this 
mutant endoderm does not branch properly and its further differentiation is affected 
(chapter3). 
In support of an important function of the protein in branching 
morphogenesis and epithelial differentiation are the data from in vivo 
overexpression of GATA-6 in the lung epithelium (chapter4). When a pulmonary 
epithelium specific promoter (from the human surfactant protein-C gene) was 
employed to direct GATA -6 expression in the lungs of transgenic mice, both 
branching and differentiation were affected. Specifically, the poorly branched 
epithelium was able to differentiate only along the proximal pathway. Distal 
epithelium which normally expresses GATA-6 showed a lack of terminal 
differentiation to Type! or Typell pneumocytes, necessary for gas exchange and 
surfactant protein production, respectively (chapter4). 
Function ofGATA-6 
GATA-6 has several functions. First, it is required in the prunltlve 
endoderm for the proper formation of the visceral yolk sac endoderm, which 
further supports the growth and the survival of the embryo (chapter 2). 
Subsequently, during organogenesis GATA-6 function is crucial for the proper 
branching and differentiation of the pulmonary endoderm to form a functional 
respiratory tree (chapter3). Within the distal epithelium, expression levels of the 
protein are critical for differentiation and when GATA-6 expression is elevated, 
terminal differentiation is blocked (chapter4). Thus, GATA-6 is an important factor 
during endoderm development in the mouse embryo. Such a unique role for a 
GAT A factor in the mouse endoderm does not come as a surprise. As already 
mentioned, xGATA -5 was shown to be necessary and sufficient for endoderm 
specification in the xenopus embryo [64] and in the Caenorhabditis elegans the 
GATA factor ENDl is crucial for the formation of the E cells, the progenitors of 
the endoderm [187, 342]. In flies, the GATA factor serpent determines the 
endodermal midgut [188,189]. 
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SUMMARY 
The gene coding for the murine transcription factor 
GATA6 was inactivated by insertion of a J3-galactosidase 
marker gene. The analysis of heterozygote GATA61lacZ 
mice shows two inductions of GATA6 expression early in 
development. It is first expressed at the blastocyst stage in 
part of the inner ceIl mass and in the trophectoderm.. The 
second wave of expression is in parietal endoderm 
(Reichert's membrane) and the mesoderm. and endoderm 
INTRODUCTION 
The GATA zinc finger transcription factors pla.y a crucial role 
in the development and differentiation of a nwnber of tissues, 
These factors bind the basic consensus sequence AffGATAfG 
through 3. conserved Cys-X2""Cys-X17-Cys-Xz-Cys zinc finger 
protein motif. Three members of the family, GATAI. GATA2 
and GATA3, ::u-e all expressed in the haematopoietic system 
and a number of other (non-overlapping) tissues (Leonard et 
aI .• 1993). Each appears to have a different function in the 
haematopoietic system as the inactivation of each of the genes 
has shown a different phenotype (pevny et al., 1991; Simon et 
aI .. 1992~ Tsai et al.. 1994~ Weiss et al., 1994: Pandolfi et al., 
1995; Ting et aI., 1996). Three additional members of the 
GATA family, GATA4, GATAS and GATA6, also show a 
partially overlapping expression pattern in the heart and the 
intestinal tract (Laveniere et al., 1994: Jiang and Evans, 1996). 
GATA4 is expressed as early as 7 dpc (days postcoitum) in the 
prospective cardiac splanchic mesoderm (Arceci et al., 1993; 
Kelley et aI., 1993; Heikinheimo et al., 1994) and continues to 
be expressed in the endocardium and the myocardium of the 
folding heart tube. It is finally expressed in the cardiac 
myocytes throughout development and adult life. Inactivation 
of the GATA4 gene leads to defects in heart tube fonnation and 
ventral morphogenesis in vivo (Kuo et al., 1997: Molkentin et 
al., 1997) and defective visceral endoderm fonnation by 
embryonic stem (ES) cells in vitro (Soudais et aI .• 1995). The 
cardiac expression of murine GATAS is first detected in the 
precardiac mesoderm. It subsequently appears in the atrial and 
that form. the heart and gut. Inactivation leads to a lethality 
shortly after implantation (5.s days postcoitum). Chimeric 
experiments show this to be caused by an indirect effect on 
the epiblast due to a defeet in an extraembryonic tissue_ 
Key words: GATA, Embryonic. Lethality. Extraembryooic. 
Endoderm, Mouse 
ventricular chambers and becomes restricted to the atrial 
endocardium (Morrisey et al .. 1997). The consequences of 
inactivation of the murine GATA5 gene have not been fully 
described but the mice are viable indicating that it may share 
functions with GATA4 and GATA6 (Molkentin et al., 1997). 
Murine GATA6 has been reported to be restricted to precardiac 
mesodenn, the embryonic heart tube and the primitive gut. It 
is also expressed in the developing respiratory and urogenital 
tracts, arterial smooth muscle cells. the bronchi, the urogenital 
tract and the bladder (Morrisey et al., 1996: Narita et ai., 1996; 
Suzuki et al., 1996). In Xenopus, the expression of GATA6 has 
first been detected at the beginning of gastrulation in the 
mesoderm and subsequently in the precardiac cells (Gove et 
al., 1997). Overexpression of GATA6 in the cardiac cells at a 
time when its expression nonnally declines (i,e. before the 
appearance of tenninally differentiated markers) results in 
arrest of cardiomyogenic differentiation, indicating that the 
GATA6 gene may act in Xenopus to maintain the precursor 
status (Gove et al., 1997). Thus the available cIata indicates that 
GATA6 may be important for heart development In order to 
address this question, we first investigated the expression 
pattern of the murine GATA6 gene by homologous 
recombination of a lacZ reporter gene into the GATA6 locus. 
which also enables us to generate a null mutation. The results 
show that the expression of the GATA6-driven lacZ gene in 
heterozygote mice is first detected before implantation in the 
blastocyst, followed by expression in the parietal endoderm 
just after gastrulation and subsequently in lateral plate 
mesoderm and the cells that will form the heart and the gut 
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However. GATA6..deficient embryos die before heart 
formation. showing abnormalities at 5.5 dpc. due to an 
extraembryonic defect Thus of all the m:llllDl:llian GATA 
factors that have been stuilied to date (GATAI-GATA6), 
GATA6 appears to be the one that is required earliest in 
embryonic development. 
MATERIALS AND METHODS 
Construction of the targeting vectors 
The mouse GATA6eDNA was cloned by screening umouse 11.5 dpc 
cDNA library (CLONTECH) with the human GATA6 eDNA us probe. 
One cosmid containing the mouse genomic locus was isolated from 
an 129 library using the eDNA probe. For the targeting vector. a 9.5 
kb KpnI fragment containing the first ATG was subeloned into psp72 
containing the PyEn-HSV thymidine kinase (TK) gene. The lacZ-
PMCll\'EO cassette (Nuez et aI •• 1995) W:iS introduced as u NOlI 
ft:l.gment in the same frame of the GATA6 eDNA into the unique Not! 
site. 79 nt downstream of the ATG (Fig. IA). To target the second 
allele. the same construct was used butinsteud of the lacZ-PMCll\'EO 
CllSsette the hygromycin-resistanee gene under the pGK promoter was 
inserted. 
ES cells transfection, analysis and differentiation 
El4 ES cells were tnnsfected. :is described (Hendriks et aI .• 1996). 
with 20 Ilg KpriI lineari7..ed targeting vector (Fig. IA). Selection (200 
!lg/ml G418 or 160 )lgfml hygromycin B and 02 mM FrAU) W:lS 
applied 24 hours after transfection and resistant clones were pieked 8 
to 10 days bter. 560 individual clones were assayed for !)-
galactosidase activity and the 41 !)-gal positives were further analyzed 
by Southern blotting using 5' external and lacZ probe (Fig. IB). 18 
were homologous recombinants and a normal karyotype was 
eonflfIlled for three of them. Double mutant ES cells were 
differentiated in vitro along with the parenbl heterozygous mutant 
clone according 10 standard protocols (Doclsehman et al .• 1985. 
Rohwedel et ill., 1994) using mainly the su~-pension culture method. 
Gel mobmty~shift assays 
l-wCJ:k-old embryoid bodies were homogeni7..ed me<:hanicaJly to 
obtain single-cell suspensions and whole-ccll extracts were prepared 
a.~ ha.,> been previously described (Meijer et al •• 1990). Gcl mobility 
shift experiments were performed as has been reported (Whyatt et aI .• 
1993) using 12 and 1.4 Ilg of protein from wild-type and mutant cells 
extract,>. respectively. For GATA binding, the high-affinity site of the 
C31T oligo (Whyattet al .• 1993) was used and for control competition 
the-200 oligo (deBoer et al., 1988) as well as the Spl oligo (Pbilipsen 
et al .• 1990) were used. The antibody for GATA4 wa.'> kindly provided 
by David Wilson. 
Generation of chimeric mice and embryos 
Two independent targeted clones were injected into C57BU6 host 
bl:iStocysts (Robertson. 1987) and males highly chimeric for coat 
colour were mated to FVB and C57BU6 females to generate mice 
heterozygous for the mutation. Double mutants ES cells were injected 
into C57BU6 bla.'>IOCYsts. which were transferred to foster females. 
Recipient'> were killed on day 8 or 9 of pregnancy to di.. •• 8eet out the 
chimeric embryos. Wild-type ES cells were injected into bla."tocysts 
derived from heterozygous inteteros:>es and the chimeric embryos 
were dissected at 7.5 dpc. 
Genotyping of the embryos 
Embryos from heterozygous matings were dissected according to 
standard method." (Hogan et al •• 1994) and part or all of the embryo. 
older or younger than 75 dpe, respeetivcly. was used for PCR 
analysis. a.'> described (Marin et aI .• 1997), using three primers (Fig. 
74 
lA). A sense primer in the GATA6 gene 150 nt5'to the NotI site (PI: 
5'-AGCA.AGCfGTrGTGGTCCAC-3'), an antisense 81 nt 3' to NotI 
(P2: 5'-TAACGCCAGGGTITTCCCAG-3'). resulting in a 231 and 
375 bp fragment for the wild type and targeted allele. respectively 
(Fig. 10). 
Whole-mount in situ analysis 
!>-gulaetosida."C activity wa.,> determined in embryonic materials. as 
described (Marin et al .• 1997; Hogan et al .• 1994). with fixation time 
varying from I minute for cells. embryoid bodies. blastocyst,> and 
blastocyst outgrowths to 3, 5. 12 and 30 minutes for 5.5. 7.5, 8.5 and 
9.5 dpc embryos. respectively. After overnight staining at 37°C. the 
embryos were postfixcd in the same fixative overnight at 4°C. For 
histological analysis. 5-7 ).I.m section.'> were obtained from stained and 
postfixed matcriuls. subsequent to parnifin embedding according 10 
standard protocols but using isopropanol instead of xylene. 
In vitro culture of blastocyst 
Blastocysts were flushed out at day 3.5 of pregnancy in M2 medium 
mld cultured in ES medium without LIF. in 5% CQz at 37°C. on 
l,;elatinizcd multiehambctcd gla.~s slides. After 5-9 days in culture. the 
slides were mounted in PBS for pbotography and subsequently the 
cells were scraped off and collected with a mouth pipette for PCR 
genotyping as described for young embryos. 
'FISH genotyping 
At embryoniC day 7.5. chimeric embryos were dissected out of their 
Reiehert's membranes and both embryo and membrane were kept in 
smllli volume of PBS on icc. When dissection w:l.~ completed, the PBS 
was spun out and the cells were exposed in hypotonic solution for 10 
minutes prior to cytospin on glass slides (Haar and Ward, 1994). The 
preparations were fixed in 75% methanoll'..5% acetic acid for 5 
minute.'> and furtherproccsscd for FISH as has been described (Mulder 
ct ill., 1995: Milot et aI., 1996). 
RESULTS 
GATA6 inactivation by lacZinsertion 
We first studied the pattern of expression of the GATA6 gene 
prior to and during heart fonnation by placing a lacZ reporter 
gene under the control of the endogenous murine GATA6 gene. 
This insertion also inactivated the gene coiling for GATA6 
protein (Fig. 1). The lacZ-neomycin resistance cassette was 
cloned in frame, 79 nucleotides downstream from the ATG 
start codon of the GATA6 gene (NotI site). creating a cassctte 
with 65 and 3 kb of 5' and 3' flanking sequence homologous 
to the GATA6 gene and a HSV-TK gene for counterselection 
purposes (Hendriks et al .• 1996). The plasmid was transfected 
into E14 ES cells and 560 clones were isolated after selection 
and counterselection (see Materials and Methods). It was 
expected mat homoJogously recombined clones would stain 
positively for ~-gal. since northern blot analysis showed that 
unilifferentiated ES cells expressed GATA6 RNA (data. not 
shown). Thus the 41 dones positive for ~-gal staining were 
selected for further analysis. Southern blot analysis with probes 
external and internal to the tmnsfected cassette (Fig. lA.B. 
probes A and B) showed that 18 clones had undergone 
:homologous recombination placing the lacZ gene under 
GATA6 control. Homologous recombination results in two 
restriction fragments after a Clal iligest with the external probe 
A; the original 15 kb fragment and a novel 6.4 kb fragment 
created by the presence of a novel Cla! sitc in the lacZ gene 
(Fig. IB,Ieft panel). A lacZprobe (Fig. lB. right panel) detects 
the some 6.4 kb restriction 
fragment, while a non-
homologous recombinant (+1+ 
lane) shows the 4 kb fragment 
internal to the vector between the 
lacZ Clal site and the plasmid ClaI 
site (Fig. lA. targeting construct 
and mutant GATA6). Although all 
18 clones contained I>-gal-positive 
cells. nOt all cells within a clone 
were stained. This may be because 
ES cell clones are a mixture of 
differentiated and undifferentiated 
celIs or more interestingly that 
undifferentiated ES cells express 
GATA6 only part of the time or 
express only one of the two 
GATA6 alleles. 
The GATA6+1- embryonic stem 
cells were retransfected with a 
second homologous recombination 
vector. This vector was identical to 
the first vector with the exception 
that the neo selection marker was 
replaced by a hygro selection gene 
(Marin et aI .• 1997). Homologous 
recombinants were identified as 
described for the heterozygous 
knockout above. resulting in 10 
clones of homozygous GATA6-1-
embryonic stem cells out of 96 
clones analyzed. We used three 
different GATA6 antibodies 
(Nakagawa et aI •• 1997; Perlman et 
aI •• 1998 and Santa Cruz) to show 
the absence of GATA6 protein in 
GATA6-1- cells. However. none of 
the antibodies was able to detect 
specifically GATA6 protein on 
western blots in wild-type cells. 
We therefore assayed GATA6-
binding activity in vitro using a 
high-affinity GATA-binding site. 
C31T oligo (Whyatt et aI .• 1993) 
and protein extracts from one week 
in vitro differentiated ES cells 
(Fig. Ie). As expected. only one 
major shift was observed 
since GATA6-binding activity 
comigrates with that of GATA4 
(Morrisey et aI., 1996). In extracts 
from wild-type cells, this shift 
decreased significantly by the 
addition of cither 0.5 or I J.Ll of 
anti-GATA4 antibody and resulted 
in a supersbift (Arceci etal" 1993). 
The GATA shift was reduced 
significantly in the double mutant 
cell extract and disappeared almost 
completely by the addition of anti-
GATA4 antibody while producing 
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Fig. 1. Targcted dh'TUption ofthc GATA6 gcnc. (A) Sebctn:l.tie representation of the targeting 
Str:l.tegy. Top line: Partial restriction =p of the murine GATA610cus in whicb the ATG is indieatcd 
with the arrowhead. Middle line: Targeting vector containing the polyo= cnhaneer-berpes simplex 
virus thymidine kineasc (tk:) gene and the neomycin resistance gene under the mouse 
pb%'Pboglycerate kinase (pGK) promoter following the E.coli {3-galactosidase (lacZ) genc. Bottom 
line: The mut:lllt GATA610cus rcsulting from the in f=c insertion of the LacZ-NEO. (B) Southern 
blot analysis of ClaI..mgested genomic DNA from neomycin resistant and f)-gat-positive ES clones. 
A 5'extcrnal and a facZ probe were used to distinguisb bomologous recombination events from 
random integration. (C) Gel retardation analysis of GATA DNA-binding activity in protein extrael~ 
from I-week·old in vitro djfferentiated wild-type and mut:lllt ES cells. Thc ~'Pecificity of the 
protein-DNA complex is demonstrated by competition with a lOO-fold molar excess ofunlabcled 
oligo (C311) Ot another GATA site (-200) or an Spl-binding site. Thc GATA complex is inhibited 
by the addition of GATA4 antibody and results in a ~llpershifl A GATA6 antibody also inhibited the 
fOnn:ltion of the complex (not shOWII). bowevcr it inhibited the fo=tion of all othet shifl~ 
including Spl and wc concluded that this antibody is not specific for GATA6. A second antibody 
showcd no activity in the shifl~ at all. (D) peR genotyping of 5.5 dpc embryos from GATA6+1-
intercro:>.~cs using three primers. PI. P2 and P3, to simultaneously amplify both wild-type (231 bp) 
and targeted (375 bpJ allcle. 
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Fig. 2. Expression of GATA6 
gene, us detected by J> 
galuctosidase activity, in 
early mouse embryos 
heterozygous for the lacZ 
insertion, (A.B) 3.5 dpc 
embryos, blastocysls stage, 
from heterozygote 
intercrosses with clear 
difference in the intensity of 
thc sUining, presuma.bly 
corresponding to the presence of one (heterozygote muunt) or two (homozygote muunt) lacZ alleles respectively. Expression sites ate both in 
the inner cell mass and in cells lining the blastocoel cavity. (C) A 7.0 dpc embryo exposed from the deciduu, just after g:L<>ll'U1ation, The only 
expression site is the parietal endoderm cells or the Reichert's membr:ooe, (d) decidua and (ec) egg cylinder, (0) A 5 ).Lm tranSverse section of 
the embryo in C in whieb the three germ layers, (e) «:toderm. (m) mesod= and (cd) endoderm with the surrounding Reichert's membrane 
(Rm) and the gUined parietal endoderm cells (PC) nrc illdieated, 
a supershift Thus GATA&.binding activity is absent or reduced 
drastically in the mutant cells (Fig. IC). Addition of anti-
GATAI antibody did not affect any of these complexes and 
anti-GATA6 antibodies inhibited any binding (data not shown). 
Both the GATA6-1- and the GATA6+1- ES cells were injected 
into blastocysts to obtain chimeric embryos and mice, 
respectively. GATA6+1- chimeras were bred to FVB and 
CS7IBL6 mice to obtain gennline transfer of the GATA&' 
negative allele. GATA6+!+ and GATA6"'- mice were 
distinguished by Southern analysis as described above for the 
ES cell lines, while PCR nnalysis with three primers (Fig. 
IA,D, primers pl. p2 and p3) or in situ hybridization (Fig. 9) 
was used to genotype embryos. 
Expression of GATA6 prior to day 9.5 of 
development 
First, we analyzed the expression pattern of the lacZmarker in 
heterozygote embryos. lacZ expression eould be seen as early 
as the blastocyst stage (3.5 dpc) in agreement with the 
expression data of GATA6 in ES cells. This expression was 
zygotic since it was observed in crosses between GATA6"'-
rrwJes and wild-type females and also indicative of the 
genotype since mutant blastocysts showed much higher levels 
of lacZ expression than heterozygotes (Fig. 2B,A, 
respectively). Staining was evident in only a proponion of the 
cells of the inner cell mass, which corresponds with the 
heterogeneous staining seen in ES cells in culture indicating 
that staining is not unifonn in equivalent cells. In addition. cells 
lining the abembryonic region of the blastocoel cavity were [>. 
gal positive (Fig. 2A.B). 
The expression of the lacZ reporter just prior to and during 
heart formation was analyzed in heterozygous embryos from 
7.0 to 9.5 dpc. Dissection of the embryos at 7.0 dpc showed 
no ~-gal staining in the embryo proper, but strong staining of 
the parietal endodenn cells on the inside of the partially or 
completely removed Reichert's membrane (Fig. 2C,D). At 7.5 
dpc, GATA6-dri.ven lacZ expression was visible in the 
mesodenn of a late primitive streak. embryo (Fig. 3A) and 
Fig. 3. Embryonic expression of the mouse GATA6 gene, as demonstrated by ~galactosidasc activity in mouse embryos beterozygous for the 
lacZ insertion in the GATA61ocus. (A) An adVlllleed pritnltive streak embryo at 7.5 dpc (ng, neural groove) ~hows mesodcnn.:U expression, 
whieh is better visualized at 8.0 dpc as part of the Interal plnte me:mderm (lpm) (B,D). This mesoderm conUins the cnrdiogenic plate (cp). 
whieh is J>gal positive as seen in a transverse section ut the level orthe head folds of an 8.0 dpc embryo in C. The expression persists:l.~ the 
two heart primordia (hp) are formed (E) and during their fusion in the midline to form the linc:l1' herut rube (F), At 8.5 dpc after the looping of 
the heart tube (ht). GATA6 is still expressed along the heart tube but staining predominates in the two horns of the sinus venosn (sv) and in the 
developing fotegut (G), Transverse section across the hcart tube rcvcn1iog that exprcs.'iion is restricted to only the myocardium (m) and 
pericardium (p). and is not evident in the endocardium (e) (H), 
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Fig. 4.lacZ expression in a GATA6"'- embryo at embryonic day 9.5. 
(A) Whole-mount [3-gal staining. Expression persists in the heart 
tube. mainly in the inflow:md outflow tracts.:md very strong 
expression c:m be seen in the foregut:md hindgut as well as in the 
midgut (B) Higber llltlgnific:ltion of the heart tube demonstrating 
strong expression in the inflow:md outflow tracts. but as shown in C. 
the myocardium of the whole heart tube is still expressing GATA6. 
subsequently staining was observed in the lateral plate 
mesoderm, which contains the cardiogenic plate (Fig. 3B-D). 
Expression persisted as the two heart primordia fonned and 
fused in the midline to form the heart tube (Fig. 3E.F). After 
looping of the heart tube (8.5 dpc), GATA6-dri.ven lacZ was 
primarily expressed in the two horns of the sinus venosa. and 
in the foregut (Fig. 3G). A transverse section of the heart tube 
shows that expression is restricted to the myocardium and 
pericardium, but absent in the endocardium (Fig. 3H). At 9.5 
dpc, expression was still observed in the heart tube. particul:ll' 
in the inflow and outflow tracts (Fig. 4A.B). The myocardium, 
but not the endocardium of the heart tube, was still positive 
(Fig. 4C). The gene was also strongly expressed in the foregut 
and hindgut and to a lesser extent in the midgut (Fig. 4A). 
The absence of GATA6 leads to an early lethal defect 
Intercrossing GATA6#- mice failed to produce any live born 
GATA6""'- mice in 62 live offspring (mice derived from two 
different ES cells clones were tested). Genotyping embryos 
from as early as 6.5 dpc also showed no GATA6+ embryos 
(Table 1). GATA6 null embryos could be found at 5.5 dpc (4 
out of 20) and earlier (day 4.5 embryos and day 3.5 
GATA6 is essential for early development 
Thblc 1. Gi!notypes resulting from GATA6 heterozygous 
mutant matings 
,/- ,/+ Tol:llnumbct 
liveborn 37 (60) 25(40) 62 
9.5 dpc 24(60) \6(40) 40 
8.5 dpc 64(58) 47(42) 111 
7.5 dpc 6 (60) 4(40) 10 
6.5 dpc 86 (65) 47 (35) 133* 
*Embryos wen:; collected from 11 GATA6+1-females and 1-3 empty 
dccldull were found per litter. 
blastocysts). We therefore analyzed the expression of the 
reporter gene during the phase of peri-implantation lethality. 
At4.5 dpc just prior to implantation, J>.gal staining is restricted 
to a population of cells on the blastocoelic surface of the inner 
cell mass adjacent to the trophectoderm (Fig. 5A). However, 
we have been unable to confirm that GATA6 is expressed at 
4.5 dpc by whole-mount in situ hybridization. It is therefore 
possible that the J>.gal staining at this stage is a left over from 
the expression at the blastocyst After implantation, at 5.5 dpc. 
J>.gol staining was not detectable in heterozygous embryos 
derived from heterozygous outcrosses. Expression could only 
be detected at this stage in a subset of embryos obtained from 
heterozygote intercrosses. In such crosses, a minority of the 
embryos that were invariably much smaller than their 
littennates showed a very specific ~-gal staining in one or a 
very few cells (Fig. 5B,C). These retarded embryos were 
presumed to be GATA6 null embryos, although we were unable 
to confirm their genotype by standard peR after the embryos 
had been nxed and analyzed for the presence of ~-gal staining. 
Sectioning of 5.5 dpc embryos revealed that a number of them 
lacked part of the visceral endoderm and showed abnonnal 
development of the embryonic ectoderm that normally 
underlies this part of the endoderm (Fig. 6). 
Differentiation and lacZ expression were also investigated in 
blastocysts flushed from heterozygous intercrosses at 3.5 dpc 
and cultured under dill'erentiating conditions (Suzuki et al., 
1997). After 5-9 days. the cultures were analyzed for cell type 
and genotyped by PCR. In the early phases of culturing wild-
type. heterozygote and homozygote GATA6 null blastocysts, 
all developed nonnally with attachment and outgrowth of the 
trophOblast cells. However. in the GATA6 null blastocysts, 
growth of the inner cell mass was severely impajred and, after 
5 days, the ICM remained very small and its celis tended to 
disperse (Fig. 7). After 9 days in culture, these celis detached 
and disappeared (data not shown). Development of small, 
Fig. 5. GATA6 expression during the phase ofpcri-impIanULtion lethality. (A) A 4.5 dpe heterozygous embryo in which the J3.gal staining is 
restricted to a few cells on one side of the blastocoelic surface of the inner cell mass adjacent to the trophoeetoderm. (B) An implanted 5.5 dpe 
embryo from heterozygous intcrcrosses, which conuins a few expressing cells and is much sm.aller than its littermatcs (C). (D) Heterozygous 
bl:lstocyst outgrowth, after 7 days in culture, in which expression is restricted to a few cells of the inner cell mass. 
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Fig. 6. H:lCIlUtoxylin and eosin~stnined 
sagittal sections of 55 dpe embryos from 
GATA6 heterozygous intcrcrosscs. 
(A,B) Nornully developed embryos: 
(C.D) embryos showing abnormal visceral 
endoderm surrounding the embryonic 
ectoderm (arrow). 
migrating parietal endodenn cells was evident in all cultured 
blastocysts. GATA6 expression was observed by i3-gal staining 
in a small subpopulation of inner cell mass cells in a l-week-
old heterozygous blastocyst outgrowth (Fig. 5D). 
These results suggest that the absence of GATA6 results in 
lethality at 5.5 dpc, shortly after implantation, due to a defect 
in cells derived from the inner cell mass. These may be 
extraembryonic in nature and possibly the primary defect lies 
in the primitive endodenn lineage. 
In order to test this extraembryonic function of GATA6, we 
made two types of chimeric embryos; the first. by injecting 
wild-type blastocysts with GATA6 null ES cells to retain 
wild-type genotype in extraembryonic tissues and, the 
second. by the reciproca.l combination to remove GATA6 
function from extraembryonic tissues (Beddington and 
Robertson, 1989). 
GATA6 is required for extraembryonic development 
Homozygote GATA6 nuH undifferentiated ES cells were 
injected into C571BL6 blastocysts and the developing 
embryos were analyzed at 8.5 and 9.5 dpc. Staining for i3-
galactosidase activity showed that the GATA6-1- ES cells 
could contribute effectively to the heart tube and sinus venosa 
and that their progeny were present in ooth the myocardium 
and pericardium (Fig. 8C~F). GATA6-1- cells also contribute 
to the gut. We therefore conclude that the absence of GATA6 
does not lead to a cell autonomous defect in the epiblast that 
is derivative of the inner cell mass giving rise to the embryo 
proper. In addition, the GATA6 null cells clearly had not lost 
their developmental potential to contribute to the heart and 
gut. The latter was confinned by the in vitro differentiation 
of GATA6 null ES cells. They were differentiated in vitro (see 
Materials and Methods) and analyzed after 23 days in 
suspension cultures. The GATA6-1i'- and GATA6..f- embryoid 
bodies showed no morphologica.l differences (Fig. 8AB) and 
both contained contracting cells. indicating that 
differentiation of cardiomyocytes was not inhibited in 
GATA6-1- tissues. 
Because the extraembryonic tissues in the chimera 
experiment were derived from the wild-type blastocyst, it 
leaves the possibility that GATA6 is essential for the 
development of the trophectoderm or the primitive endoderm, 
and that it was defects in either or ooth of these tissues that 
were responsible for the demise of the embryo. This would be 
consistent with the abnonnal endodenn observed in a number 
of 5.5 dpc embryos (Fig. 6). In order to perform the reciprocal 
chimera experiment, it was important to establish that GATA6 
embryos were normally represented among blastocysts 
selected for injection from heterozygote intercrosses. 
Blastocysts were collected. selected for injection and then 
genotyped. Homozygous null blastocysts constituted 20% of 
the population. 
After injecting intercross blastocyst:; with wild-type ES cells 
and their implant:l.tion in pseudopregnant recipient mice, the 
resulting embryos were analyzed at 7.5 dpc. The chimeric 
embryos were dissected from Reichert's membrane and the 
cells in this membrane were genotyped. Since this tissue 
receives a low. if any. contribution from the injected ES cells 
Fig. 7. In vitro blastocyst outgrowths after 5 days in culture. (A.B) Wild-type and beterozygous bla."tocysts. respectively. with the expected 
outgrowth of trophoblast cells and the formation of an inner cell mass surrounded by the visceral endoderm. (C.D) Homozygous mutants. 
which exhibit normal outgrowth of the trophectoderm but have a small or dispersed inner cell mass. There is no evidence of a visceral 
endoderm layer enveloping the ICM. In all three genotypes, parietal endoderm cell" were observed at the periphery of the outgrowth. 
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Fig. 8. Dcvclopmcotal potential of the GATA6-1- ES eell ... (A,B) j)-
gal-stained embryoid bodie.~ derived from ES cells differentiated in 
vitro for 23 days in suspension culture. There is no morphologiC!1l 
difference between heterozygote and homozygote mutults and they 
both display contraction activity. When GATA6-1-ES cells were 
injected into wild-type blastocysts their contribution to GATA6-
exprcssing tissues was assessed by J3-g:li:ICtosidnsc activity. (C) 8.5 
dpc chimeric embryo demon.~tr:1ting contribution to both heart tube 
and sinus venosa and (D) transverse section of the heart tube 
indic:l.tcs that both myocardium and pcricm-dium arc colonized, 
(E.F) 9.5 dpc chimeric embryos with contribution sites being all the 
tissues that express GATA6 (Fig, 4A), 
(Beddington and Robertson, 1989), its genotype would be 
representative of the host blastocyst. Nuclei were prepared 
from both the membrane and the embryo proper and subjected. 
to FISH genotyping using a probe specific for the mutant 
GATA6 allele (the lacZ-neo gene, green) and a probe for a 
control gene (the HIRA gene, red). 73 blastocysts were injected 
and 58 implantation sites fonned, from which 41 conceptuses 
were recovered. Genotyping showed that 32 of the 41 
Reichert's membranes were heterozygote for lacZ-neo (two red 
signals and one green. Fig. 9B), while the remaining 9 
membranes were wild type (only twO red dots, Fig. 9A). Thus 
none of the embryos was derived from a GATA6 null 
blastocyst. indicating that GATA6 is required for the 
development of extraembryonic tissues. 
DISCUSSION 
Expression and role of GATA6 in the heart 
In this paper, we describe the expression pattern and the role 
of the transcription factor GATA6 using homologous-
recombination to introduce the E. coli I3-galactosidase (lacZ; 
GATA6 is essential for early development 
Fig. 9. FISH genotyping of Reichert'S membrane nuclei derived from 
7.5 dpc chimeric embryos gcocratcd by injecting wild-type ES cells 
into bbstocysts from GATA6w- intcrcrosses. A cockt:lll probe W!lS 
used with ll. cosm.id for the HIRA locus as ll. wild-type control (red) 
and a plasmid with the facZ-neo sequences to detect the GATA6 
mutult nllcle. (A) A wild-type (two red dots) and (B) ll. heterozygous 
(two red and one green dot) mutult embryo. 
gene to inactivate GATA6 and to serve as a reporter for its 
expression. Previous expression and in vitro binding studies 
suggested a role of GATA6 in the development of the heart 
(Laverriere et al., 1994: Morrisey et al .• 1996: Evans. 1997: 
Gove et ::ll.. 1997) and we therefore first analyzed the 
expression pattern of the reporter gene during embryonic heart 
fonnation in heterozygote embryos. As expected (Morrisey et 
al., 1996), GATA6-driven lacZ expression is detected in the 
lateral plate mesoderm (8.0 dpc) containing the cardiogenic 
plate and persists during the differentiation and migmtion of 
cardiomyocytes to fonn the heart tube. By day 8.5, when the 
heart has looped, I3-gal staining is still evident in both 
myocardium and pericardium and strong expression is 
observed in the developing gut. 
Since homozygote mutants die well before heart fonnation. 
the role of GATA6 in cardiogenesis could not be assessed 
directly. Therefore GATA6-1- ES cells were generated and their 
developmental potential tested. The behavior of mutant cells in 
embryoid bodies in vitro appeared. indistinguishable from 
heterozygous or the wild-type cells with respect to 
differentiation of functional cardiomyocyres. In vivo when the 
GATA6-1- ES cells were injected into wild-type blastocysts, a 
number of nonnal, highly chimeric embryos were obtained and 
these showed. a substantial contribution of the mutant cells to 
both the heart and the gut Thus, the absence of GATA6 protein 
does not result in a cell autonomous defect in developing 
cardiomyocytes. This supports the suggestion from the analysis 
of GATA4 mutants (Narita et al., 1996; Kuo et al .. 1997; 
Mo1kentin et M .. 1997) that there is a functional redundancy 
between the two members of the family concerning cardiac 
development. Unfortunately, elucidation of such a redundant 
role is not possible through the study of heart development in 
a double mutant background since GATA6+ lethality is much 
earlier than the specification of cardiogeruc mesoderm. 
GATA6 null embryos and early expression 
All GATA6 null embryos fail to develop to gastrulation and die 
shortly after implantation at 5.5 dpc. Thus we investigated the 
expression of GATA6 during peri-implantation development. 
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Expression can first be seen in blastocysts (3.5 dpc) in a 
subpopulation of cells in the inner cell mass and in some cells 
lining the blastocoelic cavity. Interestingly, not all inner cell 
mass cells stain and such nonuniform staining is also seen in 
heterozygous lacZ-targeted ES clones, where blue staining is 
evident as a 'salt and pepper' pattern in an otherwise apparently 
homogeneous population of undifferentiated ES cells. Thus 
GATA6(lacZ) may be cell cycle regulated, monoallelically 
expressed or reveal some of the heterogeneity in pluripotent 
cells. Before implantation at 4.5 dpc. when the primitive 
endodenn has already differentiated as a distinct layer on the 
surface of the inner cell mass (Nadijcka and Hillman, 1974; 
Gardner, 1985). GATA6-driven lacZ is restricted to a localized 
population of cells on the blastocoelic surface of the inner cell 
mass adjacent to the trophectoderm. This very restricted 
expression in a subset of ICM cells can also be seen in 
heterozygote blastocyst outgrowths in vitro (Fig. 5D). We were 
unable to confinn this restricted expression pattern at the RNA 
level by in sim hybridization of GATA6 RNA. It is therefore 
possible that GATA6 is not expressed at that stage. !>-gal 
activity may be very stable and remains detectable for a longer 
time than GATA6 RNA. It would seem that it is this first phase 
of GATA6 expression in the ICM of the blastocysts that is 
critical for the survival of the embryo. However, it is not clear 
whether GATA6 expression marks ICM cells that will become 
the epiblast (giving rise to the embryo proper) or cells that will 
differentiate into prirrritive endoderm. or a mixture of the two. 
At gastrulation. anew site of expression is detected. reflected 
by the very strong staining in the parietal endodenn cells on 
the inner surface of the Reichert's membrane. Although these 
cells are derived from the primitive endodenn. it does not 
appear that the expression at day 4.5 necessarily corresponds 
to precursors of the parietal endoderm. At 5.5 dpc, no 
expression in parietal endoderm could be detected and 
therefore GATA6 is not continuously expressed in this lineage 
from the blastocyst stage. The only expression that could be 
detected at 5.5 dpc was seen in a few retarded embryos from 
heterozygote intercrosses. Staining was seen in a few cells and 
they appeared to be in extraembryonic sites. Since no staining 
was ever seen in heterozygote outcrosses, these embryos are 
presumed to be GATA6 homozygotes and thus indicate that 
absence of GATA6 causes abnormalities immediately after 
implantation. which are manifested as gross retardation and 
abnonnal primitive endoderm differentiation (Fig. 6). 
Extraembryonic requirement for GATA6 
The suggestion. based on expression pattern, that GATA6 is 
required for the development of extraembryonic tissue is 
supported by the generation of chimeric embryos. In a previous 
study (Beddington and Robenson. 1989). it was shown that ES 
cells when injected into blastocysts contribute mainly to the 
epiblast. Occasionally a very low contribution could be 
observed in trophectoderm and primitive endoderm. Injecting 
GATA6-1- ES cells into wild-type blastocysts generated a 
number of normal highly chimeric embryos. This endorses the 
notion that GATA6 is normally required in extraembryonic 
linaeges. This conclusion is further supported by the opposite 
experiment that demonstrated the inability of the wild-type ES 
cells to rescue the GATA6"'-phenotype. Moreover, death of the 
embryo (in vivo) or inner cell mass (in vitro) is not due to a 
cell autonomous requirement for GATA6 in the epiblast but 
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rather to a defect in neighboring supportive tissues. Such a 
crucial role for visceral endoderm in growth and patterning of 
the embryo has been demonstrated in the analysis of other 
knock-out phenotypes such as HNF4 (Chen et al .. 1994). evxl 
(Spryropoulos and Capecchi. 1994), nodal (Varlet et al .• 1997) 
and sl1U1d2 (Waldrip ct al .• 1998). Given the normality of the 
tropbectodenn outgrowth in GATA6"'· blastocysts in vitro and 
the presence of parietal endoderm cells, it is likely that the 
primary defect lies in the visceral endoderm. 
Function of GATA6 
All GATA6 null embryos fail to develop to gastrulation and die 
shortly after implantation at 5.5 dpc. Thus the first wave of 
GATA6 expression in the ICM of the blastocyst is critical to 
the survival of the embryo. The expression of the GATA factor 
with overlapping expression in heart, GATA4, has not yet been 
detennined in vivo prior to gastrulation. However, about one 
third of the embryos with an inactivated GATA4 gene fail to 
gastrulate and this is thought to be due to defective formation 
of visceral endoderm from prirrritive endoderm at day 4.5 
(Molkentin et al .• 1997). This is supported by the observation 
that GATA4-deficient ES cells fail to form visceral endoderm 
in culture (Soudais et al .. 1995). Like GATA6"'- cells, GATA4 
null ES cells contribute extensively to normal chimeras when 
injected into wild-type blastocysts (Narita et aI .• 1997). The 
majority of GATA4 null embryos show a defect in the lateral-
to-ventral folding of the precardiac splanchic mesoderm and 
its underlying endoderm at 7.5 dpc (Molkentin et al., 1997). 
Both of these tissues also express GATA6. GATA6 expression 
is increased in the GATA4-deficient tissues and this may be 
responsible for the rescue of the majority of the embryos until 
after gastrulation (MoIkentin et aI.. 1997). Thus GATA6 
appears to be the more critical factor at the earliest stages 
where its absence cannot be compensated by GATA4. The 
opposite appeors to be the case in the tissues fonning the heart 
:md gut. Although the level of GATA6 is raised, the absence of 
GATA4 leads to a lethal defect in folding, while the basic 
ability of the cells to differentiate appears to be maintained 
(Molkentin et al .• 1997). Interestingly. this lethal folding defect 
in GATA4"'- embryos is rescued in the presence of wild-type 
visceral endodenn (Narita et aI •• 1997). Therefore. even here 
the primary defect appears to be extraembryonic. We were of 
course unable to detennine the effect of a complete absence of 
GATA6-expressing cells during early heart and gut formation 
because of early lethality. However, GATA6 null ES cells were 
able to contribute to all the early beart and gut cells in chimeric 
embryos. which shows that the absence of GATA6 does not 
lead to a cell autonomous defect in these tissues. The cells keep 
their basic ability to differentiate as was observed in the 
GATA4 null embryos. However the chimera experiments do 
not show that the absence of GATA6 could have caused similar 
cell movement problems as observed in the GATA4 null 
embryos. 
Overexpression of GATA4 in P19 cells leads to an increase 
in beating cardiogenic myocytes. while its absence leads to 
extensive apoptosis and cell death (Grepin et al., 1997). 
Overexpression of GATA6 at the time that its expression 
normally decreases in heart formation in Xenopus leads to an 
excess of cells and thickening of the myocardial muscle (Gove 
et al .. 1997). Sirrrilar observations bave been made for GATAI 
in the haematopoietic system. The inactivation of GAT Al leads 
to an arrest of erythropoiesis in the foetal liver due to apoptosis 
of differentiating red cells (Weiss and Orkin, 1995). 
Overexpression of GATAlleads to the opposite effect (Whyatt 
et 301.. 1997: Whyatt and F. G., unpublished data). 
GATA2 and GATA3 are, among other tissues, also expressed 
in the haema.topoietic system (Leonard et aI., 1993). In the cas.e 
of GATAI and GATA2, they have been shown to be 
autoregulatory and crossregulatory (Weiss et al .. 1994: Tsai et 
aI., 1991) and they can substitute for each other to a 
considerable extent (Weiss et aI •• 1994). Nevertheless, they 
each have a unique role in the development of the 
haematopoietic system resulting in different phenotypes when 
the genes have been inactivated in vivo (Pevny et al., 1991: 
Tsai et al., 1994: Pandolfi et al., 1995: TIng et al., 1996). This 
suggests that at least part of the function of GATA proteins is 
not related to the unique propenies present in each of the 
particular GATA proteins, but rather on the conserved central 
GATA DNAwbinding motif (fsai et al" 1998). In other words, 
as long as sufficient amounts of any GATA protein are 
produced at the appropriate time in panicular cells they will be 
functional. 
Thus we suggest that GATA6 happens to be the first GATA 
factor that is required for the growth of a population of cells 
that contributes to the extraembryonic tissues in the developing 
blastocyst. Absence of GATA6 would lead to the malfunction 
of an extraembryonic tissue (probably visceral endodermal as 
defined by position and chimeras), that is required for the 
support and growth of the epiblast 
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SUMMARY 
Recent loss-of~function studies in miee show that the 
transeription factor GATA6 is important for visceral 
endoderm differentiation. It is also expressed in early 
bronchial epithelium and the observation that this tissue 
does not reccive any contribution from Gata6 double 
mutant embryonic stem (ES) cells in chimeric micc suggests 
that GATA6 may playa crucial role in lung development 
The aim of this study was to determine the role of GATA6 
in fetal pulmonary development We show that Ga1a6 
mRNA is expressed predominantly in the developing 
pulmonary endoderm and epithelium, but at ElS.5 also in 
the pulmonary mesenchyme. Blocking or depleting GATA6 
function results in diminished branching morphogenesis 
both in vitro and in vivo. T1'FI expression is unaltered in 
INTRODUCTION 
The fonnation of a lung requires a well organized program to 
coordinate the balanced interplay between activation and 
repression of gene transcription as it develops from a cluster 
of ceUs in the floor of the primitive foregut to the highly 
vascularized gas exchange organ (Hogan, 1999; Warburton et 
aI., 2000). Several evolutionarily conserved signaIing pathways 
have been implicated in the different stages of fetal pulmonary 
development In particular members of the fibroblast growth 
factor. bone morphogenetic protein, hedgehog/Gli. wingless 
and epidennal growth factor families have been demonstrated 
to be key regulatory factors for lung morphogenesis and 
epithelial differentiation, but lung endodenn specification is 
less well understood (for reviews see Hogan. 1999; Warburton 
et al., 2000). Recently, a member of the GATA family of 
transcription factors. GATA6, has been implicated in endodenn 
specification (Morrisey et aI., 1998). In vertebrates, the GATA 
family of transcription factors contains a conserved zinc--finger 
motif that binds to the consensus sequence AffGATNG 
resulting in transcriptional regulation of genes in different cell 
chimeric lungs whereas SPC and CCIO expression are 
attenuated in abnormally branched areas of chimeric 
lungs. Chimeras generated in a ROSA26 background show 
that endooermal cells in these abnormally branched areas 
are derived from Gata6 mutant ES cells, implicating that 
the defect is intrinsie to the endoderm. Taken together, 
these data demonstrate that GATA6 is not essential for 
endoderm Specification, but is required for normal 
branching morphogenesis and late epithelial ccll 
differentiation. 
Key words: GATA6. Br.mching morphogenesis. Lung. Endoderm 
differentiation, Mouse 
lineages (for reviews see Charron and Nemer. 1999: Evans, 
1997; Jordan and Van Zant, 1998; Orkin. 2000). The GATA 
transcription factors can be subdivided into two main groups. 
First GATA1. GATA2 and GATA3. which all have unique 
functions in the hematopoietic system (Leonard et aI" 1993; 
Pandolfi et al., 1995; Pevny et al., 1991; Simon et al., 1992; 
Tmg et aI., 1996; Tsai et aI., 1994; Weiss et aI., 1994; Whyatt 
et aL. 2000) and, in case of GATA2 and GATA3. in many other 
tissues, including the nervous system and the kidneys. Second, 
GATA4, GATAS and GATA6, which are mainly expressed 
and involved in the formation of the extra~mbryonic and 
embryonic endodenn. as well as in the cardiogenic mesodenn 
(Arceci et aI .. 1993: Koutsourakis et aI., 1999; Laverriere et al •• 
1994: Morrisey et aI., 1996; Morrisey et al., 1997:1: Morrisey 
et al., 1997b; Morrisey et al" 1998). 
Radioactive in situ hybridization experiments have 
demonstrated that GATA6 mRNA is expressed in the 
developing embryonic bronchial epithelium and in chimeric 
experiments this endodermally derived tissue did not receive 
any contribution from Gata6-1- ES cells (Morrisey et aI., 1996; 
Morrisey et al.. 1998). The conclusion of these studies was that 
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GATA6 is required for specification of lung endoderm. In 
addition, the promoters of several lung specific genes, such as 
the genes for human thyroid transcription factor 1, human 
sUIfactant protein C, mouse surfactant protein A and mouse 
Clara cell marker 10, contain GATA motifs (Ikeda et aI" 1995; 
Korthagen et aI" 1992; Ray et aI •• 1993; Wert et aI., 1993) and 
GATA6 has also been shown to activate both sUIfactant protem 
A and thyroid transcription factor 1 reporter gene transcription 
in vitro (Bruno et al., 2000; Shaw~White et aI., 1999). Taken 
together. these data strongly suggest that GATA6 plays an 
important role during lung development. 
We therefore searched to identify the specific role(s) of 
GATA6 in fetal pulmonary development In order to obtain a 
more detailed insight into the spatial~temporal distribution of 
GATA6 mRNA, non~radioactive in siru hybridization during 
fetal lung development in vivo was performed. The observed 
expression patterns in early embryonlc lungs suggest a role for 
GATA6 in branching morphogenesis. which we investigated 
using organotypic explant cultures with antisense 
oligonucleotides. To confirm and further investigate the role of 
GATA6 in lung development in vivo. we also generated highly 
chimeric embryos by injecting wjJd~type blastocysts with 
Gata6~r- embryonic stem (ES) cells. The latter experiments 
enabled us to overcome the early embryonlc lethality in 
Gata6-1- mice, which is due to extra~embryonlc defects 
(Koutsourakjs et al •• 1999; Morrisey et al •• 1998), because in 
such chimeras, the extra~embryonic tissues are provided by 
the wild~type host blastocyst. Highly chimeric lungs were 
histologically analyzed and the expression of molecular 
markers for endoderm specification and epithelial cell 
differentiation (thyroid transcription factor 1, surfactant protein 
C and Clara cell marker 10) was investigated using 
immunohistochemistry and in situ hybridization. 
Branching morphogenesis was dramatically affected in vitro 
when antisense oligonucleotides for Gata6 were added to lung 
cultures, In chimeric embryos. pulmonary endoderm was 
fonned but it branched abnormally and failed to undergo late 
epithelial cell differentiation, based on diminished sUIfactant 
protein C (SPC; Sftpc-MouseGenomeInformatics)andClara 
cell marker 10 (CClO: Utg - Mouse Genome Informatics) 
expression. Using ROSA26 recipient blastocysts, we 
demonstrate that this abnonnal epithelium is derived from 
Gata6-1- ES cells. We conclude that GATA6 is essential for the 
later stages of branching morphogenesis and late epithelial cell 
differentiation. but not for lung endoderm specification, 
MATERIALS AND METHODS 
Whole-mount in situ hybridization 
Wild type embryonic roy (E) lOS and E12.5 embryos were isolated 
from pregnant FVB female mice according to standard methods 
(Hogan et al .. 1994) and the lungs were dissC(:ted from these embryos 
using microsurgical tecbniques. The lungs were fixed in 4% (w/v) 
parafonoaldebyde in pbospbate~buffered saline (PBS) at 4QC for 4 to 
6 bours. dehydrated in a gradt:d series of ethanol and kept in 100% 
mcthanol at -20°C until used. The wbolc--mount in situ hybridi7..ation 
protocol was adapted from the protocol described by Wilkinson 
(Wilkin.~on. 1993). In short, following hydration, the lungs were 
bleached for I hour in 6% (v/v) hydrogen peroxide in PBS containing 
0.1% (v/v) 'I\vecn~20 (PBl) and pcnneabili7.cd with proteinase K (10 
j..I.g.ml-1 in PBl) for 15 minutes at room temperature. Subsequently. 
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the lungs were post~fixed in 4% (w/v) paraformaldehyde in PBS and 
prehybridized in bybridization mixture, containing 50% formamide.. 
5x SSC (NaCl 0.75 moM, sodium citrntc 0.Q75 moM. pH 4.5).1% 
sodium dodccyl sulpbate, 5 J..I.g.m.l-1 yeast tRNA, 50 ).tg,ml-1 hepllrin 
in water for 1 hour at 70°C. Hybridization was carried out for 16 to 
18 bours at 70°C using thc same hybridization mixture.. but now 
containing a digoxigcnin (DIG)-labelcd sensc or antisense GATA6 
RNA probe. A 1.5 kb fragment of the 5' end of the mouse Gata6 gene 
that was described previously (Brewer ct al .. 1999) was used to 
generate a probe for in situ bybridV..ation on sections. A PstI~Norr 
suhclone from the 5' pan of this 1.5 kb fragment was used to generate 
n probe for whole~mount in situ hybridization. The eDNA fragment.~ 
were DIG~labeled according to a protocol provided by the 
manufacturer (Rochc Diagnostics, Almere, Thc Netherlands). The 
next duy. the lungs were stringently washed and treated with RNAse 
to avoid nonspecific background staining, Following a blocking step 
using 10% (v/v) sheep serum in 0.14 moVl NaCl, 2.7 mmoVl KCl. 25 
mmoVl TristHCl pH7 05 and 0.1 % (v/v) Tweell~20 in water (1BST) 
including 2 mmolll levamisole.. the lungs were incubated with an 
:llkaline pho~l'hatase<oupled antibody (1:2000). against DIG for 16 
to 18 hours at 4°C. For at least 3 roys the lungs were then wa.o;;hcd in 
TBST and 2 mmolllievamisole. The lungs wcreehangcd to 0.1 molll 
:-.iaCl, 0.1 molll TristHCI. pH 9.5. 0.05 molll MgCh and 0.1% (v/v) 
Twecn~20 (NT:Ml) and the bybridi7.cd probe was Vi~'U:ili7.cd using 
337.5 jlg.ml-1 NBT and 175 Jlg,ml-1 BCIP mixture a.~ a substrate. 
NonspecifiC labeling was removed in 95% ethanol. and thc lungs were 
kept at 4Q C in PBT containing 1 mmolll EDTA. 
Branching morphogenesis 1n vitro with antisense 
oligonucleotides 
EIl.5 and El2.5lungs were harvested from wi1d~type embryos under 
a dissection microscope. The lungs were transferred to porous 
membranes (8 ).U'Jl pore size) from Nucleopore (Wbaunnn. Ny), and 
incubated in 12·well culture plates from Costar (Coming, NY). Thc 
membranes were pre"soaked in MEM (Gibeo) for I hour before the 
explants were placed on them. The explants were incubated as floating 
cultures in 500 ).tl Dulbecco's modified Eagle's medium. nutrient 
mixture F~12 (Gibeo) supplemented with 100 Ilglml streptomycin, 
100 unitsiml peniCillin and 0.25 mglml a.~corbic acid. The explants 
were cultured at 37°C in 95% air and 5% CO:!. Ten cultured 
lungs were treated with 40 1L-\1 phosphorothioated oligonucleotides. 
t3rgeted against the translation initiation site of the murine Gata6 
mRNA in the antisense direction with the following sequcnce: 
GTCAGTCAAGGCCAT. Tcn cultured lungs wcre treated with the 
same coneentrntioll scnsc-oricntated Oligonucleotides with the 
following sequence: ATGGCCITGACTGAC. Ten untreated cultured 
lungs served a.~ controls, The lungs were cultured for up to 72 hours 
and branching morphogencsls was monitored daily and imagcs 
ettptured using a dissccting microscope (Leica MZ12) and the Leica 
Digital I:mttging Systems. 
Generation of chimeric embryos 
In COIlt:ra.~t to standard procedures. we injccted more than 20 Gara6~I-, 
or Gara6+!~ for the control experiment, ES cells into each blastocyst 
in order to obtain highly cbimeric embryos. These injectiolls were 
perfonoed eithcr in C57BU6 or ROSA26 (Friedrich and Soriano, 
1991) blastocyst..~ and the ES cell lines used have been previously 
described (Kout..~ourakis et al •• 1999), Chimeric lungs were dissected 
at EI2.5. EI3.5. El5S or EI8.5 and either processed for explant 
cultures (E13.5), a.~ described above, or fixed and used for histologl~ 
analysis and in situ hybridi7..ation. as described above (E12.5. El55 
:tIld Elg.5). Head or tail tissue of the embryos wa.~ used to determine 
the percentage of chimerism using Glucose Phospbate Isomerase 
(GPI) electrophoresis (Ho!f.Ul et aI .• 1994). 
In situ hybridization and immunohistochemistry 
Non~radioaetive in situ hybridi7.ation on 6).1m :;cctions with SPC and 
eelO RNA probes was carried out essentially as described before by 
Motoy:una et al. (Motoy:una et :11 •• 1998). In short. tissue sections 
were rchydr::tted and washed in PBS. Pretrea.tment included 
postflX:J.tion in 4% paruform:l1debyde for 15 minutes. followcd by 
proteinase K digestion (20 mg/ml) for 15 minutes atroom temperature 
and acetylation (0.1 molll tricthanolamine and 0.25% :1Cetic 
anhydride) for 10 minutes at room tcmpcrnturc. Sections were then 
dehydr::tted and air-dried before addition of the bybridization solution, 
Digoxigenin*lnbeled probes werc added to frcsbly prepared 
hybridization solution (50% deionized formamide. 10% dextran 
sulfate. J.5x Denbardt's reagcnt. 0.5 mg/ml of yeast tRNA, 0.3 molll 
XaCI. 5 mm01l1 EDTA and 25 mmolll Tris. pH 75) at aconcentration 
of 1 ng/Ill. Following dcnaturntion at 80°C. the probe was added to 
the tissue section and incubated for 16 to 18 hours at 55°C. After brief 
washes with 5x sse and 50% formamide at 55°C. the tis~'Uc was 
tre:l.ted with RNase A (10 Ilglml) for 30 minutes at 37°C. The 
digoxigenin nucleic :1Cid detection kit (Roche Diagnostics. Almere. 
Thc Netherlands) was used for immunologica.l detection of the 
hybridi)'.ed probe. TiSSue was then eounterstaincd with Methyl Green 
and prepared for viewing. 
Mouse specific SPC and CClO cDNA fragment. .. (330 and 315 
bases. respectivcly) were DIG labeled according to a protocol 
provided by the manufacturer (Roche Diagnostics. Almere. The 
Netherlands). Immunohistoebemistry with a monoclona.l antibody 
against thyroid transcription factor 1 (TfFl) (Neomarkcrs. CA. USA) 
in a concentration of 1 in 100 was carried out as described before 
(Kcijzer et al .• 2000). 
RESULTS 
Spatial-temporal expreSSion of Gata6 mRNA during 
fetal lung development 
Starting from EIO.5. when five primary lung buds have just 
evaginated from the foregut, Gata6 mRNA was detected in 
developing lung endodenn (Fig. lA). At this stage. the Gata6 
mRNA was predominantly expressed at the tips of the growing 
lung buds. TWo days later at El2.5. when branching 
morphogenesis of the lung buds is proceeding rapidly in order 
to establish the furure bronchial tree. Gata6 mRNA was still 
observed in the branching endoderm. However. at this stage the 
&ignal was observed in the entire endodenn lining the 
developing lung buds. instead of being limited only to the tips 
of the growing buds (Fig. IB). On sections ofwild~type E15.5 
lungs. in which branching morphogenesis is almost completed. 
and differentiation and vascularization are beginning. Gata6 
rnRNA was expressed in the endoderm lining the growing 
airways. as well as in parts of the mesenchyme surrounding 
these airways. albeit at a lower level (Fig. 10. AtE18.5, when 
the bronchial tree is complete, and the lung tissues are 
differentiating into the different cell types that will constitute 
the lung after birth. Gata6 rnRNA was observed mainly in 
epithelial cells lining the bronchioli. but also to a lesser extent 
in the epithelial cells lining the sacculi (Fig. lD). At this stage. 
the signal in the mesenchyme was difficult to distinguish. 
possibly because of the thinning of this tissue layer. 
Hybridization with sense RNA GATA6 probes generated no 
specific signal in either whole*mount or section in situ 
hybridization experiments at all stages (results not shown). 
Antisense oligonucleotides against Gata6 reduce 
branching morphogenesis in vitro 
Based on the rnRNA expression pattern of Gata6. in particular 
GATA6 and fetal pulmonary development 
expression in the endoderm lining the early lung buds. an 
important role for GATA6 in branching morphogenesis was 
anticipated. Antisense oligonucleotides targeted against the 
translation initiation site of Gata6 were used in explant cultures 
of isolated fetal lungs to investigate this role. When ElLS 
lungs were culrured for 72 hours in the presence of antisense 
GATA6 oligonucleotides (Fig. 2B). branching morphogenesis 
of these lungs was clearly reduced when compared with the 
patterns of branching morphogenesis oflungs exposed to sense 
GATA6 oligonucleotides (Fig. 2A) or to lungs culrured in 
medium alone without oligonucleotides (not shown). A similar 
reduction in branching morphogenesis was observed when 
E12.5 lungs were culrured for 72 hours with antisense 
(Fig. 20) oligonucleotides. Again, lungs exposed to sense 
oligonucleotides (Fig. 20 and control lungs (not shown), 
which were culrured without oligonucleotides, demonstrated 
similar patterns of normal branching morphogenesis. 
GataS-
'
- chimeric lungs display diminished 
branching morphogenesis in vitro 
In all experiments highly chimeric (more than 50%) embryos 
and lungs were selected based on GPI analysis (results not 
shown). Isolated E12.5 Gata6+ chimeric lungs were smaller 
in size and had less lung buds (Fig. 3B) when compared with 
non-chimeric littennates (Fig. 3A). From a different litter. 
E13.5 Gata6+ chimeric and non·chimeric lungs were cultured 
for 4 days as organotypic explants. At the time of isolation. 
both lungs were comparable in size. but the Gata6+ chimeric 
lungs had fewer branches (Fig. 30) than the non-chimeric 
lungs (Fig. 3C). After 4 days of culture, the Gata6+ chimeric 
lungs demonstrated diminished branching morphogenesis in 
certain areas of the lung (Fig. 3F. arrow). whereas in other 
areas, branching morphogenesis patterns were the same as wild 
type (Fig. 3E). 
GataS-
'
- chimeric lungs display diminished 
branching morphogenesis in vivo resulting in 
respiratory insufficiency 
When Gata6-1- chimeric lungs were isolated at E15.5 they 
appeared similar to lungs isolated from non-chimeric 
litterrnates. The size was comparable. the lungs had four lobes 
on the right, one lobe on the left and no defect in branching 
morphogenesis was observed macroscopically (Fig. 4A.B). 
However, when these lungs were analyzed microscopically. a 
clear defect in branching morphogenesis indicated by the large 
airspaces was observed in the Gata6-1- chimeric lungs (Fig. 
40, arrow). when compared with non*chimeric lungs (Fig. 4C). 
When chimeras were generated with the parental heterozygous 
ES cells. which were used to generate the double mutant lines 
(Koutsourakis et al .. 1999). no abnormalities were observed in 
highly chimeric E15.5 lungs (results not shown). Chimeric 
El8.5 lungs. generated with Gata6+ ES cells (Fig. 4F) were 
again the same size as the non-chimeric lungs (Fig. 4E) from 
their litterrnates. In addition. chimeric lungs had foUl' lobes on 
the right and one lobe on the left. However. at this stage 0. 
clear defect in branching morphogenesis was observed 
macroscopically in some Gata6-1- chimeric lungs (Fig. 4F. 
arrows). This defect in branching morphogenesis was 
confirmed at the microscopic level (Fig. 4H). 
Eight pups were delivered by Caesarian section at E18S 
following blastocyst injection. Without knowing their 
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Fig. 1. Spatial-temporal distribution of Gata6 mRNA during 
embryonic and fetal pulmon:uy development CA) At EI0.5. Gata6 
mRNA is ptcdomlnillltly expressed at the tips of the prim:l.ry lung 
buds. (B) l\vo days later atE125. Gata6 mR."'A expression h:lll 
expanded and is now expressed in the entire endoderm lining the 
actively branching lung buds. (C) When hranehing morphogenesis is 
almost completed at EI5.5. Gata6 mRNA is observed in the 
endoderm lining the growing airways. and in particular in the distal 
endoderm. In the mesenchyme. Gata6 mRNA is also observed, but at 
a lower level. (0) Finally, during maturation and differentiation at 
EI8.5, Gata6 mRNA is expressed in epithelial cells lining the 
sacculi. 
Fig. 2. GATA6 antisense oligonucleotides inhlbit branching 
morphogenesis in vitro. Representative pictures of experiment~ with 
ElLS (A,B) or E12.5 (c'D) wild-type lungs. cultured as organotypic 
explant~ in the presence of sense CA.C) or antisense (B,D) 
oligonucleotides targeted against the trnnslation initiation site of 
Gata6. All pictures were taken at the same magIrificmion. 
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chimerism, the pups were stimulated to breathe. Out of the 
eight pups, two were mwnmified and three were born dead. 
Out of the three pups that were born alive. two appeared 
purplish-blue and one was pink. All three breathed normally. 
GPI electrophoresis demonstrated that only the pink pup was 
non-chimeric, and all other seven pups were highly chimeric 
(results not shown). 
Expression of SPC, CC10 and TTF1 in Gata~ 
chimeric lungs 
In order to investigate if cell differentiation was altered in 
Gatll6-1- chimeric lungs, non-radioactive in situ hybridization 
with probes for SPC, a marker for type II cells that indicates 
distal epithelial cell differentiation, and CClO, a marker 
for Clara cells that indicates proximal epithelial cell 
Fig. 3. Gata6-J- chimerie lungs display dlminished branching 
morphogenesis in vitro, When isolated at E12.5, Gata6-1- chimeric 
lung$ (B) are sm:iller and havc fewer branches than wild-type lungs 
isolated from alittcrm:l.te CAl. EI3.5 wild-type CC) and Gataa-'-
chimeric (0) lungs at day 0 of culture as organotypie cxplant.~. After 
4 clays of culture (E.F). the GatafJ'- chimeric lungs had areas of 
l:lol1IUll and ll.l'Cll.S of diminished branching morphogenesis (F). 
wherea.~ in the wild type lung branching morphogenesis hru:l. OCCUlTed 
ns normal (E). All pictures are representative of a series of 
experiments. and are llt thc same magnification. (Arrow indicates 
urea with diminished branching morphogenesis.) 
Fig. 4. B=ching morphogenesis in vivo is diminished in Gata6-J-
chimeric lungs whcn comparcd with wild-type lungs. At E15.5 (A-
D), lungs appeared macroscopically indistinguishable when isolated 
from wild-type (A) or Gara6-J- chimeric embryos (B). However, 
when microscopic sections were analyzed, Gata6-J- chimeric lungs 
had bigger airspaces CD) that the lungs of wild-type embryos (C). At 
ElS.5, GaJa6-J- chimeric lungs (F,H) displayed diminished 
branching morphogenesis both macroscopically (F) and 
microscopically (H) when compared with lungs ofwild-typc 
liUcrm.alcs (E.G). All pictures arc represcntative for u series of 
experimenL~ and are:l.t the same magnifiC:l.tion. (Arrows indie:l.tc 
areas with diminished branching morphogene~is.) 
differentiation, was performed. The promoters of the genes for 
both these proteins have previously been demonstrated to 
contain GATA motifs, indicating that thc transcription of thesc 
genes may be regulated by GATA transcription factors (Ray et 
al" 1993; Wert et aL, 1993). Another epithelial cell marker 
which has been shown to be regulated by GATA6 in vitro is 
TrFl. Localization of TrFl protein was investigated in the 
Gata6-1- chimeric Jungs. 
At El55 (Fig. SA-C) and ElSS (Fig. SD-F), normal SPC 
expression was observed in Gata6-1- chimeric lungs in the 
areas that appeared to have branched normally (Fig, 5B,C.E). 
In contrast, no SPC expression was observed in areas with 
GATA6 and fetal pulmonary development 
abnormal big sacculi (Fig, 5B,C,F). Normal SPC expression 
was observed in the wild-type lungs in distal epithelium at 
E15.5 (Fig. SA) and in type II cells at E1SS (Fig. 5D). 
At E1S.5, no CClO expression was observed in either wild-
type or Gata6-f- chimeric lungs, which was expected. because 
the gene for CClO is not expressed at that stage (results not 
shown). At El8.S. CCIO was expressed. in the proximal 
airways of wild-type lungs, as well as in the normally branched 
parts of the Gata6-1- chimeric lungs (Fig. 5G,H). In the 
abnormally branched parts of the Gauz6-t- chimeric lungs. no 
CCIO expression was observed (Fig. Sf). 
At E15.5 and EI8.5 TIFl protein was localized normally in 
epithelial cells of both wild-type and Gata6-f- chimeric lungs 
(Fig, 6A-F). No differences were observed. between areas with 
normal or abnormal branching morphogenesis in the Gata6+ 
chimeric lungs. 
Contribution of GataD'- ES cells in chimeric lungs 
In order to identify the origin of the endoderm of the 
abnormally branched areas. Gata6-1- ES cells (white) were 
injected into ROSA26 blastocysts (blue). In the targeted. ES cell 
clones we used. for generation of the chimeras, Gata6 was 
inactivated by insertion of a lacZ marker gene (Koutsourakis 
et al., 1999). However. when we investigated ~~galactosidase 
activity in early embryonic lungs. we could not detect activity 
in developing airways lined with pulmonary endoderm (results 
not shown). In contrast, !3-galactosidase activity was detected 
in developing major vessels later during lung development 
(results not shown). Therefore.. we did not expect any 
interference between ~-galactosidase activity in ROSA26- and 
ES cell-derived endoderm. 
Using this approach, a similar phenotype ofE12.5 lungs was 
observed upon isolation as in the previous experiments. The 
Gata6-f-BROSA26 chimeric lungs were smaller and had 
developed. fewer lung buds (Fig, 7 A), More interestingly. 
after detection of ~-galactosidase activity, completely white 
endodennal buds as well as mixtures of white and blue 
endodennal cells and completely blue endodermal buds were 
observed in highly chimeric lungs (Fig. 7B). In E1S.5 
Gata6-J-B ROSA26 chimeric lungs, the some observations 
were made (Fig. SA.B). Areas with reduced branching 
morphogenesis had almost completely white endoderm derived 
from Gata6-J- ES cells (Fig. SA,B, arrows). whereas areas with 
normal branching morphogenesis had completely blue 
endoderm, derived from the wild-type ROSA26 host blastocyst 
cells (Fig. SA,B). 
DISCUSSION 
Based on experiments using chimeric embryos and 
extrapolation of results obtained in other organs and model 
systems. GATA6 was presumed to be essential for the 
specification of foregut endoderm into pulmonary endoderm 
(Kalb et aI., 1998: Morrisey et al., 1998). Using experiments 
with antisense oligonucleotides in organotypic explant 
cultures, and (in particular) chimeric experiments with 
Gata6-1- ES cells, we provide evidence for a different and 
more extensive role for GATA6 in fetal pulmonary 
development than the previously proposed role of endoderm 
specification. In lung expJants with already specified lung 
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Fig. 6. Thyroid trllIlscription factor I (TIFl) protein distribution as a 
marker for pulmonary endoderm specification. In wild-type (A,C,E) 
and Gata6-1- chimeric (B,D,F) lungs, similar patterns ofTIFl 
protein distribution were observed at ElS.5 (A-D) and EIS.5 (E,F), 
(AB) Low-power overview ofEIS.s. (C-F) Same magnification. 
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Fig. 5. mRNA distribution of 
molecular maI'kers for distal 
(SPC) (A-F) nod proximal 
(CCIO) (G-I) epithelial cell 
differentiation. In both EIS.5 
(A-C) and EIS.5 (D-F) 
embryos, SPC mRNA was 
expressed in normally 
branched arcas of wild-type 
(A.D) and Gata6-!- chimerie 
(BE) lungs. No SPC mRNA 




- chimeric lungs 
(B,C,F), At EI8.S, CClO 
mRNA was expressed in 
normally branched areas of 
both wild-type (G) nod 
Gata6-!- chimeric lungs (H), 
wherea.'> in abnormally 
branched areas of Gata6-!-
chimeric lungs, noCCIO 
mRNA expression could be 
observed, All pictures are at 
the same magnification, 
except B, which is a low-
power overview of C. 
endodenn (wild type) we could abrogate branching 
morphogenesis in vitro by Culturing the explants in the 
presence of antisense oligonucleotides against Gata6, In 
agreement with this, highly chimeric lungs displayed 
diminished branching morphogenesis both in vitro and in vivo 
at different gestational ages. Proximal and distal epitheli:i1 cell 
differentiation was attenuated in chimeric lungs, as indicated 
by diminished expression of markers for distal and proximal 
epithelial cell differentiation, SPC and CCIO mRNA, 
respectively. TIF1, an early pulmonary epithelial cell marker 
that has also been shown to be regulated by GATA6 in vitro, 
was expressed as normal in chimeric lungs both at EIS.5 
and EI8.S, indicating that endodenn specification occurred 
nonnally. In accordance with this. we found that Gata6-!- ES 
cells contribute to pulmonary endodenn in highly chimeric 
lungs. and, consequently, the observed phenotype of reduced 
branching morphogenesis and attenuated epithelial cell 
differentiation is the result of loss of function of GATA6 in 
pulmonary endodenn, 
GATA6 is essential for branching morphogenesis 
Using both in vitro and in vivo experiments, we demonstrate 
here that GATA6 plays an essential role during certain stages 
of branching morphogenesis in the lung. Specification of 
foregut endodenn into pulmonary endodenn occurred 
normally in the chimeric lungs. because we obtained highly 
chimeric embryos with lungs that had undergone 
morphogenesis. Outgrowth of two endodermally derived 
primary lung buds initiates the process of lung formation. 
Thus. highly chimeric lungs successfully completed the earliest 
phase of lung development, i.e. the specification of pulmonary 
endodenn. The next event in lung development, formation of 
four primary lung buds on the right and one primary lung bud 
on the left in mice. also occurred normally in highly chimeric 
lungs, since all isolated lungs at El2S. E13.5. E15.5 and E18.5 
had four lobes on the right and one lobe on the left side. This 
indicates that primary branching morphogenesis does not 
require GATA6. Consequently. the observed phenotype of 
. reduced branching morphogenesis in lungs of highly chimeric 
embryos is the result of an essential role for GATA6 in 
secondary branching morphogenesis, the next stage of early 
pulmonary development Either by blocking wild-type GATA6 
translation with antisense oligonucleotides. or by depleting 
GATA6 function in chimeric lung endoderm. we demonstrate 
that absence of GATA6 gives rise to reduced branching 
morphogenesis. This resulted in lungs with very big airspaces. 
However. these lungs appeared no smaller than wild-type 
lungs. and when a marker for proliferation (Ki-67) was 
investigated in chimeric and wild-type lungs. no differences 
were observed (results not shown). Thus, the observed 
defect in branching morphogenesis is not the result of 
growth or proliferation inhibition by GATA6. For future 
studies it will be very interesting to investigate expression 
patterns of other molecules that have been demonstrated 
to pi:J.y an important role during branching 
morphogenesis. Endodermally expressed markers like 
sonic hedgehog (SHH) (Litingtung et al .• 1998), bone 
morphogenetic protein 4 (BMP4) (Bellusci et al .. 1996) 
GATAS and fetal pulmonary development 
endodenn into pulmonary endoderm occurred nonnally in the 
chimeric lungs. Hence, we conclude that GATA6 is not 
involved in pulmonary endodenn specification. as has been 
suggested before (Morrisey et ::tl. .. 1998). This conclusion 
corroborates with recent data obtained in experiments with 
Xenopus in which both GATA4 and GATAS were demonstrated 
to induce early endodermal marker genes. whereas GATA6 was 
demonstrated not to induce these endodermal markers (Weber 
et al" 2000). 
GataS-l- ES cells do contribute to pulmonary 
endoderm 
Using ROSA26 blastocysts (blue) as host blastocysts for 
GaJa6-1- ES cells (white). we were able to demonstrate 
contribution of GaJa6-1- ES cells to pulmonary endoderm.. 
Abnormally branched areas in E15.5 chimeric lungs had 
consistently white endodenn (GaJa6-1-) and normally 
branched areas blue endoderm (wild type) and therefore we 
and hepatocyte nuclear factorlforkbead homolog 4 
(HFH4; FOXJl - Mouse Genome Informatics) (Chen et 
al .. 1998). as well as mesenchyrnally expressed markers 
like fibroblast growth factor 10 (FGFIO) (Sekine et al .. 
1999) and GATA5 (Morrisey et al .• 1997a) are likely 
candidates. 
GATA6 is essential for late epithelial cell 
differentiation, but not endoderm specification 
In highly chimeric lungs. we could not detect expression 
of SPC and CCI0 mRNA in abnormally branched areas, 
indicating that both proximal and distal epithelial cell 
differentiation is disturbed in these parts of the lungs. 
In areas that had undergone normal branching 
morphogenesis SPC and CCIO were normally expressed. 
These data provide evidence for a functional role of the 
GATA motifs in the promoters of the genes for human 
SPC and murine CCIO in vivo (Ray et al., 1993; Wert et 
al .• 1993). Another gene that is thought to be regulated 
by GATA6 on the basis of in vitro studies is TIFI (Shaw-
White et al .• 1999). In addition. TIFI alone has been 
demonstrated to regulate transcription of SPC and CCIO 
(Kelly et al" 1996; Zhang et al .• 1997). Nevertheless. we 
could not detect any differences in protein expression of 
TIFt between chimeric and wild-type lungs using 
immunohistochemistry with an antibody against TIFI. 
This indicates that downregulation of the expression of 
the late epithelial markers SPC and CCI0 does not 
function through down-regulation of TIFl, which 
suggests that if GATA6 and TIFI regulate SPC and 
CCIO gene transcription, they do it through different 
pathways. The fact that we observed normal expression 
of TrFl protein. a marker for lung endoderm 
specification, indicates that specification of foregut 
Fig. 7. Distribution of Gata6-1- ES eell contribution into ROSA26 host 
lungs. (A) Gata6-1- ES cclls (white) contribute to both mesenchyme and 
endoderm ofE12.5 chimeric lungs (right). which are smaller and have fewer 
branches than lungs from wild-type littennates (left). In a section ofthc 
chimeric lung (B), blue (wild-type ROSA26). mixcd white and blue. and 
white (Gata6-1-) endoderm are observed, clearly indicating that Gata6-1- ES 
cells do contribute to pulmonary endoderm (Please note. as opposed to the 
usual experiment, that the white areas are abnormal and the blue areas 
non:nal). Arrows indicate white endoderm derived from GaJa6-1-ES eells. 
Fag. 8. Distribution of Gata6-1- ES cell contribution in E15.5 lungs. Both 
sections of different Gata6-1- chimeric lungs contain areas with abnonn!ll 
branching morphogenesis that have whlte endoderm (Gara6-1-) and areas 
with nonn!ll branching morphogenesis which have bluc endoderm coming 
from the wild-type ROSA 26 blastocyst. (Arrows indicate white endoderm 
derived from Gata6-1- ES celIs). 
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conclude that reduced branching morphogenesis in Gata6+ 
chimeric lungs is the result of defective GATA6 mutant 
endodenn. Since we observed different areas with either blue, 
white or mixed white and blue endodennal cells and not lungs 
or lobes that were completely white or blue, it is likely that the 
lungs originate from a substantial number of cells from the 
foregut. Our observations are in contrast with data presented 
by another group, demonstrating that Gata6+ ES cells do not 
contribute to the bronchial epithelium in chimeric lungs. and 
concluded that GATA6 is required for establishment of the 
endodermally derived bronchial epithelium (Morrisey et al., 
1998). The contradiction in observations can be explained by 
the different approach that we used in order to obtain animals 
that were highly chimeric. Whereas regular protocols suggest 
the injection of nine to 12 ES cells into blastocysts to generate 
chimeric embryos (Hogan et al., 1994), we used double the 
number of ES cells to obtain highly chimeric embryos. GPI 
electrophoresis revealed that most chimeric embryos were 
derived from at least 50% Gata6-1- ES cells and only chimeric 
embryos that were derived from more than 50% Gata6-1- ES 
cells were used in our experiments. Ifwe assume that selection 
by competition between wild-type and mutant cells occurs 
during the earliest stages of lung development in favor of wild-
type cells, then the regular amount of Gata6-1- ES cells (as 
used by Morrisey et 31.) may not have progeny in pulmonary 
endodenn. However. by using more Gata6+ ES cells, mutant 
cells were abJe to survive competition and to contribute to 
pulmonary endodenn. To overeome any interference that 
resulted from the percentage of wild-type cells present during 
early pulmonary specification of these chimeric lungs, it will 
be of interest to generate embryos exclusively derived from 
Gata6-1- ES cells. However. in all our experiments we never 
found embryos that were close to 100% chimeric (based on 
GPI electrophoresis), although a number of implantation sites 
with resorbed embryos were present. Based on the fact that 
GATA6 is not only expressed in extra-embryonic tissues. but 
also in embryonic tissues (Koutsourakis et aI., 1999; Morrisey 
et al., 1996; Morrisey et aI., 1998) it is likely that embryos 
exclusively derived from Gata6-1- ES cells do not survive to 
later stages of gestation. Hence, it is unlikely that the use of 
methods such as the generation of tetraploid embryo chimeras 
would answer this question. It will probably require the 
generation of conditional knockout mice. 
Role for GATA6 in epithelial~mesenchymal 
interactions 
Since branching morphogenesis is highly dependent on 
epithelial-mesenchymal interactions (Hogan and Yingling, 
1998), it is tempting to speculate which tissue layer causes 
the defect that reduces branching morphogenesis. Since the 
spatial-temporal distribution of Gata6 mRNA was 
predominantly observed in developing lung endodenn, it is 
most logical to postulate defective endoderm as the site where 
the primary defect is localized. Defective mutant Gata6-f-
endoderm appears unable to undergo nonnal branching 
morphogenesis and late epithelial cell differentiation resulting 
in the observed phenotype in the chimeric lungs. This would 
lead to the conclusion that the observed phenotype is based on 
a cell-autonomous defect in Gata6-1- endodennal cells. 
However, there is an alternative explanation. Specification of 
pulmonary endodenn and primary branching morphogenesis 
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occurs nonnally in a Gata6-1- environment. but at the initiation 
of subsequent branching morphogenesis, as yet unidentified 
signals produced by the endodenn are not processed nonnally 
by the mesenchyme. which in turn sends abnormal or no 
signals to the (up till that moment normal) endodenn. From 
then on. the endodenn would be instructed incorrectly by the 
mesenchyme, and would not undergo normal branChing· 
morphogenesis. resulting in big airspaces and attenuated 
epithelial cell differentiation. As a consequence, the observed 
phenotype is based on a cell-nonautonomous defect. 
Whichever scenario proves right. fUIther investigation is 
warranted, and studies using transgenic and conditional 
knockout mice would be invaluable. Another important 
question not addressed in this study is what the early target 
genes for GATA6 in pulmonary development :lfe. It is of 
interest whether known 'master' genes of branching 
morphogenesis such as Bmp4 (Bellusci et al.. 1996), Shh 
(Litingtung et al .. 1998) and members of the fibroblast growth 
factor family (Post et al .. 1996; Sekine et aI .• 1999) are also 
transcriptionally regulated by GATA6. Future studies using 
immunoprecipitation, yeast two-hybrid screens and DNA 
microarray techniques, as well as detailed promoter analysis, 
should bring more insight. 
GATA6 function during pulmonary development: a 
hierarchical model 
Based on the results of our experiments. a reconsideration of 
the position of GATA6 in the hierarchy of factors involved in 
pulmonary development is warranted. To date Gata6 was 
considered to be one of the master genes in lung development 
(Whitsett and TIchelaar, 1999). Together with HNF3~ (Ang 
and Rossant. 1994) and TIFl (Kimura et aI., 1996), GATA6 
was positioned high up in the hierarchy because all three 
factors were thought to be essential for the specification of 
foregut endodenn into pulmonary endoderm. However. in this 
study. we provide evidence that GATA6 is not essential for 
pulmonary endoderm specification. but plays an important 
role in branching morphogenesis and late epithelial cell 
differentiation. Therefore, we postulate that GATA6 functions 
(in concert with TIFl) in the process of branching 
morphogenesis and late epithelinl cell differentiation. 
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ABSTRACT 
The transcription factor GATA-6 is expressed in the fetal pulmonary epithelium of 
the developing mouse lung and loss of function studies strongly suggested that it is 
required for proper branching morphogenesis and epithelial differentiation. We 
have further investigated the role of GATA-6 in this process by utilizing a 
pulmonary epithelium specific promoter to maintain high levels of GATA-6 
protein dnring fetal lung development. Transgenic mice expressing a myc-tagged 
GATA-6 cDNA under the control of the human Surfactant Protein-C (SP-C) 
promoter were generated and their lungs were analyzed during fetal stages. 
Transgenic lungs exhibit branching defects as early as embryonic day (E) 14.S and 
molecular analysis just before birth (EI8.S) shows a lack of distal epithelium 
differentiation whereas proximal epithelium is unaffected. Electron microscopic 
analysis and glycogen staining confirm the lack of differentiation to mature Type II 
cells. Thus, elevated levels of GATA-6 protein affect early lung development and 
in analogy to other GATA factors in other tissues, GATA-6 also plays a crucial 
role in the terminal differentiation in this case of the distal pulmonary epithelium. 




The complexity of the lung tissue with respect to morphogenesis and cell type 
constitution reflects the complexity in the control of its development. Early 
specification (around embryonic day 9.5 in the mouse) is far from understood and 
molecules like HNF-3[3 that is thought to be involved, has a more general role in 
foregut and midgut fonnation (Ang and Rossant, 1994; Dufort et al., 1998). For the 
initial lung bud outgrowth mesenchymal-epithelial interactions are crucial since 
genetic studies have shown that molecules like FGF-10, Gli-2 and Gli-3, all 
expressed in the lung mesenchyme, are key factors (Min et aI., 1998; Motoyama et 
aI., 1998). Mesenchymal-epithelial interactions are also important throughout 
branching morphogenesis and in the current concept of lung budding, localized 
high expression of FGF-IO induces the endodenn to bud (Hogan, 1999; Weaver et 
al., 2000). This pre-programmed process is reiterated and leads to the 
establishment of an extensive respiratory tree which, by the end of the 
pseudoglandular stage oflung development (E16.5), consists of proximal and distal 
airways. At this stage, epithelial cells undergo extensive differentiation to give rise 
to a number of distinct cell types (ciliated, nonciliated secretory, goblet, basal, 
alveolar Type I and Type II cells), which will establish a functional lung. Although 
some studies describe these different cell types morphologically and in tenns of 
surfactant protein expression (Ten Have-Opbroek, 1991; Ten Have-Opbroek et al., 
1988; Ten Have-Opbroek et aI., 1990) their differentiation program remains 
obscure at the molecular level. 
BMP-4 expression in the endodenn is thought to contribute to the acquisition of 
cell fate with distal epithelium resulting from exposure to high growth factor 
concentration (Weaver et al., 1999). A number of other molecules including FGFs, 
glucocorticoids and some transcription factors like TTF-l, HFH-4 and GATA-6 
have been implicated in epithelial cell differentiation and surfactant protein 
production (Perl and Whitsett, 1999; Warburton et al., 2000; Whitsett and 
Tichelaar, 1999). TTF-l was shown to positively influence BMP-4 levels and its 
absence results in a lack of distal structures and the lack of surfactant proteins 
expression (Minoo et al., 1999). The HNF3/forkhead homologue-4 (HFH-4) has 
been associated with induction of proximal fate and specifically the appearance of 
ciliated cells (Tichelaar et al., 1999). GATA-6, a member of the GATA DNA 
binding family of zinc finger transcription factors, is expressed in the early 
branching endodenn and it was thought to be essential for bronchial endodenn 
specification (Morrisey et aI., 1998). However, recent studies have shown that the 
protein is not required for early specification but for nonnal branching 
morphogenesis and epithelial differentiation. Lung endodenn depleted of GATA-6 
fails to branch nonnally and to acquire either distal or proximal fate (Keijzer et aI., 
2001). Furthennore, GAT A binding sites have been identified in the promoters of 
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Nkx2.1, Clara cell marker-1 0 and Surfactant Protein-A and -C (Bruno et aI., 2000; 
Shaw-White et al., 1999; Wert et aI., 1993). 
GATA proteins have been shown to play key roles in the differentiation of a 
number of distinct cell lineages and their levels can influence cell choices between 
differentiation and proliferation (Molkentin, 2000). GATA-l functions in 
erythrocytes and alteration of its levels results in a block of differentiation (pevny 
et al., 1991; Whyatt et al., 1997). Overexpression of GATA-2 blocks 
differentiation of early haematopoietic progenitors (Briegel et aI., 1993) and 
overexpression ofGATA-3 is involved in the differentiation ofT-cells (Hendriks et 
al., 1999; Zheng and Flavell, 1997). In vivo loss of function studies in mice have 
shown distinct roles for GATA-4, -5 and-6 during development and both GATA-4 
and -6 primarily function in the extraembryonic visceral endoderm (Koutsourakis 
et al., 1999; Kuo et al., 1997; Molkentin et al., 1997; Morrisey et al., 1998). In 
vitro studies have implicated GATA-6 in the differentiation program of vascular 
smooth muscle cells, VSMCs (Mano et al., 1999), and more recently in glomerular 
mesangial cells, GMCs (Nagata et aI., 2000). In Xenopus embryos, it has been 
demonstrated that decreasing GATA-6 expression is associated with differentiation 
of cardiac precursors. When GATA-6 levels were sustained high, the cardiac 
differentiation program was blocked (Gove et al., 1997). 
In this study we utilized a previously characterised promoter/enchancer from the 
human Surfactant Protein-C (SP-C) gene (Wert et al., 1993) to keep GATA-6 
expression levels elevated in the pulmonary epithelium. Transgenic embryos were 
generated and their lungs were analyzed morphologically at various stages. Just 
before birth molecular as well as Electron Microscopic analysis were performed to 
evaluate the status of differentiation of the lung epithelium. Our results parallel 
data from other GATA factors and show that elevated GATA-6 expression in the 
lung epithelium, in vivo, not only affects its normal branching pattern but also 
impairs the differentiation program in the distal airways. 
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MATERIALS AND METHODS 
Construction of the GATA-6 transgene 
The full GATA-6 cDNA was constructed by joining the two EcoRI fragments 
which were isolated from a mouse EI1.5 library (CLONTECH) (Brewer et al., 
1999; Koutsourakis et ai., 1999). 3' UTR was eliminated by PCR from the unique 
PstI site to the stop codon (144bp) and a unique site was introduced in the 3' PCR 
primer in order to clone the last non-coding exon, intron and polyA (PA) (2.8 kb) 
from the human -globin gene (Drabek et ai., 1997). PCR between the first ATG 
and the unique NotI (520bp) site was used to eliminate 5' sequences. In the 5' PCR 
primer the myc epitope (EQKLISEEDL) was introduced immediately after the 
ATG of GATA-6 (Elefanty et al., 1996). The sequence of all PCR generated clones 
was confmned before further cloning. The complete (1.7 kb) myc-tagged GATA-6 
cDNA was transfected in COS-I cells and the overexpressed protein was 
immunoreactive in situ with both the anti-myc (9EIO) and the anti-GATA-6 
(SantaCruz) antibodies (data not shown). The human SP-C promoter (Wert et al., 
1993) was cloned as a 3.7 kb blunted NdeI-SalI fragment in blunted SalI of pBS 
and the myc-GATA-6-globinPA as an JOIOI fragment. The transgene was released 
with ClaI between the pBS polylinker and the ClaI that was present at the end of 
the PA. The 8.2 kb fragment was gel purified with CONCERT™ Matrix (GIBCO 
BRL) and passed through ELUTIP-D column (Schleicher & Schuell). 
Generation of transgenic embryos 
Transgenic mouse embryos were generated by pronuclear injection of FVBIN 
oocytes with transgene concentration 2-3 nglf.ll according to standard protocols 
(Hogan et al., 1994). Day of injection and transfer to pseudopregnant females was 
considered as day 0.5 for the subsequent staging of the dissected embryos and 
lungs. Part of the tail of the dissected embryos was used for southern blot 
genotyping using the human -globin PA as a probe. 
In situ hyhridization and immunohistochemistry 
Fetal or newborn lungs were dissected out and fixed in 4% PFA overnight at 4°C 
before processing for paraffin embedding according to routine protocols. 5-7f.lm 
thick sections were used for H&E staining, RNA in situ hybridization (Motoyama 
et ai., 1998) and immunohistochemistry (Keijzer et al., 2000). Digoxigenin labeled 
RNA probes were made from cDNA fragments of 1.5kb for GATA-6, 0.33 kb for 
SP-C and 0.315 kb for CC-IO according to the protocol supplied by Roche 
Diagnostics. For TTF-I, a monoclonal antibody (Neomarkers, CA, USA) was used 
in I: I 00 dilution and the sections were microwave boiled in citrate buffer for 
100 
l5min. The same dilution was used for the monoclonal anti-myc antibody (9E10) 
but for antigen retrieval, trypsin treatment (0.6mg/ml for 5min at RT) was used. 
Electron Microscopy 
The caudal lobes ofEl8.5 fetal lungs were fixed in 2.5% glutaraldehyde in 0.15 M 
cacodylate buffer pH 7.3 at 4°C for a few days until the genotypes were known. 
One trangenic and one wild type littermate lobe were washed in 0.1 M cacodylate 
buffer and postfixed in 1 % OS04 in 0.1 M cacodylate buffer and fmally embedded 
in epon as has been previously described (De Bruijn and Den Beejen, 1975). 
Ultrathin sections were contrasted with Uranyl-acetate and Lead-citrate prior to 
Electron Microscopic analysis (Hanaichi et al., 1986). 
PAS staining 
From the epon-embedded E18.5 lungs, semithin (l)ll1l) sections were used for 
periodic acid Shiff's staining as previously described (Nevalainen et al., 1972). 
RESULTS 
GATA-6 expression and over-expression in the pulmonary epithelium 
Expression of GATA-6 in the developing embryonic bronchial epithelium has been 
described previously (Morrisey et al., 1996). In a recent study (Keijzer et al., 
2001), a more extensive analysis of GATA-6 expression revealed that initially it is 
expressed at the tips of the growing buds (E10.5) and by E12.5 it is expressed in 
the entire endoderm lining the developing buds. By EI5.5, GATA-6 mRNA is 
predominantly expressed in the endoderm lining the growing airways and to a 
lower extent in parts of the surrounding mesenchyme (Fig. IA). This expression 
pattern, although not at a comparable level, is quite reminiscent to that of SP-C at 
the same developmental stage (Fig. 1B). This observation led us to employ the 
3.7kb promoter/enhancer of the human SP-C gene (Wert et al., 1993) in order to 
sustain high GATA-6 expression levels in the developing epithelium in vivo. The 
complete mouse GATA-6 cDNA was cloned downstream of the SP-C promoter 
and was followed by the human -globin last exon, intron and polyA for mRNA 
stability. Sequences coding for the myc epitope were introduced in frame with the 
first ATG of the gene (Fig. I C). The SPC-mycGATA6 transgene was injected into 
fertilized eggs and lungs were isolated from embryos at different developmental 
stages, EI4.5, E16.5 and EI8.5. Embryos were genotyped by Southern blotting 
(data not shown) and transgenic lungs were identified. All the analysis was 
performed in Fo transgenic founder embryos. Transgenic lungs were not 
significantly different in size from their wild type littermates (data not shown). 
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human sp-c mycGATA-6 globin PA 
Figure 1 
Distribution of GATA-6 (A) and SP-C (B) mRNA in E15.5 lungs. Both genes, 
although at a different level, are expressed in cells lining the distal epithelium (blue 
is the detected mRNA and the tissue is counterstained with methyl-green). In C the 
transgene used to overexpress GATA-6 in the pulmonary epithelium is 
schematically depicted. A myc-tagged version of the complete mGATA-6 cDNA is 
under the control of the 3.7 kb human SP-C promoter and it is followed by the 
human -globin last intron and polyadenylation signaL 
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Only after careful examination of the whole transgenic lungs, a difference in the 
texture was noticed, especially in the affected lungs at E18.5 (data not shown). At 
this stage, out of 5 transgenic founder, 3 were expressing the trans gene and they all 
had a comparable phenotype (Fig. 2F and 4H). Sections from the same transgenic 
E18.5 lung were used for both morphological (Fig. 2F) and transgene expression 
analysis (Fig. 3B&D). Expression analysis of molecular markers (Fig. 4) and EM 
(Fig.5) were performed on sections from a different transgenic EI8.5lung. 
Branching morphogenesis in the SP-C/GATA-6 transgenic/eta] lungs 
Starting at embryonic day 14.5, the transgenic lungs looked similar in size with the 
wild type but they had undergone less extensive branching judged by the fewer 
terminal buds (Fig. 2B). Two days later, at EI6.5, the defect in branching 
morphogenesis was more pronounced because of the presence of grossly dilated 
terminal buds separated by excess of mesenchyme (Fig. 2D). Just before birth, at 
EI8.5, the phenotype was comparable to that seen at E16.5 and the overall growth 
of the tissue was not severely affected (Fig. 2F). The mesenchyme appears to be 
thickened although it is at present not clear whether this is due to an actual increase 
in the number of mesenchymal cells or the lack of being intersected by branching 
endoderm. Postnatally, although the remains of a transgenic pup were found 
subsequent to its perinatal death, few transgenic pups were born alive and they 
were breathing normally. These transgenic pups were left to breathe for few hours 
before they were sacrificed for genotyping and histologic analysis. In figure 2H a 
section of an abnormal lung among the transgenic pups is shown with a phenotype 
similar to the clinical centro-acinar aeration pattern. The severity of the phenotype 
was less than that seen in E18.5 lungs (Fig. 2F) most likely due to the lower 
expression levels of the transgene. Expression of the transgene in the affected 
E18.5 lungs was confirmed by immunostaining for the myc epitope (Fig. 3B) and 
GATA-6 mRNA, transgenic and endogenous, was detected by in situ hybridization 
(Fig. 3 C and D). 
Molecular analysis 0/ differentiation in the GATA-6 over-expressing epithelium 
Since extensive differentiation and the initiation of surfactant production start at 
the saccular stage of lung development (EI7.5), which extends even after birth (to 
P5), we decided to investigate epithelium differentiation in E18.5 transgenic lungs. 
Thyroid Transcription Factor-I (TTF-I or Nkx2.I) protein, a marker for specified 
pulmonary endoderm (Minoo et aI., 1999), was abundantly present in transgenic 
lungs (Fig. 4B and C). However, the staining in all cells lining the dilated terminal 
buds is more intense than the characteristic staining for this stage of development 
as seen in wild type E18.5 lungs (Fig. 4A). Clara Cell marker-IO mRNA (Ray et 
al., 1996) was expressed in transgenic lungs at a normal level indicating the 
presence of non-ciliated sectretory cells in the proximal epithelium (Fig. 4D-F). In 
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the distal epithelium, topologically represented by the dilated buds, Surfactant 
Protein-C (Kalina et al., 1992) expressing cells could be detected among the cells 
lining the epithelium (Fig. 4H and I) although the number of cells and their 
distribution were very different from that observed in wild type lungs (Fig. 4G). 
SP-C is expressed in the Type II cells which function mainly in surfactant 
production and they can further differentiate into Type I pneumocytes, the 
functional cells for gas exchange. 
Morphological analysis of differentiation in the GATA-6 over-expressing 
epithelium 
From morphological studies (Ten Have-Opbroek, 1991; Ten Have-Opbroek et al., 
1988) it was shown that before maturation, Type II cells have an excess of 
glycogen present in their cytoplasm and their nucleus is less round. We therefore 
stained the epithelium of the transgenic lungs (EJ8.5) for glycogen (Fig. 4J-L) and 
used Electron Microscopy to examine the ultrastructure of the cells lining the 
dilated buds (Fig. 5). Periodic acid Shiff s staining (PAS) for glycogen revealed 
that a very high percentage of cells lining the distal epithelium of the transgenic 
lungs is positive for glycogen in their cytoplasm (Fig. 4K and L). Normally at this 
stage, due to advanced differentiation, glycogen positive cells are hardly detectable 
in the lining of the distal epithelium (Fig. 41). The caudal lobe of a transgenic (Fig. 
4) and a wild type littermate lung were processed for Electron Microscopy. In the 
epithelium of the wild type lung, normal Type II cells could be easily identified by 
the cuboidal shape, the almost round nuclei and the presence of several 
multilamellar bodies (Fig. 5C). Squamous Type I cells were also observed 
surrounding capillaries (Fig. 5E, arrows indicate capillaries). Both Type II and I 
cells were represented in every alveoli that was examined. In contrast, examining 
the epithelial lining in the dilated alveoli in the transgenic lung we were not able to 
find any typical Type II or I cells. Instead, a number of cells with more irregular 
nuclei and numerous glycogen fields in their cytoplasm were found (Fig. 5D, 
glycogen fields are indicated by arrowheads). Although formation and localization 
Figure 2 
Histological analysis of SP-C/GATA-6 transgenic lungs during fetal lung developmenL At EI4.5, 
transgenic lungs (B) are smaller than wild type CA) and they have fewer tenminal buds. Two days 
later, at E16.5 the branching defect is more prominent with big dilated distal buds present in the 
transgenic lungs (D) while fine branching is already apparent in wild type littenmates Cc). This 
phenotype is more dramatic just before birth, at EI8.5, with the presence of abnormally shaped and 
sized distal alveoli (F) in contrast to nonnal alveolization that can be seen in wild type lungs (E). A 
few transgenic pups were born alive and the most severely affected one (H) had a milder branching 
phenotype when compared to most of the EI8.S transgenic lungs (F). This phenotype is similar to the 






Expression of the SP-C/GATA-6 transgene in EI8.S lungs. The anti-myc antibody was used 
to detect chimeric protein in transgenic lungs (B). Intense staining can be seen in the 
epithelium lining the abnormally dilated alveoli (brown). Wild type lungs show no staining 
(A). GATA-6 mRNA was detected in both wild type and transgenic lungs by in situ 
hybridization. In C, normal GATA-6 expression in parts of the epithelium and in the 
surrounding mesenchyme can be seen in wild type EI8.S lungs (blue). In transgenic lungs 
(D) the signal for RNA expression (blue) is very intense in the lining of the epithelium as 
seen with the anti-myc antibody staining (B). For this analysis, sections from the lung that 
is shown on Figure 2F were used. 
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of capillaries appeared normal, the squamous cells present around them had 
different morphology than that of a typical Type I cell and some even had glycogen 
in their cytoplasm (Fig. SF, arrow indicates capillary and arrowhead glycogen). 
Proximal epithelium appeared normal and ciliated cells were observed as in the 
wild type epithelium (data not shown). 
DISCUSSION 
Depletion of GATA-6 expression in the pulmonary endoderm, both in vitro and in 
vivo, resulted in lack of branching morphogenesis and failure of the epithelium to 
differentiate (Keijzer et al., 2001). To better understand the role of this 
transcription factor in lung development we used the SP-C promoter to artificially 
maintain high levels of GATA-6 expression in the fetal pulmonary epithelium in 
vivo. This alteration also resulted in defective branching morphogenesis and 
epithelial differentiation. However, the branching phenotype was manifested later 
during development and in a less severe form probably due to the late onset of the 
transgene expression (Wert et al., 1993). The promoter is active after pulmonary 
endoderm specification, initial budding and lobe determination but before the 
differentiation program starts at the pseudo glandular stage (E 14.S) of lung 
development (Perl and Whitsett, 1999; Warburton et aI., 2000). Hence, GATA-6 
expression in the SP-C/GATA-6 lungs is already elevated in the primordial 
epithelium before any proximal or distal fate had been acquired. Nevertheless, this 
overexpression affected only distal epithelium where the gene is normally 
expressed. Thus, this study shows that GATA-6 has a specific regulatory role in the 
differentiation program of the distal epithelium and also confirms that GATA-6 
protein levels are crucial during both lung morphogenesis and cell type 
specification (Keijzer et al., 2001) 
Branching morphogenesis in the SP-C/GATA-6 transgenic lungs 
The interaction between epithelium and mesenchyme is a determining factor in 
lung development starting from the initial budding and continuing during 
branching morphogenesis involving well-studied molecules like FGF-I0, BMP-4 
and SHH (Hogan, 1999; Weaver et al., 2000). The localized high expression of 
FGF-IO in the mesenchyme promotes the endoderm to bud and to express high 
levels of BMP-4. Subsequently, BMP-4 together with SHH downregulates FGF-IO 
to prevent new budding at the same position while allowing the newly formed bud 
to grow. When a certain distance has been reached, the high expression domains of 
FGF-IO present on either side or both sides of the growing bud induce new 
budding resulting in lateral or dichotomous branching, respectively. GATA-6 
expression in the endoderm coincides with branching morphogenesis but unlike 
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Figure 4 
Molecular analysis of differentiation in the transgenic epithelium at EI8.5. ITFw 1 protein localization 
in wild type (A) and transgenic (B and C) epithelium shows the abnonnally, for this stage, TTF-J 
positive epithelium which lines the complete transgenic alveoli (brown). In D and E, F the normal 
expression of CC-J 0 mRNA, a marker for proximal non-ciliated cells, is shown in both wild type and 
transgenic lungs, respectively (blue). In the distal epithelium, expression of endogenous SP-C, a 
marker for Type II cells, can be seen in a wild type lung (G) and the decreased levels with the 
different distribution in the transgenic lung (H and I) (blue). Periodic Acid Shiffs staining for 
glycogen (purple) revealing that in contrast to the wild type lung (J), the transgenic lung has an 
alveolar epithelium which is lined almost exclusively by glycogen positive cells (K and L). 
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BMP-4 expression (Weaver et al., 2000), there are no detailed GATA-6 expression 
data during the induction and growth of a bud. In EI0.5 lungs GATA-6 mRNA has 
been localized to the growing tips of the initial buds (Keijzer et al., 2001). At that 
stage, the SP-C promoter becomes active resulting in high expression of GATA-6 in 
all SP-C expressing cells throughout the transgenic endoderm. This alteration of 
GATA-6 expression results in the branching defects in the transgenic lungs which 
could be explained in two ways. Either by distorting a molecular pathway intrinsic 
to the branching endoderm or by interrupting a pathway involved in processing an 
inductive signal from the mesenchyme. 
In cardiac development, FGFs and BMPs have been placed upstream of GATAs 
(Schultheiss et aI., 1997; Monzen et al., 1999; Reifers et aI., 2000). Cardiac 
induction involves GATA-4 and its co-factor Nkx 2.5 and they are both necessary 
to establish cardiac phenotype (Durocher et al., 1997). An analogous regnlatory 
pathway appears to operate in the lung endoderm. TTF-l (or Nkx 2.1), a gene from 
the same Nkx homeobox family and GATA-6 are expressed in the lung endoderm 
from early pulmonary specification and both are required for branching 
morphogenesis (Lazzaro et al., 1991; Keijzer et aI., 2001). It has been suggested 
that TTF-l expression may be downstream and depends on GATA-6 expression 
(Shaw-White et aI., 1999), however, TTF-l expression is normal in GATA-6 -/-
endoderm showing that TTF-l expression is independent of GATA-6 (Keijzer et 
aI., 2001). Unfortunately it is not known whether GATA-6 is still expressed in 
TTF-l -/- embryos (Minoo et al., 1999) 
GATA-61evels and pulmonary epithelium differentiation 
Expression of GATA-6 starts in the primordial epithelium and it is restricted to the 
distal epithelium by EI5.5. The levels of its expression are difficult to quantitate by 
in situ hybridization. By expressing GATA-6 under the control of SP-C, a constant 
high level of the protein was present from the onset of differentiation resulting in a 
distal epithelium attenuated of any terminal differentiation. Unlike overexpression 
of TGF- 1 (Zhou et al., 1996) and HNF-3 (Zhou et al., 1997) that resulted in 
endodermal arrest at the primordial or pseudoglandular stages, GATA-6 
overexpression did not affect initiation of the differentiation program. The pathway 
of proximal epithelium differentiation was unaffected since both ciliated cells, seen 
in the EM analysis, and non-ciliated secretory cells, visualized by CC-10 
expression, were detected as normal. Along the distal epithelium no mature Type II 
cells were present and all the cells were still expressing TTF-l. Normally the 
presence of numerous glycogen fields in the cells lining the distal airways is 
indicative of their differentiating status (Sorokin, 1965). This has been described in 
detail in an extensive morphological study of the features of Type II alveolar 
epithelial cells by Ten Have-Opbroek (1988). Later during lung development, 
before birth, a multi-step formation of multilamellar bodies (MLB) is thought to 
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FigureS 
Electrou Microscopic analysis of the distal epithelium at EI8.5. A low power overview of a 
wild type and a transgenic lung is shown in A and B, respectively. In the distal epithelium 
of a wild type lung both typical Type 11 cells, with multilamellar bodies in their cytoplasm 
(C) and flat Type I pneumonocytes, around capillaries, can be detected (E). In the 
transgenic lung atypical cells lining the alveoli are detected and the presence of glycogen in 
their cytoplasm is a common feature (D). Flat cells are present around the capillaries (F) 
although they look distinct from wild type Type I cells and some of them still have 
glycogen in their cytoplasm (arrowheads point to glycogen fields and arrows indicate 
capillaries, magnifications: A and B X620, C-F X5800). 
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compartmentalize glycogen (Ten Have-Opbroek et at., 1990). Our data show a 
continued presence of glycogen in the distal epithelial cells suggesting that GATA-
6 is involved in a particular stage of this maturation process. When the levels are 
elevated, the cells do not initiate the [mal differentiation step which is 
characterized by multilamellar bodies formation. Instead, most of the cells lining 
the alveolar epithelium have glycogen in their cytoplasm, as visualized by periodic 
acid Shiffs staining (Fig. 4K and L), indicating a block in the Type II 
differentiation pathway. The flat Type I cells which function in gas exchange, are 
thought to originate from further differentiation of Type II cells although it is not 
clear whether they are derived from a mature Type II cell or from one of the 
intermediate stages during their maturation. In the GATA-6 overexpressing lungs, 
flat epithelial cells surrounding the capillaries were observed and their shape and 
localization suggest that they are Type I cells. However, some of them still had 
glycogen fields, they were not as flat as normal Type I cells and their nucleus had 
an irregular shape. At this [mal step, differentiation is thought to be driven by 
growth and particularly by the intercalation of the forming capillaries with the 
epithelium (Ten Have-Opbroek et aI., 1988). Thus, the apparent Type I-like cells 
we see, could be the same precursors of Type II cells as discussed above, except 
that they are in close proximity with the capillaries and have less glycogen fields. 
This would suggest that elevated levels of GATA-6 would prevent the formation of 
fully differentiated Type I cells even when in contact with capillaries. In 
conclusion our data demonstrate that GATA-6 plays an important role in lung 
organogenesis and especially during the multi-step process of maturation of Type 
II cells. Elevated GATA-6 protein levels result in a block of terminal 
differentiation to mature Type II and Type I pneumocytes. 
III 
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Hepatocyte nuclear factor-3beta limits cellular diversity in the developing 






Among the members of the GATA family of transcription factors GATA-
4, -5 and -6 constitute a subfamily, based on high sequence homology and 
overlappiug expression patterns during embryogenesis. Initially, it was anticipated 
that the proteius are important for cardiogenesis based on their dynamic expression 
pattern during heart development. As a result, they have been described as the heart 
related subfamily of GATAs [1]. However, iu view of the recent data there is a 
number of reasons to question this name. First, targeted iuactivation of GATA-4 
revealed that the gene is required for normal ventral-to-lateral folding of the 
embryo rather than for heart-specific morphogenesis and differentiation [2, 3]. 
Further analysis of chimeric embryos with GATA-4-/- ES cells demonstrated that 
the primary requirement for the protein is actually iu the extraembryonic visceral 
endoderm [4]. Second, GATA-6 iuactivation iu the mouse poiuted to a primary 
function of the protein in the visceral endoderm [5] (chapter 2). In addition, 
chimeric loss of function and transgenic gaiu of function of GATA-6 iu the lung 
endoderm showed that the levels of GATA-6 proteiu are crucial for normal 
puhnonary morphogenesis and differentiation (chapter 3 and 4). Third, 
experimental evidence from Xenopus as well as zebrafish suggest a role for 
GATA-5 in early endoderm formation iu these species [6, 7]. However, endoderm 
formation iu the mouse is not affected by GATA-5 [8]. Thus, endoderm is 
emergiug as the common theme for this subfamily of transcription factors. This 
also holds true during evolution since analogies can be found not only in frogs but 
also in flies and worms [9-11]. Therefore it may be more appropriate to refer to 
GATA-4, -5 and -6 as the endoderm related subfamily of GAT As. 
Primary function of GATA-6 
GATA-6 appears to be required earlier than any other GATA factor during 
mouse embryonic development. Mutant embryos cannot survive past the 
implantation stage and they die around embryonic day 5.5 [5] (chapter 2). Prior to 
implantation, the mouse embryo is a very simple structure and yet only part of it, 
the epiblast, gives rise to embryonic tissues. The rest of the cells are organized in 
the surrounding membranes, which playa crucial role in the support and the further 
growth of the underlying epiblast. However, the parietal and the visceral endoderm 
do not just provide a filtrative or nutritive function by their attachment to the uterus 
or the embryo. In the last few years a more specific function of the visceral 
endoderm has been revealed. It has been shown to pattern the underlying totipotent 
cells of the epiblast and this inductive function contributes significantly to our 
understanding of gastrulation and the events preceding it [12]. Based on molecular 
expression patterns and by using ES cell technology to either inactivate a gene or 
generate chimeric embryos with different genotypes in embryonic and 
extraembryonic tissues, the recent data assigned anterior-posterior patterning 
activity to the visceral endoderm [13]. This function is mediated by part of the 
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visceral endoderm that is referred to as anterior visceral endoderm (A VB), simply 
because it marks the anterior site of an epiblast that still consists of totipotent cells 
and has no sign of primitive streak formation. 
The precise expression pattern of GATA-6 in the visceral endoderm is still 
not very clear. Radioactive in situ hybridization on sections of ES.5 embryos gives 
a signal around the embryo and makes localization to parietal endoderm of the 
Reichert's membrane or to visceral yolk sac endoderm very difficult. Moreover, 
any localized expression within the visceral endoderm cannot be easily recognized 
[S]. The -galactosidase reporter gene that we inserted into the GATA-6locus gave 
a more or less ubiquitous expression pattern at the blastocyst stage, which is 
subsequently restricted to very few cells at E4.5. Based on their localization, these 
cells could be primitive endoderm, however, they can only be a small portion of it 
and it is unlikely that they represent cells already differentiating to visceral 
endoderm [14, IS]. By ES.S, expression completely disappears and appears again 
later at E7.S, in the parietal cells of the Reichert's membrane (chapter 2). This 
expression pattern is very intriguing but subsequent findings that the LacZ gene 
does not faithfully recapitulate GATA-6 expression in all lineages at later 
developmental stages (chapter 3), mandate a more cautious interpretation of l3-
galactosidase reporter activity. The validity of the LacZ expression pattern could 
only be cOnImned by comparison to the expression pattern of the endogenous 
GATA-6 gene. However, attempts to detect GATA-6 mRNA on whole mount 
preparations of early pre- and post-implantation embryos were not successful. 
Although the precise expression pattern of GATA-6 during visceral endoderm 
differentiation is not clear, the implication of the protein in the differentiation of 
this cell lineage is well supported. It is based on the morphology of the E5.5 null 
embryos and the in vitro outgrowth of mutant blastocysts (chapter 2). Additionally, 
expression of HNF-4, which is considered as an important factor for visceral 
endoderm differentiation [16, 17], was markedly reduced in the mutant embryos 
[5]. It was even suggested, based on in vitro experiments, that the gene is a 
downstream target ofGATA-6 [5]. Differential screening of wild type and GATA-6 
mutant embryoid bodies revealed additional GATA-6 target genes in this lineage. 
Of particular interest is the gene encoding the mitogen-responsive phosphoprotein 
Dab2, which is not expressed in GATA-6 null visceral endoderm and in in vitro 
studies it is directly and specifically regulated by GATA-6 [18]. Thus, the 
possibility remains that loss of HNF-4 expression is simply due to a poor 
differentiation of visceral endoderm in the GATA-6 mutants. 
While the regulatory targets of GATA-6 have not been extensively 
analyzed, data from our study (chapter 2) and from others [5] indicate that GATA-
6 function is essential for the differentiation of the visceral yolk sac endoderm. 
Although it is unlikely that the protein is involved in any subsequent patterning 
activity of this tissue, these findings add a new crucial gene function for visceral 
endoderm differentiation to a very small list. In addition to TGF-13 signaling [19, 
20], only HNF-4 [17] and vHFN-l [21, 22] have been implicated in the 
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differentiation of this lineage. The way that GATA-6 regulates differentiation is 
not yet clear and it will be very interesting to identifY more target genes of the 
protein. Furthermore, the early ubiquitous expression pattern of GATA-6 in the 
blastocyst raises the question why the protein is initially present in almost all cell 
types and during the subsequent 24 hours it is restricted to one cell population 
affecting its differentiation. If perhaps maintenance of GATA-6 expression was a 
requirement for visceral endoderm specification, then the regulation of the gene at 
the blastocyst stage would be an interesting issue. Unfortunately, the main obstacle 
in addressing such interesting questions further is the small size of the embryos at 
these stages and the limited amounts of available material. 
GATA-6 in lung development 
In addition to the described expression pattern of GATA-6 in the lung 
endoderm [23], an observation was published showing that GATA -6 mutant ES 
cells do not contribute to the pulmonary epithelium [5]. Consequently, GATA-6 
protein was considered as one of the first factors crucial for pulmonary endoderm 
specification [24-26]. We decided to further study the role of GATA-6 in the 
specification of the anterior foregut to lung endoderm by generating highly 
chimeric embryos with GATA-6 mutant ES cells. The prediction was that embryos 
ahnost exclusively derived from mutant ES cells would have no specified lung 
endoderm. To our surprise, highly chimeric embryos had lungs, which had 
undergone initial branching and lobe formation (chapter 3). The use of genetically 
marked blastocysts (ROSA26) clearly indicated that chimeric lungs at E12.5 had 
some endodermal buds in their lobes that were almost exclusively GATA-6 -/-. The 
implication of these findings is that foregut can be specified to lung endoderm in 
the absence of GATA-6. Although the signals for lung endoderm specification are 
not known yet [27], it seems that GATA-6 deficient cells are able to process them 
normally and even undergo initial lung morphogenesis and differentiation. But 
these findings are also in sharp contrast to the previous observation about exclusion 
of GATA-6 mutant cells from pulmonary epithelium [5]. In both studies the ES 
cells used were of the same genotype, namely GATA-6-/-, and therefore any 
resulting defect in gene regulation was common. Thus, the difference in the data 
can only be explained by the difference in procedure, in particular the number of 
the injected ES cells. In our experiments we used double or more, the number of 
ES cells that is normally injected since we were aiming for highly chimeric 
embryos. Although the number of injected ES cells was not mentioned in the other 
study [5], it is likely that normal numbers of ES cells were used, perhaps even less 
than normal. It is common practice that when a gene has an essential function and 
it is required early in embryogenesis, chimeras are initially generated with low 
numbers of ES cells to avoid any interference with normal development which may 
be seen in highly chimeric embryos. Assuming this difference in procedure, we 
envisage that if there are only a few GATA-6 mutant cells in the population of 
foregut cells that is destined to form lung any advantage of the wild type cells in 
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growth would result in the subsequent elimination of mutant cells from the lungs. 
However, a high percentage of mutant cells in the foregut would not allow such a 
stringent selection resulting in GATA-6 mutant endodermal buds. 
Another implication of our data is that there must be a substantial number 
of cells in the foregut that are specified as lung endoderm. If there were only few 
cells, the picture would have been black and white in the chimeric experiments and 
give either an exclusively mutant or an exclusively wild type lung. Instead, a 
variety of patterns were observed in the generated chimeric lungs. Some buds were 
exclusively blue (ROSA26-wild type blastocysts), others were completely white 
(GATA-6-1- ES cells) and others were a mixture of blue and white cells (chapter 3). 
The ability of GATA-6 mutant endoderm cells to undergo morphogenesis 
and differentiation is limited to the early stages of lung development. Subsequent 
to initial budding and lobe formation, endoderm consisting of GATA-6 mutant cells 
does not branch properly to generate a normal respiratory tree. The molecular 
mechanism underling this defect is not yet clear. In the current molecular model for 
branching morphogenesis, epithelial-mesenchymal interactions playa critical role. 
FGF signaling initiating in the mesenchyme and BMP-4, Shh and TTF-l (or 
Nkx2.1) activities in the epithelium seem to mediate these interactions (Figure 4) 
[28-30]. How does GATA-6 fit in this model? In cardiac induction, GATAs are 
downstream of BMPs [31, 32] and they act in concert with Nkx2.5 to promote 
cardiogenesis [33]. In zebrafish it was even suggested that both GATA and Nkx are 
induced by FGFs [6]. Although in vitro studies suggested that GATA-6 regulates 
TTF-J expression [34], the normal expression of the gene in the GATA-6 mutant 
endoderm supports the idea of a co-function as opposed to cross regulation 
(chapter 3). Unfortunately, BMP-4 mutant lungs are not available in order to 
investigate expression of GATA-6, but an option would be to use transgenic lungs 
for the BMP-4 antagonist Noggin [35]. If GATA-6 were induced in the epithelium 
directly by the FGF-IO from the mesenchyme the implication would be that 
GATA-6 protein has a role similar to BMP-4 during branching morphogenesis. 
Such a requirement for GATA-6 in the epithelium in order to respond to the 
proliferative and chemoattractant action of FGF-IO can be easily tested. Highly 
chimeric endoderm can be generated with GATA-6 mutant ES cells into ROSA26 
blastocysts. This endoderm can be used in the in vitro FGF-IO bead-based 
branching model [28] and the genotype of the endoderm that has branched 
successfully and surrounded the bead can be determined. If the FGF-IO inductive 
activity is mediated by GATA-6, any endoderm around the bead has to be blue 
(wild type). On the other hand if mutant endoderm responds normally to FGF-IO, 
then GATA-6 function in the epithelium is more likely to be independent of FGF 
signaling. The implication would be that GATA-6 is part of a completely different 
pathway that regulates branching morphogenesis. 
If the latter possibility holds true, two directions will be important to 
establish a GATA-6 based model for branching morphogenesis. First, the 
identification of target genes for GATA-6 protein in the lung endoderm is required. 
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This can be achieved by differential expression screening of blue and white 
endoderm from chimeric lungs. Second, a yeast two-hybrid screen with parts of the 
GATA-6 protein could be explored to identify other proteins from lung endoderm 
that may interact with GATA-6. One protein, FOG-2 has been found to interact 
with GATA-4 and --6 [36-38]. It appears to be expressed in the embryonic lung 
endoderm (M van Dooren, unpublished), suggesting a potential co-function with 
GATA-6 during lung development. Target genes and interacting proteins will also 
help to elucidate the mechanism by which GATA-6 controls distal differentiation. 
The connection with BMP-4 function in epithelial cell fate acquisition is another 
interesting aspect for investigation. According to the distal signaling center model, 
high BMP-4 expression induces distal fate while in its absence cells acquire 
proximal fate [35]. Since overexpression of GATA-6 results in a block in terminal 
distal differentiation (chapter 4), it appears that the two molecules actually 
antagonize each other. This in turn suggests that they function in concert to induce 
and fine tune epithelial differentiation. 
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Members of the GATA family of transcription factors control differentiation of 
distinct cell lineages by binding to GATA sites in the promoter of lineage specific 
genes. GATA-6 is the last member of this family and it is expressed during early 
heart and gut development. We studied the role of GATA-6 protein during 
embryogenesis by targeted gene inactivation in mouse Embryonic Stem (ES) cells. 
GATA-6 heterozygote mutant mice were generated and when intercrossed 
no homozygote mutant mice were born alive. The lack of the protein results in an 
early embryonic lethality just after implantation at embryonic day 55 (E55). 
Histological analysis of in vivo and in vitro developed null embryos suggested that 
the defect is in the visceral endoderm, which is a derivative of the primitive 
endoderm and give rise to the visceral endoderm of the yolk sac. Confirmation of 
this observation was obtained by generating chimeric embryos. In such embryos 
the genotype of the embryonic tissues and of the extraembryonic visceral 
endoderm was different, corresponding to the genotype of the injected ES cells and 
the host blastocyst, respectively. When GATA-6-/- ES cells were injected into wild 
type blastocysts, the resulting chimeric embryos had embryonic tissues mutant for 
GATA-6 and they survived to E9.5 appearing normaL In the converse experiment, 
when GATA-6 mutant blastocysts were injected with wild type ES cells, the GATA-
6 mutation was confined to the extaembryonic tissues, including the visceral 
endoderm. Such embryos did not survive later than E5.5, proving that the primary 
cause of lethality in the GATA-6 homozygote mutant embryos is the lack of the 
GATA-6 protein in an extraembryonic tissue. 
In chimeric embryos generated by GATA-6 mutant ES cells the rescued 
early lethality by the wild type extraembryonic tissues allowed the study of GAT A-
6 function in embryonic tissues expressing the gene. Puhnonary endoderm is a 
tissue in which GATA-6 is the only member of the GATA family to be expressed. 
Analysis of lungs from highly chimeric embryos revealed that GATA-6 mutant 
cells form lung endoderm, which subsequently shows branching defects and lack 
of epithelial differentiation. These defects lead to respiratory failure at birth. The 
importance of the GATA-6 protein levels for normal lung development is further 
demonstrated by the in vivo overexpression of GATA-6 under the control of the 
human Surfactant Protein-C promoter. Transgenic embryos have abnormally 
branched endoderm and although differentiation to proximal epithelium appears 
normal, terminal differentiation to distal epithelium is blocked. Both mature Type I 
(gas exchanging pneumocytes) and Type II (surfactant producing cells) cells are 
absent in the GATA-6 overexpressing lung epithelium. 
Thus, GATA-6 protein is first required early in embryogenesis (E5.5) for 
normal differentiation of the visceral endoderm, which gives rise to the yolk sac 
endoderm . Subsequently, the protein plays an important role during puhnonary 
branching morphogenesis and differentiation to distal epithelium. 

Samenvatting 
De GATA familie van transcriptie factoren regelen de differentiatie van 
verschillende celsoorten door middel van binding aan GATA sequenties in de 
promoter van weefsel specifieke genen. Het meest recent ontdekte lid van deze 
familie van genen, GATA-6, komt tot expressie in een vroeg stadium van de 
ontwikkeling van het hart en de darm. Wij hebben de rol van GATA-6 bestudeerd 
tijdens de embryogenese door een inaktivatie van het GATA-6 gen in Embryonale 
Starn (ES) cellen. 
Homozygote GATA6 muis mutanten worden niet geboren na kruising 
van heterozygote muizen. Het onbreken van het GATA-6 eiwit resulteert in een 
vroeg embryonale dood kort na implantatie op dag 5.5 (E5.5) van de 
ontwikkeling. De histologische analyse van in vivo en in vitro gegroeide GATA-6 
negative embryo's suggereert dat er een defect is in het viscerale endoderm, wat 
zelf ontwikkelt uit het primitieve endoderm. Een bevestiging van deze 
waarneming werd verkregen uit het maken van chimere embryo's. In zulke 
embryo's is het genotype van de embryonale weefsels en dat van het 
extraembryonale viscerale endoderm verschillend en komen respectieveiijk 
overeen met het genotype van de geinjecteerde ES cellen en dat van de 
ontvangende blastocyst. Wanneer GATA-6-/- ES cellen gemjecteerd worden in 
wild type blastocysten, is het resulterende embryonale weefsel mutant voor 
GATA-6, maar de embryo's overleven zeker tot E9.5 en zien er normaal uit. In de 
tegenovergestelde proef, wanneer GATA-6 -/- blastocysten worden gemjecteerd 
met wild type ES cellen is de GATA-6 mutatie beperkt tot de extra-embryonale 
weefseis, inclusief het viscerale endoderm. Zulke embryo's overleven niet later 
dan E5.5 en laten zien dat de primaire doodsoorzaak door de afwezigheid van 
GATA-6 in het vroege embryo gelegen moet zijn in een extra-embryonaal weefsel 
Het feit dat de GATA6-/- embryo's gered worden van een vroeg 
embryonale dood het wild type extraembryonale weefsel, maakte het mogelijk om 
de functie van GATA-6 te bestuderen in de weefsels van deze chimere embryo's'. 
Long endoderm is een weefsel waarin GATA-6 als enige van de familie van 
GATA factoren tot expressie komt. Analyse van de long van zeer chimere 
embryo's liet zien dat de GATA-6 -/- cellen long endoderm vormen, maar dat het 
daarna een longvertakkingsdefect heeft en dat de differentiatie van het epitheel 
afwezig is. Deze defecten lei den tot de dood na de geboorte door 
ademhalingsgebrek. Het belang van de juiste concentratie van GATA-6 voor een 
normale ontwikkeling van de longen werd ook nog aangetoond door GATA-6 tot 
overexpressie te brengen in vivo door het GATA-6 gen te plaatsen onder de 
controle van de promoter van het Surfactant Protein-C gen. Zulke transgene 
embryo's hebben een abnormaal vertakt endoderm. De differentiatie naar 
proximaal epitheel lijkt normaal, maar' de differentiatie naar distaal epitheel is 
geblokkeerd. Zowel volwassen Type I (gas uitwisselende pneumocyten) als Type 
II cellen (surfactant producerende cellen) zijn afwezig in het epitheel dat GATA-6 
tot overexpressie brengt. 
GATA-6 is dus eerst noodzakelijk in de vroege embryogenese (E5.5) voor 
de normale differentiatie van het viscerale endoderm waaruit het dooierzak 
endoderm gevormd wordt. Later speelt het eiwit een be1angrijke rol in het 
vertakkingproces van de longen en de differentiatie van het distale long epitheel. 
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